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SUMMARY
The peritoneal immune def ences of patients on 
continuous  a m b u l a t o r y  peritoneal di alysis (CAPD) were 
examined in order to de te rmine whether any defects exist 
which may ac cou nt  for the suscept ib ility to p erit on itis of 
some patients.
Overnight dwell peritoneal dialysis e f f luen t (PDE) was 
obtained from u ni nfected  CAPD patients and found to contain 
up to 10^ leucocytes per bag. The average differential 
cell count was 70% macrophages, 21% lymphocytes, 6% 
n e u t ro ph ils and 3% eosinophils. The numbe r of cells 
isolated decreas ed with time on CAPD, per haps due to 
thickening of the me mbr ane or trapping of cells by the 
formation of adhes io ns in the peritoneum.
The a b i li ty  of the peritoneal macr o p h a g e s  from CAPD 
patients to ingest and kill St aphylo co ccus epi dermi d 1s was 
examined. This organis m was chosen because it Is the major 
cause of per itoni ti s in CAPD patients. In most cases the 
macroph ag es were able to eff ici en tly p h a g o cytose  and kill 
op son ised S . e p i dermidi s in v i t r o . However when these cells 
were compared to normal controls they were found to be 
defec ti ve in their intra cellular killing ability. A l t hough  
no overall cor r e l a t i o n  was found betw een  the degree of 
p h agoc yt osis or int racellular killing and s u s c e p t i b i l i t y  of 
patients to peritonitis, cells from two patient s with a 
high incidence of peritoni tis did show a b n o r m a l l y  poor 
ingestion and/or killing. This suggests that in some 
patients defe ct ive phag ocyti c activit y may be a
X i X
con tribu ti ng factor in de termi ning su sc ep t i b i l i t y  to 
per i toni 1 1s .
The a b i lity  of peritoneal ma crophage s to produce 
and exp ress class II major h i s t o c o m p a t i b i l i t y  an ti ge n (HLA- 
DR) were examine d in order to provide info rma tion on the 
ac t i v a t i o n  or m a t u r a t i o n  state of cells from CAP D  patients. 
Both these paramet er s were decreas ed compa re d with normal 
controls. However, the degree of H^O^ release and HLA-D R 
e x p r e s s i o n  by the peritoneal macrop ha ges from CAP D patients 
was similar to that of blood monocytes. The se  results, in 
c o n j un ct ion with those of the bactericidal assays suggest 
that the cells isolated from the p e r i toneum  of CAPD 
patien ts are rela ti vely immature macr op hages and resemble 
blood monocytes. Peritoneal ma crophages from patients 
com me ncin g CAPD released more H^O^ and showed a greater 
pr oport io n of HL A-DR positive cells than those from 
patients e s t a bli sh ed on CAPD or normal control peritoneal 
macrophages, indicating that patients may have an initial 
infla mma tory response. This may possib ly be caused by the 
recent imp lant ation of the catheter.
The levels and act ivit ie s of the serum proteins  IgG, 
C3 and t ra nsferr in  (Tf) in the PDE were examin ed  as they 
are believ ed  to have important roles in defence. Levels of 
all these proteins in PDE were only 1-2% of those in serum, 
and when the levels were com pared with each other and with 
total protein levels signific ant c orrelat io ns were found in 
each case. The levels of these proteins in PDE were 
in dep endent of those in the c o rres po nding patients* sera, 
s ug ges tin g that entry of serum proteins into the peritoneal 
cavi ty does not involve a specific trans po rt process but
XX
depends on the p e r m e ability  of the peritoneal membrane. 
There was also an inverse c orre la tion be tw ee n the level of 
total protei n in PDE and length of time on C AP D which again 
implies that changes may occur in the p e r m e a b i l i t y  of the 
peritoneal membrane.
A po sit ive corr e l a t i o n  was found b e t we en  the 
ops on isin g cap ac it y of PDE and the IgG or C3 concentration, 
and there was an inverse c orrel at ion betw ee n the ops oni c 
ac tiv i t y  of PDE and freq uency of peritonitis. These 
results strongly  suggest that the levels of opsonin s in the 
pe ri tone um  are sub-optimal in CAPD patients.
The b a c t e r i o s t a t i c  ac ti vi ty of Tf in PDE was exa mined 
by me asurin g the i_n vitro growth of S. e pi de rmidis in cell- 
free PDE. More growth of the bacteria occ ur red in PDE than 
in sera or normal peritoneal fluid, and in PDE the growth 
rate c or re la ted inversely with the Tf concentration. 
Ad dit i o n  of extra Tf to the PDE reduced the growth of 
S.epidermi d i s , but had no effect when added to serum or 
normal peritoneal fluids. An inverse co rr e l a t i o n  was also 
found b e t we en  the degree of reduction in growth of 
S . e p i d er midis  on ad d i t i o n  of extra Tf and the original 
level of Tf in the PDE. Overall, these results indicate 
that the levels of Tf in PDE provide sub-optimal inhibition 
of e x t r a cel lu la r bacterial multiplication.
A longitudinal study was carried out on a group of 
CAPD patients who were exa mi ned for up to 9 months from the 
day of com m e n c e m e n t  of dialysis. These patient s showed a 
general de cli ne in the levels and acti v i t i e s  of the 
cellular and humoral defence mechanisms in the pe ritoneum 
with time on CAPD. The decline was p a r t i c u l a r l y  pro minent
XX i
In the first 4-6 months.
Overall, the findings indicate that the immune 
defences of the p erito ne um of patients on CAP D are sub- 
optimal. The peritoneal cavity of the C AP D patient can 
therefore be cons idered an immunoc om promise d site and this 
should be taken into account in the m a n a g e m e n t  of these 
patients.




The immune system of man is an ext re me ly 
complex ne twork  of mechanisms, which have been  devel oped in 
order to pr ovide many ways In which to defend our selves 
against p a t h ogen ic  micro-organisms. These include both 
innate mechanisms, ie those we are e s s e n t i a l l y  born with, 
and acqui re d defence mechanisms, which enable us to mount 
specific immune responses. As most infections enter the 
body via epithelial surfaces the exterior defences of the 
body are of importance. These include the skin coverin g 
the body surface, the lysozyme actio n of most secretions, 
the mucus and cilia of epithelial membra nes and the acidic 
pH of the stomach.
Among the innate defences, soluble factors of the 
blood, such as the co mp lemen t system and cellular factors, 
such as blood and tissue pha gocytes are very important. In 
addition, n o n - s p e c i f i c  inf lammation at the site of 
infection is an essential part of the host defence.
Ac qui re d immunity consists of an tibodie s secreted by 
d i f f e r en tiate d B-lymphocytes, and ce ll -m e d i a t e d  immunity by 
spe cif ic T-lymphocytes. These systems are activat ed  in 
response to an t i g e n i c  stimulation.
Often the innate defence mech an isms and acquired 
Immune systems interact together ag ainst invaders. 
An ti bodi es  pro duced by d i ff er entiate d B cells help 
phagocy tes  to rec ognise their targets and T cells produce 
lymphokines which  stimulate activat io n of phagocytes. Also 
m a c r o ph ages and other an tigen- p r e s e n t i n g  cells play an
Important part In the rec ogn it ion of fore ign bacterial 
antige ns by lymphocytes and their subsequ ent stimulation.
A d e l icate balance therefore exists, with all arms of 
the immune system being dependent  on each other for optimal 
activity. Any defect which may arise, in no matter what 
area, may sev erely comp romis e the system as a whole and 
leave a patien t prone to infection.
U 1  S flM TJJbm a^ AMBVLATOMY PHiTONlAL DiALYiH
Continu ou s Ambul atory Peritoneal Dialysis or 
CAPD represen ts a very eff ec ti ve form of renal dialysis for 
patients with ch roni c renal failure, which removes waste 
products (primarily urea and creatinine) from the blood by 
dif fu sion  thr ough the membran e of the peri toneum 
(Oreopoulos ejt a 1 , 1980; Pop ov ich et^ a 1 , 1978) .
Very simply, CAPD  is a portable internal dialysis  
technique, which uses the continuous presen ce  (24 hours a 
day, 7 days a week) of dialysis solution in the peritoneal 
cavity, except for periods of drainage and instilla tion of 
fresh sol ut io n 3-4 times per day. After each exchange, 
which occurs at 4-6 hour intervals or 84 0hour s overnight, the 
indwelling peritoneal catheter is capped, and the patient 
is free to part ic ipate in his usual daily activities. CAPD
the refore exch anges  the relatively long dialy si s sessions of
4-6 hours,
A 3 days per week in h a e m o d i a 1y s i s , for three or four 30-45 
minute interrupti ons of daily activities  eve ry day.
The peritoneal membr an e which lines the abdominal 
cavity and par tic ip ates in the diffus io n of water and 
solutes during CAPD is composed, in the normal undi al ysed 
patient, of a compact surface layer of mésothélial cells 
with p ro tr uding nuclei and numerous micr ovilli (Di Paolo 
et a 1,1966). This layer also has a ne two rk of capillary 
and lymphatic vessels. After pro longed CAPD, however, a 
reduction and su bs equ ent d isapp ea rance of microvilli Is 
seen, along with widening  of interc ellul ar Junctions.
Popov i c h  e ^  aj_ (1978) showed that CAPD can provide
a cc ep table or even better control of serum che mi stry than 
other dialysis techniques, with resultant improvement in 
the pa tient health. Being continuous, CAPD patients have
steady state chemistries, prevent ing  the sympto ms and
problems a s s o ci at ed with rapid flu ct uations  in serum 
c he mi stry and body fluid volumes that occur with 
haemod i a 1 y s i s (Popovich ej^ a 1 , 1976 ) eg minimal
ca r d i o vas cu lar stress.
CAPD is pa rti c u l a r l y  suited to diabetics, as excel lent 
control of blood sugar is achieved by I n t r a p e r i t o n e a 1 
insulin, and it also has a favourable effect on the 
d e t e r i o r a t i o n  of retin opa thy (Amair e_t a 1 , 1982 ). Pop ovich  
et a 1 (1978) noted, however, that removal of small
mo lecules (urea) with CAPD is only 60% as efficien t as with 
h a e m o d i a 1y s i s . Removal of larger molecules, the so called 
middle molec ul es  (MW 800-2000) with CAPD is, however, much 
more ef ficient compar ed with haemodia 1ysis (Bergstrom 
et aj_, 1979; Po po vich e ^  a I , 1978 ) .
CAPD, in spite of its many advantages, has been
o v e r s hado we d by a number of complications, the two most
important of which are a high Incidence of peritoni tis 
(infection of the peritoneum), and a high rate of protein 
loss (10-20 g/day), par ticula rl y during peritonitis 
(Krediet e;t a 1 , 1986 ; Rubin e ^  a 1 , 1981 ; Po p o v i c h  et a 1 , 
1978). Rubin ejt aj_ (1981) suggested that the increased
pro tei n loss may be due to altera tions in peritoneal blood
flow, which may affect membra ne surface area or 
permeability. The problem of excessive pr otei n loss can, 
however, be c ompens at ed  by the ingestion of a high protein 
diet.
P e r i to ni tis is still the major drawback  of CAPD. 
About 70% of infections are caused by Gra m  positive
organisms, such as S t a p h y 1ococcus e p i d e r m i d i s ,
S t a p h y 1oCOecus a u r e u s , and streptococci whereas Gram
neg ati ve organ ism s acco unt  for about 15% of cases. The 
rema ini ng peri to nitis episodes are due to other organisms, 
including fungi (Smith e_^ aj_,1986). If the infection is 
not a d e q u a t e l y  treated sufficient adh esio ns  may occur to 
o b l i terat e the peritoneal cavity, p a r t i c u l a r l y  if the 
organi sm is a fungus or a yeast ( C o le s, 1985). Infection 
of the p erit on eum may result from poor technique during 
bag changes and c o ntamin at ion with skin flora (Smith 
et a_l_, 1986 ; Vas, 1981) and the fact that coag ulase negative 
staphylococci, which are common skin commensals, are 
re sp onsi bl e for most infections, supports this conclusion. 
Nevertheless, some patients are unu su ally sus ce ptible to 
p eri tonitis  (Tsakiris e_t aj_,1986; V a s , 1981), and this 
suggests that impairment of host defence me ch anism s may be 
involved. Although  the mechanism s of this increased
su scep t i b i l i t y  are not clear, deficienc ie s in various
cellular immune functions have been implicated (Alobaidi 
et aj_, 1986; Tsakiri s e_^ aj_, 1986; G o l dste in  ej^ a 1 , 1964) , as 
well as inadequate levels of serum proteins (Keane 
e t a 1,1984 ; Verb rugh e t a 1,1983). It remains to be 
de termined  whether CAPD  induces defects in the normal host 
defences of the abdominal cavity and whether these changes 
are important in the pat hoge nesis of per it onitis and it is 
this aspect with which the work reported in this thesis is 
c o n c e r n e d .
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As mentioned above staphylococci, major commensals of 
man have consiste ntly proved the common est cause of 
peritonitis in CAPD patients (about 40% due to 5.
epi dermidis and 20% to S_^ aureus ) . All staphylococci are 
Gram positive cocci that produce catalase which can be s u b ­
divided by their capaci ty to produce or not produce the 
enzyme coagulase which clots rabbit plasma. aureus are
coagulase positive whereas S_^ epi derm i d i s are coa gulase 
negative. S_^ aureus can also be dis tingui sh ed from S . 
epidermidis by the presence of protein A which binds to the 
Fc portion of immunoglobulins, and by its ability to 
produce a large variety of toxins, haemolysins and 
leucocidins which play a major role in its pat hogen ic ity 
(Gemme 1 1, 1984).
S . epi derm i d i s , often pre vi ou sly dis missed as culture 
contaminants, are assumi ng greater importance as true 
pathogens. There is now c onside ra ble evid ence to show that 
coa gul ase-neg ative s t a p h y 1ococci are the major cause of 
Infections of prosthet ic  devices and i n t r a - v a s c u 1ar 
catheters (Archer, 1985). Virt ua lly ail of the S .
epi dermidis infections are hos pital-acquired, and multip ly  
an ti biotic resistant which pro bably reflects the selection 
pressure of widespread a n t i biot ic  use in the hospital. 
Va nc omycin is one of the few anti bi otics eff ective agai nst 
these organisms (Bailie a 1 , 1987). Co lo n i s a t i o n  of
patients and hospital staff with an ti b i o t i c  res ibtant S . 
epidermidis precedes infection with these organisms. S . 
epiderm id i s is also the most common cause of b a c t eremi a 
among patients receiving i m m unosup pr essive therapy.
Its pathog enicity may be related to its ab ility to
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adhere to and grow on polymer surfaces such as catheters 
and by the production of an extra-cellular slime substance 
(Gray e_t_ a 1 , 1904). This slime inhibits the proliferative
responses of 1y m p h o c y tes and possibly opsonisation of 
bacter ia.
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Pro te ct ion of the peritoneum  from microbial pathogens 
is bel ie ved to depend on three mechanisms. The first is a 
simple removal m e c h a n i s m  by which the i n t r a p e r i t o n e a 1 
c i r c ul at ion of fluid carries particles to the diaphram, and 
hence via the lymphatics to the tho ra cic duct and 
e ve n t u a l l y  to the blood stream (Dunn e_t a 1, 1985 ; Hau 
et a 1,1979). Ba cteria  can be d emon st rated in the lymphatics 
within minu tes after their inoculation into the periton eum 
(Dunn ej^ a 1 , 1985 ; Hau e_^ a 1 , 1979 ) . Of Interest here is the 
finding that b a c t erem ia  is ^uncommon in peri to nitis  
ass oc ia ted with CAPD (Duwe e ^  a 1.1981 ; V a s , 1981). This 
co ntras te d with an incidence of over 30% in surg ically 
induced perito ni tis (Vas,1981). A l t ho ug h this may be 
related to mi crobiologica l differences, it is possible 
that peritoneal dia lys is may interfere with the normal 
mech an isms of lymphatic a b s o rption and e l i m i n a t i o n  of 
bacteria by impeding the passage of pat ho gens into the 
systemic circulation. Such a defect in normal lymphatic 
function was sug gested by Duwe e ^  aj_ (1981) to result from 
mechanical factors a ssociat ed  with the instilla tion of 
large volumes of fluid into the abdominal cavity. It is 
not known what co nt r i b u t i o n  altered lymphatic functio n 
makes to the dev elopm en t of perit onitis in CAPD.
Secondly, pr otectio n depends on a killing mec ha ni sm in 
which host phagocytes, about 80% of wh ic h are nor ma lly 
ma c r o ph ages (Alobaidi e_t ^ , 1 9 8 6 ;  V e r brugh et^ a 1, 1983) act 
as effector cells (Dunn ej^aJ_, 1985; Ve r b r u g h  et al, 1983). 
Although macrophages, lymphocytes and p o l y m o r phonu cl ear 
leucocytes are found within the peritoneal cavity, the 
p re do minanc e of macr ophage s at the start of the bacterial 
infection led to the c on cl usion that these cells represent
the first line of host def ence in the e l i m i n a t i o n  of 
bacteria during the initial stages of infect ion (Dunn 
et a 1,1985). They are largely replaced by
polymor p h o n u c l e a r  n eu tr ophils  as the pre domin an t phagocy tic 
cell during episodes of perit oniti s (Rubin et a 1,1980 ; 
Hurley e_t a 1 , 1977) .
The final mechan is m involved is s e q u e s t r a t i o n  due to 
fibrin for mati on  which leads to direct trapping of m i c r o ­
organisms as well as to the formation of adhesi on s betwee n 
surfaces, both of whi ch ph ys icall y isolate invading m i c r o ­
organisms (Dunn and Simmons, 1982; Hau et aU[_, 1979). Hau and 
Simmons (1978) also found, however, that this may impair 
bacterial cl ear ance from the peritoneum, the reby pro moting 
the d e v e l opment  of clinical peritonitis. The pr ot ectiv e 
role of fibrin is there fore controversial. Interference of 
phag oc ytic function app ears to account for the defect, 
underlini ng  the importance of these cells in protectin g the 
p er it oneum from infection.
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The mono nuc lear pha gocytes ari se pri ma rily  
from a p opulat io n of pha go cy tic cells that or iginate  in the 
bone mar row (promonocytes), are then tran sporte d by the 
blood stream as immature mon ocytes and finally migrate into 
the various tissues of the body where they d if ferent ia te 
into functional resident tissue m a c r oph ag es (van Furth 
et a 1,1979 ; van Furth and C o h e n , 1968).
The or igin and kinetics of these cells have been 
investigated in several animal species (most exte n s i v e l y  in 
the mouse). In man the study of mon onucl ea r ph ag ocy tes has 
been much more limited and has mainly concer ne d blood 
monocytes. It is highly probable, however, that the 
mo no nucl ea r pha gocyte system identified in animal studies 
is also app l i c a b l e  to man.
M ac ro phages  are e xtensi ve ly found thr oug hout the body 
including the peritoneal, alveolar and pleural spaces, 
where they are gen erally free to move around, and In less 
motile, fixed forms in the spleen, liver and lamina propria 
of the gastrointesti nal tract (van F u r t h , 1980).
The m a c r o ph ag es that occur under normal physiological 
conditi ons  are called resident ma crophages  and are distinct 
from those that appear with inflammatory stimu lation 
(exudate macrophages). Whereas the m o n o cytic  origin of the 
ex udate m a c r op hage is generally accepted (Daems,1980; van 
F u r t h , 1980; van Fur th and C o h e n , 1968), the origin of the 
resident m acr op hages is still disputed.
1.2.1. atllln al R##ld#nt Maorophag»,
A c c or ding to van Furth (1980), all macrophages, both 
under steady state (resident) and inf lamm atory conditions  
(exudate) are assumed to derive from blood mo nocytes  and 
any ph e n o t y p i c  dif feren ce s noted among ma cr o p h a g e s  are 
us ua lly att r i b u t e d  to diffe rences in their maturational 
state or local adap t a t i o n  to the e n v i r onme nt  (Kaplan and 
G a u d e r n a c k , 1982 ; Bar-Eli e ^  a 1 , 1981 ; Simon e_^ a 1 « 1977 ). 
This was con fi rmed by Parw ar esch ej^ aj_ (1981), using 
esterase isoenzyme patterns when they showed that prolonged 
cu ltu ring of blood monoc ytes results in a gradual 
transition of their pat tern to that of resident 
m a c r o p h a g e s .
However altho ug h kinetic studies support the view that 
resident m ac ropha ge s are monocy te derived (van Furth and 
C o h n , 1968) doubts have still remained (Daems and De 
Bak ker,19B2; D a e m s , 1980; Vo 1k m a n , 1976) mai n l y  because of 
the dif fer en ces in per ox id atic act iv ity be tw een blood 
mon oc yt es and resident macrophages. A so lution  to this 
pr oblem was explained, however, by Beelen  and Fl uitsma  
(1982), when they clea rly  showed both k i n e tica ll y and 
c y t o c h e m i c a 11 y that resident macrophage s are recruited 
from blood mono cytes via the transitional stage of exudate- 
resident macrophages. This does not, of course, exclude the 
p o s s ib il ity that very o ccasi on ally a residen t mac rop hage 
may be capable of division. The opposing view was that 
there are two func ti onally divergent types of mac ropha ge s  
i.e. resident m ac ro phages and monocytes derived macr op hages 
that differ in origin (Daems and De Bakker,1982; 
D a e m s , 1980; Vo 1 k m a n , 1976). Daems and De Bakker (1982)
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su gge sted that peritoneal resident m a c r o p h a g e s  are derived 
from locally p ro li ferati ng  cells which themsel ves arise 
from specifi c stem cells in the bone marrow, diffe ring from 
the stem cells of the m o n o c y t e / g r a n u l o c y t e  series.
The origin of the resident m a c r o p h a g e s  is still 
ther efo re controversial and not resolved conclusively.
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The cells of the mononuc lear phagocyte system 
are Involved in many areas, including de fe nc e against micro 
organisms, and in scav enging dead or da maged cells or
debris. They are also important as secretors of
b i o l o g i c a l l y  activ e compounds, and play an important role 
in the reg ulat io n of h a e m a t o p o i e s is and iron metabolism. 
Ma cr opha ge s possess a number of cell surface receptors and 
ant ige ns whi ch are involved in a variety of functions-
D * ( # n o #  A i a l n t t  M l e r e - o r tn n l i ii n
1.3.1.1. M ac ro ph ages as Pha goc yt ic Cells
E ng u l f m e n t  and killing of mic r o - o r g a n i s m s  is an
essential step as sumed  by macrop hages in the defence
against infection. Pha gocyt os is can be di vided into three 
stages: attachment, ingestion, and ki lling of micro-
o r g a n i s m s .
A tt a c h m e n t  and ing estion can be medi at ed through Fc
and com pleme nt  receptors or by the n o n - s p e c i f i c  binding of 
part icl es to glyco proteins on the m a c r o p h a g e  membrane,
wh ich  bind to c a r b oh yd rate const it ue nts of the bacterial
cell walls or cell membranes. These m echan is ms are
di scu ss ed in detail in section 1.3.4.
On ing estion of the molecu le or particle  the phagosome 
n or ma lly fuses with lysosomes in the cell forming a 
phagolysosome. Lysosomes  are m e m b r a n e - b o u n d  vesicles
co nt aini ng  a var iety of enzymes that are capable of 
de gra di ng ingested debris (Jacques and B a i n t o n , 1978).
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Most m i c r o - o r g a n i s m s  are destroyed  w i thin a few minutes, 
and wi th in  2 hours exte ns ive d e g r adatio n may occur. Oxygen 
in ter mediate s (0^ , HgO^, OH*) appear to be r e s p o nsibl e for 
the initial killing of mic r o - o r g a n i s m s  (see section 
1. 3.6.6) .
The c o n s e q u e n c e s  of phagocyto si s are dif fe rent for 
int rac ellu la r and e x t r a c el lular parasites. For the
e x t r a cell ul ar parasite, une quipp ed  for int rac ellular 
survival, p h a g oc ytosis represents the end. The oppos ite 
is the case with intracellula r parasites, as their def ence 
m ec ha nisms tend to be related to their a b i l i t y  to resist 
host microb icidal properties. For many e x tracell ul ar 
b a c t e r i a  e f f e ct ive a n t i p h a g o c y t i c  devices have evolved 
(reviewed by Horwitz, 1982), the most imp ortant of whi ch is 
the a n t i p h a g o c y t i c  capsule. Other a n t i p h a g o c y t i c
d et er minant s are the M protei n cell surface an ti gen  of 
group A streptococci, pi 1i and the pro te in A of S .aureus 
which is known to bind the Fc region of Imm unoglo bu lin G 
(IgG) from various species. Other ways for the bacteri a to 
avoid p h a g o cy to sis is to kill the p h a g ocyte  itself by 
produ cin g s ub stances  that are highly toxic to leucocytes eg 
st rep t o l y s i n s  0 and S, and streptococcal 8 - h a e m o 1y s i n s .
1.3.1.2. M a c r o ph ag es as Cy to toxic Cells
Ma cr o p h a g e s  can kill neo plas ti c cells by non- 
ph ag o c y t i c  mechanisms. When a p p r o p r i a t e l y  act ivate d
macroph ag es s e l e ctive ly  and effici en tly lyse n e o p lastic 
cells in a contac t-depende nt, n o n - p h a g o c y t i c  process 
req uiring several days termed mac rop ha ge m e d iate d tumour 
c y t o t o x i c i t y  (Adams and N a t h a n , 1983), M a c r o p h a g e s  can also
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bind and lyse a n t i b o d y - c o a t e d  target cells via Fc 
receptors. This is known as a n t i b o d y  de pendent
cellular c y t o t o x i c i t y  (ADCC) and was d e m o n st rated by 
C o n kl in g e ^  aj_ (1982) in human peripheral blo od monocyte s 
and alveolar macrophages. The abil ity of ma cr o p h a g e s  to 
des troy tumour cells in a no n-s p e c i f i c  way makes It 
possibl e to env is ag e a role for ma cr o p h a g e s  in
immunological s ur ve illanc e of tumours (Fe rna ndez- Cruz
et a 1,1985 >.
1 3 . 2 .  R e m o v a l  5 1 6  f i M  D a m a g e d  C e l l e  u u L  D e b r i e
Changes in e rythro cy te surface membran es  caused by 
im mu no globul in  (1 g ) coating, physical or chemical injury,
surface ca rb o h y d r a t e  alte ra tions or aging results in 
e r y t h r o p h a g o c y t o s i s  by the mono nuclear phagoc yt e system 
(Maruta and M i z u n o ,1971) as well as clearing  of normal 
debris. T h r ough this a b i lity to catabol ise  red blood cells, 
the mono nu clear phagocytes also play an important role in 
iron metabolism. The major part of the iron derived from 
degra ded  h aemoglo bi n is released to the pl asm a and bound by 
T ra n s f e r r i n  (Tf) which carries it to the bone ma rro w for 
e r y t h ropo ie sis (B r o c k , 1985). However in a variety of
condition s such as acute and chronic infections and chr onic 
infla mma tory diseases a type of mild an ae mia occurs, which 
seems to be due at least in part to an impaired release of 
iron from the p hagoc yt ic monon uclear cells of the 
reticulo endothe li al system (R o e s e r ,1980).
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The formati on  of gr anulocy te and mon o c y t e  colonies in 
culture is dependent on substances with specif ic  colony 
stimulat ing ac t i v i t y  ( M e t c a l f , 1982; Golde and CLine,1972). 
Control of marrow stem cell p ro lifera ti on may depend on 
pr od uc tion of p r os ta glandin s (PG) by ma cr o p h a g e s  which 
limits stem cell proliferation, and is pro du ced in response 
to raised levels of colony stimulatin g ac t i v i t y  (Kurland 
et a 1,1976). M ac rophage s therefore control the
p r o l i f e r a t i o n  of their own and other progeni tor cells 
through both positiv e and neg ati ve feedback systems.
1,3,4, Mmoroehmge C#11 Surfmo# R#o#Ptor#
Optimal pha gocy to sis of opsonin- co ated mi cr o- o r g a n i s m s  
and part ic les is me diated mainly by receptors for either 
the I g Fc domain or low mol ecular weight fragments of the 
com pl emen t compone nt C3 (Newman e_^ a 1 , 1965 ; S i l v e rstei n and 
Loike,1980). This response is highly specific and
localised, each step of pha gosome forma ti on and fusion 
being dir ected  by sequential engagement of opsonin and 
receptor, a process termed the "zipper hypothesis " of 
p h a g oc yt osis (reviewed by Silv erstei n and Loike,19B0).
Me mbr a n e  receptors provide the essential reco gn ition 
fu nct ion required for control of m ac rophage  responses to 
changes in their cellular environment. Passwell e ^  a_l_
(1980) also showed that the binding of Fc fragments to Fc 
receptors on human cells induced selective se cre tio n of 
some protei ns but at the same time decreases the synthesis 
and sec re ti on of others.
In ad d i t i o n  to receptors for I g and c o m p lement the
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ma cr opha ge  surface bears receptors for a variety of 
hormones, including insulin (McKeever and Spicer, 1980) and 
other protei ns such as fibronec tin (Wright and M e y e r , 1985) 
and lactoferrin (van Snick and M a s s o n , 1976).
Ma c r o p h a g e  plasma membran es also show lectin-like 
re ceptors for carb o h y d r a t e  which may play a crucial role in 
r ecogn it io n and en docytosi s of glycopro te ins and m i c r o ­
or ganisms (Haeffner-Cavai 1 1 on ej^ a 1 , 1982; Glass e_^ a 1 , 1981 ; 
W e i r , 1980; Weir and ô g m u n d s d ô t t i r ,1977).
Re ce ptor s for co lony stim ul ating factor have also been 
found on ma croph ag es (Guilbert and S t a n l e y , 1980). This 
receptor through the binding of colony s ti mulati ng  factor 
not only initiates proliferation, but induces morphological 
changes such as spreading in mature m a c r op hages and 
d i f f e r e n t i a t i o n  along the m o n o c y t e - m a c r o p h a g e  lineage in 
immature myeloi d stem cells (M etcalf, 1982).
1.3.4.1. Recep to rs  for 1m m u n o g 1o b u 1 ins
M a c r op ha ges express distinct plasma mem br ane receptors 
for dif fe re nt isotypes of I g . Newman e_t (1985) showed
that human peritoneal ma crophages po sse sse d receptors for
the Fc port ion of IgG, while Melewicz e_^ aj_ (1982)
detecte d Fc receptors for IgE on human peripheral blood 
lymphocytes and monocytes. Receptors for the Fc portion
of IgA have also been found on human monoc yt es and
p o l ym orpho nu cl ear leucocytes, which may be involved in 
de fence of the mucosal surfaces (Fanger e ^  a 1,I960) and 
evi de nce for the pre sence of specific IgM re ceptors on 
ma croph ag es  was provided by Uher e_^ aj_ (1981).
Green ej^ (1985) showed that Fc rec eptors are
16
pro ba bly t r a n s memb ra ne glycoproteins, which are synthesis ed  
in the rough e n d o pl asmic reticulum and transported 
i n t r a c ellular ly  to the plasma membrane. Binding of I g to 
its receptors can modulate cell behav iour dramatically. 
For example, cross linking of the IgE receptor s triggers 
explosive d e g r a n u l a t i o n  of mast cells and basophils,
releasing preformed  mediato rs  with Important physiological 
c on se quence s (Metzger ej^ a 1♦1986 ; M e t z g e r , 1983). IgE
receptors can also me di ate  the end ocyto si s of small IgE 
complexes (Isersky et a 1,1983) and human monocyt es lyse
IgE-coated e r y t h ro cytes (Melewicz e_^ a I , 1961 ) , and
parasites i_n vitro (Joseph et a 1 , 1976) .
Apart from the well known a tt achmen t and
in t ern al isation  of ligand-bound particles (Silverstein and 
Loike,1980), interaction of macr ophage IgG-Fc receptors
with immune comp lexes or opsonised  parti cles also leads to 
se con dary events including a n t i b o d y - m e d i a t e d  cytol ysis of 
target cells (Conkling eJL aj_, 1982), the release of 
inflammato ry  agents (Humes e ^  a_l_, 1980), as well as neutral 
proteases (Ragsdale and Arend,1979). On lymphocytes, Fc 
receptors appear to be involved less in e n d o cyt ic  and 
c yt otoxic functions than in mod ulati ng a n t i b o d y  pro duct io n 
( Nea upor t-Sautes e_t a 1 , 1979 ).
Human leucocytes express at least two di fferent Fc 
receptors spe cific for IgG; a low av id ity  receptor which is 
found on tissue macrop ha ges and n e u t ro phils and a high 
avidity  Fc receptor found on blood monocytes and 
macrophag es (Kurlander et a 1,1984). The low avidity
receptor is believed, from the work of Un kele ss  (1988), to 
be p r i m arily  for immune complex clearance  i_n v i v o . The
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high a v i dity  receptor, in contrast, may be Involved in the 
transport  of immuno globul in s .
Ligand  binding can mo dul ate the plas ma membra ne 
e xp re ssion of Fc receptors in macr op hages by al tering the 
recepto r's  pa thw ay of intracellular trans port during 
endocytosis. Uptake of mu lt ivalent 1 g immune complexes 
leads to a large irrev ersible loss of surf ace Fc receptors 
due to their del iv ery to and d eg radati on  in the lysosomes 
(Mellman and P I u tner , 1984 ; Mellma n ej^ a^^l983). Recep tor s 
tagged with a m o n o valent ligand are also internal ised but 
avoid trans port to lysosomes by rapidly re cycling to the 
cell surface (Mellman e_t a 1 , 1984 ) . These findings suggest 
that cr o s s - l i n k i n g  of adja cent Fc receptors to m u l t i valent  
ligands may prevent rec ycling and pro vide the signal for 
transport to lysosomes. Interferon (IFN) was also found to 
alter the number of Fc receptors (Ezekowitz and 
G o r d o n , 1986; Rhodes e ^  a 1,1963; Vogel e ^  a 1,1983), and 
these factors may therefore play an important role in the 
activ i t y  of phagocytes.
1.3.4.2. Rec ep to rs for Comp 1ement
Human blood mon oc yt es and macrop hages have at least 
two dis tin ct membra ne receptors - CRl and CR3, that 
rec ognise pr imari ly  the C3b and iC3b fragments of C3 
r e s p e ct ively (Newman ej^ aj_, 1985; Ross and L a m b r i s , 1982). 
In ad d i t i o n  studies have suggested that under certain 
con dit ions mo nocyte s may also express a CR2 receptor that 
is specif ic  for the d region of iC3b (Inada ejt a 1 , 1983 ) .
CRl, whi ch binds C3b, is poorly ex pr essed on resting, 
c ir cu lating  p h a g oc ytic cells, but rapid "up regulation " is
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seen with a variety of stimuli such as lymphokines (Joiner 
et a 1,1984). This m e c ha nism for increasing the exp re ssion 
of CRl could prepare c h e m o t a c t i c a 11 y m i g rati ng  cells for 
r e c o gn it ion of material that has been op s o n i s e d  with C3b. 
The mo lecule  binds part icles coated wit h C3b to the 
p ha go cyte surface. The second C3 receptor, CR3, has a 
higher a f f in it y for C3bi, a cleavage product of C3b, than 
for C3b. Recent  studies showing that ch il dren deficient in 
the e x p r e s s i o n  of CR3 are highly sus cept ib le to bacterial 
infections (Dana e_t a 1 , 1984 ; Ross and Newman, 1980) 
repre sen t the best evidence  that this receptor is important 
in phagocytosis.
Fc receptors are able to move freely within the plasma 
me mbr an e and are thought to function ind epe ndent ly  of 
re ceptors for comp lement (Michl et a 1,1979 ; Griffin 
et a 1, 1975). In contrast, studies by Ka plan  e ^  aj_ (1978) 
indicate that unlike Fc receptors, the c omple me nt receptors 
on m a c r op ha ges nor ma lly occup y a rel at iv ely fixed mem br ane 
distribution. This may be important as work by Gr iffi n and 
Mullinax (1981) and Ka pla n e ^  aj_ (1978) su gge sted that for 
a receptor to promote par ticle ingestion it must be able to 
move wi thin the plane of the plasma membrane.
E hl en berger  and Nu ssenzweig (1977), and Mantovani 
et a 1 (1972) sugge sted that C3 and IgG may have separate
roles in phagocytosis. IgG, through its Fc fragment, 
directly stimula tes particle Ingestion, but is relativel y 
inefficient at inducing particle binding. On the other 
hand C3 pr imaril y media tes the binding of the particle via 
comp lemen t receptors. A marked synergy exists bewee n C3 
and IgG in inducing phagocytosis. Dependi ng  on the
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experimental conditions, the presence of partic l e - b o u n d  C3 
can reduce by 100 fold the amount of IgG required to 
produce pa rti cle interna lis ation  (Ehlenberger and 
N u s s e n z w e i g , 1977). This suggests that the role of C3 in 
op s o n i s a t i o n  is ma in l y  one of est abl is hing contact betw een 
particle and phagocyte.
Another important finding is that al t h o u g h  the 
quantity of ingestion mediated by the Fc receptors is 
greater in activat ed  than in n o n a c tiva te d macrophages, 
virtual ly  all Fc receptors of both resident, eli cited  and 
activated  m ac ro phages  me di ate att achm en t and ingestion 
(Bianco ejt a 1 , 1975 ) . With com ple ment rec ep tors there is, 
however, a q u a l i ta ti ve diff erence in functi on  in activate d 
and n o n a c ti vated m acro ph ages i.e. res ident peritoneal 
m ac ro phages  bind C 3 b - co at ed particles via the c o rr es pondin g 
receptor, but do not ingest them, wher eas  eli cited and 
a ct ivated m acr op hages can both bind and ingest such 
particles. Ph ago c y t o s i s  of comp 1eme n t - o p s o n i s e d  particles 
therefore occurs among activated  po pulations  of mac ro ph ages 
(Griffin and M u l l i n a x , 1985,1981; Bianco e ^  a 1,1975) and
may therefo re be a marker for mac r o p h a g e  a c t i vat io n 
( E d e I s o n , 1981). The ab ility of human peritoneal ma cr ophage 
CRl and CR3 receptors to mediate p ha go cytosi s was also
shown to be ma t u r a t i o n  dependent (Newman e_t a I , 1985 ) .
Furthermore, in human ma cr ophages intera ction with 
f ibron ec ti n causes receptors for 03 to av idl y promote 
pha go cy tosis in the abs enc e of IgG (Wright and M e y e r , 1985). 
The a c t i v a t i o n  of com plem en t receptors by fibron ect in 
occurs rapidly, is co mplete ly  rev ers ible and is not
a c c o m pa nied by a change in the number of C3b or C3bi
2 0
rec eptors (Wright e_t ^ , 1 9 8 4 ) .  C3 receptors on ph ag ocy tic 
cells may the re fo re exist in two states, one that leads to 
a t t a ch me nt wi thout p h a g o c y t o s i s  and a second one that, like 
the lgG“Fc receptor, mediates ingestion as well as 
at t a c h m e n t  (Bianco ejt a 1 , 1975 ) .
1.3.6. H L A - D R  E x p r # # # i o n
M a c r op ha ges play an important role as a c c e s s o r y  cells 
in the init iation and regu lation of spe ci fic immune 
re sponses by pr esenting an tig en  to T cells (reviewed by 
U nan ue e_t aj_, 1984 and U n a n u e , 1981 ) . The membran e
g ly co protei ns  that appear to be crit ically  involved in this 
ant igen p r e s e n t a t i o n  are the I-reg io n-assoc ia ted antigens 
in rodents (Schwartz e_^ aj_, 1978) which are e q u i valent to 
the h u m a n - l e u c o c y t e  antigens  (HLA-DR) in man. These 
mo le cu les are gly coprot ei ns con sisting of two n o n c o v a 1 e n 1 1 y 
linked p o l y p e p t i d e  chains of 3 4 0 0 0 -36000  dal tons (alpha 
chain) and 2 4 0 0 0 - 2 8 0 0 0  dal tons (beta chain; reviewed by 
Accolla e ^  aj_, 1984 and Lafuse and David 1984) which are 
rec ogn ised by the T cell receptor (reviewed by K ro ne nberg  
et s^, 1986 and Ha sk ins  ej^ a 1 , 1984 ) on helper T cells in 
co nj u n c t i o n  with the antigen. Ziegler and Unanue (1981) 
provided direct evi de nce that a m a c r o p h a g e - a n t i g e n  
process in g event is essential to T cell reco g n i t i o n  of the 
antigen. Du rin g this process the an t i g e n  is pa rtially  
ca tabol is ed by the m a c r o p h a g e  and then p r e s ented with the 
la to the T cell receptor leading to subsequ ent 
p r o l i f e r a t i o n  of a n t i g e n - s p e c i f i c  T cells. The levels of 
la pos it ive macro ph ages can be m a r k e d l y  increased in 
response to local immunological stimulation, indicating
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that this p o p u la ti on is sensitive to environmental 
regulatio n (Seller ejt a 1 , 1980 ) . This a m p l i f i c a t i o n  of the
la po sitive m acrop ha ges in rodents and man is regulated by 
lymphokines produc ed by ac tiv ated T cells (Stastny and 
N u n e z , 1984; Seller and Ho, 1982; Scher e_t a 1 , 1962 ; Steeg 
et a 1 , 1962 ) now known to be gamma IFN (Gershon ej^ a 1 , 1985 ; 
Szte in e ^  a 1,1964 ; Basham and M e r i g a n , 1983 ; Steeg 
et a 1,1982).
Data from Calamai e ^  aj_ (1982), Bel 1er and Unanue
(1981), and S t e inma n e_t^  aj_ (1980), indicate that there is 
an i n t e r c on version  of la positive  and la negativ e 
phenotype, and the presence or abs ence of la does not 
de mar cate a stable subset of macrophages. Calamai e_^ aj_
(1982), for example, showed that all macr o p h a g e  precursors 
generated macr op hages with the potential to express la, as 
100% of colonies cont ain ed la positi ve  cells after 
st imula ti on  by T-cell lymphokine. This sugges ts that there 
are not separate  and divergent lineages of la positive and 
la ne gati ve  macr ophag es  but, as found by Scher ejt aj_ 
(1982), la positive and la negative ma cr o p h a g e s  derive from 
a po te n t i a l l y  commo n la negative stem cell.
Stu dies of HL A-DR ant igen e x p r ess io n on ma cr ophages 
and m a c r o p h a g e  pre cur sors (monocytes) in man have been 
less ext en si ve than those in mice and som et imes di vergent 
or con f l i c t i n g  results have been reported. Ac cording  to 
Ng ej^ aj_ (1982) and Alb r e c h t s e n  (1977) only a s u bp op ulation  
of m o n o c y t e / m a c r o p h a g e s  in man express HLA-DR. Others 
(Smith and A u l t , 1981; Raff ej^ a 1,1980) have concluded  that 
pro bab ly all such cells were positive, a l t hough  large 
gradu ati ons in the intensity of flu oresce nc e were noted.
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Smith and Ault (1981), also showed that peritoneal 
m a c r o phag es  from CAP D patients stained at the time of 
isolation showed a similar level of HLA-D R e xp ressio n to
that found with purified blood monocytes. During short 
term culture of both mon oc yt es and peritoneal cells, a 2-3 
fold increase in the average amount of surface HLA-DR per 
cell was seen, which after 12 hours reached a pla teau and 
diminished only slightly  thereafter.
More recent work by other groups has not solved this 
question of the degree of HLA-DR expres sion by monon uclear 
phagocytes. Costabel e_t a_l_ (1986), Clerici e_t a_l_ (1984), 
Sztein et a 1 (1984) and Colder and Doe (1983) found 45-94%
of human macr op hages expr essed  HLA-DR wh er eas  Razma aj_
(1984) found much lower levels (21%). Possi b l e  reasons for 
these c o n f li ct ing results will be discuss ed  in Chapter 4.
PG, which are the well known med iators of inflammatory 
reactions, also function as important mod ul ators of la
expression. They markedly inhibited la expre ss ion on 
murine imacrophages prev io usly stimula ted by lymphokines 
(Snyder ej^ aj_, 1982) . Kunkel e_^ a_l_ (1986) also showed that 
PG could suppress murine  macropha ge la an t i g e n  expression, 
but it a p p ea re d to have little effect on the ex pr e s s i o n  of 
HLA-DR an ti ge n by human mon ocytes and macrophages.
Gruner e_^ (1986) found decreased e x p r e s s i o n  of HLA-
DR antige ns  on human peripheral blood m o n o nu cl ear cells 
after one day of culture with ops onised zymosan. This 
decrease was pre ve nted by 0 carotene, a scavenger of 
reactive oxygen intermediates (ROI), or by superox ide 
dlsmutase. ROI are formed at inf lammatory sites and during 
phagocytosi s by m a c r o p h a g e s / m o n o c y t e s  in the course of the
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r espir at or y burst (see sect ion 1.3.6.6; Rossi e_^ a 1 , 1986;
Babior, 1984). The effec t of R O 1 on HL A-DR e x p r e s s i o n  was 
verified using m o n o n ucl ea r ceils from pa ti ents with a 
he t e r oz ygous form of chroni c granulomatous  disease, which 
are de ficie nt  in the pr o d u c t i o n  of ROI b e c au se of a genetic
defect in the enzyme  NAPDH oxid ase  (Gall in et a l , 1983). No
a l t e r a t i o n  in HL A-DR  antigen e x p r ession  after culture with 
opsonised  zymos an was shown (Gruner ejt a^, 1986). The effect 
of RDI on HL A-DR exp r e s s i o n  is thought to be due to their 
a b i lity to interfere with the quantity and spe ctrum of 
arac h i d o n a t e  met a b o l i t e  production, some of wh ich  influence 
la e x p r e s s i o n  (Snyder et a 1, 1982).
M « c r o p h » i « i  u .  i P O f t o f y  C>l ll
M a c r o p h a g e s  secrete a large and di ver se  range of
substances. The enzyme content and s e c retory  activ i t y  of
mo n o nuclea r ph ag ocy tes are related to the degree of
cellular d i f f e r e n t i a t i o n  and to the effects of exo ge no us 
stimuli.
1.3.6.1. Di gest 1ve Enzymes
Lysozyme, which med iates d i g e s t i o n  of the
peptidog 1 yean of bacterial cell walls, is a well known and
major s e c r e t o r y  pr oduct of macrophages. It is secreted 
c o n t i n u o u s l y  and all popu latio ns  of m a c r o p h a g e s  produce and 
secrete large amounts of lysozyme irrespe ct ive of their
state of activation, phagocy to sis or exp os ur e to 
lymphokines ( G o r d o n , 1980; Go rd on ejt a 1 « 1974 ) .
The se le ctive  release of lysosomal acid hyd rolases eg 
g 1u c u r o n i d a s e  and acid phos phatase by mon onuc le ar
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ph ag ocytes occurs in response to numerous ex ogenous stimuli 
(Page e_^ aj_, 1978). Res ident  peritoneal m ac rophag es  secrete 
lysosomal hydr ol ases at low levels, whereas ma cr ophages
obtaine d from in fla mma tory exudates or stim ulated  by
lymphokines cont ain and secrete increased amounts of 
lysosomal hydr olases (Tanner ej^ aj ,^ 1984; So be rman and 
K a r n o v s k y ,1981 ; Schnyder and Baggio 1 i n i ,1980).
The third cat eg ory of diges tive enzy mes  secreted by 
m a c r op ha ges are the neutral proteases, including
collagenase, elastase and pl as minogen activator. Elicited 
or a c t i vated  macrophages, on triggering, synt hesis e greatly 
increased amou nts of neutral proteases compared with
resident m a c r o phages  (Gordon, 1980; Schnyder and
B a g g i o l i n i , 1980).
1,3.6.2. Interleukin-1
M o n o nucle ar  phagocy tes are a major source of 
Interleukin-1 (IL-1) and release it in response to a wide 
variety of stimuli, including viruses, bacte r i a  and fungi. 
It p a rt ic ip ates in immune responses by inducing cell
dif fer entiation, an t i b o d y  secretion, p r o l i f e r a t i o n  and 
lymphokine p r o d uct io n (Kampschmidt, 1984; St aruch and 
Wood, 1983; Smith e_t a 1 , 1960 ) .
1.3.6.3. Arac h i d o n i c  Acid M e t a b o 11sm
M a c r op ha ges are a major source of these important
i m m u n o r e g u 1atory molecules, in particu lar  pr ostagla nd ins
(PG) and their release from macrophage s may occur in
response to a number of dif ferent stimuli eg immune 
complexes, lymphokines, en dotoxi n or opsonis ed  bac teria 
(Pawlowski e ^  a 1,1983 ; Gemsa,1981; G o o dwi n and W e b b , 1980;
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Humes e_t a 1 , 1977 ) . They appear to be able to act as 
neg ati ve feedback signals in those immune res ponses that 
require m a c r o p h a g e - l y m p h o c y t e  interactions (Gemsa,1981; 
Goodwin  and W e b b , 1980) eg by inhibiting IL-1 production.
1.3.6.4. Interferon
Interferons (IFNs) are a h ete ro geneous  family of 
proteins. Type 1 or viral IFN of wh ich monon uclear 
phagocytes are si gni ficant producers (N e u m a n n , 1982) is 
induced by virus infection or bacterial stimulation. Type 
II, (immune IFN or gamma IFN) is induced by specific
antigens, mi togens or other stimuli and is the predominant 
form produc ed by stim ulated lymphocytes (reviewed by 
Trinchieri and P e r u s s i a , 1985).
IFN is known to enhance the capacity of m acropha ge s to 
secrete H^O^ and to kill intracellular parasit es  as well as 
increasing HL A-D R an tigen expressi on  (Gershon e_t a 1 , 1985 ; 
Wilson and Wes ta 1 1 , 1985 ; Sztein et_ a 1 , 1984 ; Nathan 
et aj_>1963). It also increases the number of Fc receptors 
(Ezekowitz and Gordon, 1988; Rhodes ej^ a_l_, 1983, Vogel 
et aj_, 1983) which would probably enhance pha gocytos is  as a
result. It is the refore a major m a c r opha ge  act iva ting
factor, which  is able to regulate the immune response 
through its direct effect on mononu cle ar cells (reviewed by 
Virelizier  and A r e n z a n a - S e i s d e d o s ,1985).
1.3.6.5. Other Se cretor y Products
Ma cr o p h a g e s  secrete multiple compone nt s of the 
comp le ment system (Bentley ej^ a 1,1981), including Clq, C2, 
C4, C3, and C5 which means that they generate  all the
component s n e c e ss ar y for local o p s o n isation  of particles.
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1. 3.6 .G. React 1ve Oxygen 1nte rmed iates
In respons e to sti mulat io n ma cr ophage s are capable of 
releasing reacti ve oxyge n intermediates such as hydrogen 
peroxid e hydroxyl radical (OH*) and superox ide
anion (0^ ) (Rossi e ^  aj_, 1986; B a b i o r , 1984).
A c t i va ti on of mem b r a n e - b o u n d  NADPH (or NADH) initiates 
this reacti on  in which oxygen is reduced to superoxide
<0^ ):
NADP Fla vop ro tein
(N A D + ) ^  / reduced
NADPH /  ^  Fla vop ro tein
(NADH) oxidised
The latter converts to H^Og either sp ont a n e o u s l y  or by the 
su peroxide  d i s m u t a s e - c a t a 1ysed reaction
Og" + O2" +2H+--- >H2Û2 + 0%
H^Og may further react to produce the hydroxyl radical 
(OH*) whic h is thought to have an important role in cell 
damage and killing ( B a b i o r , 1984).
The produc ti on of microbicidal 0^ m e t a bo lites is 
en han ced m a r ked ly  in macrophages that have been activat ed  
by the pres ence of infection in the host (Takemura and 
Werb, 1984; J o h n s t o n , 1981), and sometimes in those elicited  
by injection of Infla mmato ry agents ( J o h n s t o n , 1981). This 
capacity to respond to stimu latio n with increased release 
of reacti ve 0^ m eta bo lites appears to play an essential 
role in the increased microbicidal c a p a b i l i t y  of activate d 
m acrop ha ge s (Nathan e_^ a 1 , 1983, 1979 ; Johns ton, 1981 ) .
It is now known that these Ijn vivo a d a pt iv e changes 
are m e d ia ted by lymphokines, in part icular gamma IFN
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(Wilson and Wes ta 1 1 , 1985 ; Nathan ej^ a 1 , 1963 ) which is 
relea sed  by s peci fi cally sensiti sed T - l y m p h o c y t e s  (reviewed 
b y D e  Ma ey er-Gu i gnard and De Maeyer,1985; Schreiber ejt 
aj_, 1983). j_n vitro induction of microbic idal ac ti vity does 
not require contact with  sensitised lymphocytes and is n o n ­
specific. Once established, the acti vated  m a c r o p h a g e s  can 
kill not only the bacterial species that led to activation, 
but also u n r el at ed ones.
The m e c hani sm  of killing is not yet clearly
defined, but it is thought to involve the cells abilit y to 
ox idise thiol groups in enzymes and to cause bond breakage 
in proteins and DNA, leading to lethal alte r a t i o n s  in cell 
m e t a bo li sm CCrapo 1977; Miche Ison, 1977).
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1.4. SERUM PROTEINS M â  THEIR RQLB iü ANTIMICROBIAL
ACTIVITY
1,4,1. Immunoglobulin Comp Itmont
P h a g o c y t i c  cells rec ognise mi cro- o r g a n i s m s  by complex 
processes, the most important of which is o p s o n i s a t i o n  i.e. 
the coating of micro- o r g a n i s m s  with molecu le s which
fa cilitat e phagocytosis, of which I g and compl em ent are the 
most important.
Immunoglobulins, or antibodies are induced when the 
host's lymphoid system comes into contact wit h imm unogenic 
foreign molec ul es  (antigens). Five distinct classes of I g 
mo lec ules are produced  in man, namely IgG, IgM, IgA, IgD,
and IgE. These differ from each other in size, charge,
amino acid c o m p ositi on  and ca rb ohydr ate content. There is
also consi d e r a b l e  h e t e r oge ne ity withi n classes. IgG (MW
150000) is the major I g in normal human serum acco untin g 
for over 70% of the total I g and is the main antibo dy
disc uss ed in this thesis.
Co m p l e m e n t  is a system of interacting proteins, the
compone nts  of which interact in an orderl y sequential
fashion giving rise to a cascade analogous  to that of the 
clotting system, in that activation  of each com ponent
(except the first) depends upon a c t i v a t i o n  of the prior 
c om ponent or co mponents  in the sequence (reviewed by
Joiner et a 1,1984).
O p s o n i s a t i o n  of bacteria  may occur by three dif ferent 
mechanisms. Firs tly  specific antibody, na me ly  IgG alone
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may act as an opsonin, or specific IgG or IgM may Induce 
co mplemen t a c t i v a t i o n  via the classical pat hwa y of Cl, C4, 
and C2. Finally the a l t e rnat iv e pathway of C3 activa tion 
provides a n o n s p e c i f i c  m e c h ani sm  of o p s o n i s a t i o n  (Keane and 
P e t e r s o n , 1984; W i n k e l s t e i n , 1973).
Most specific antibodi es  to bacte ri a are directed 
against surfaces or cell-wall comp one nts such as the 
pept i dog 1 ycd'^i (Peterson et^ aj_, 1978). The a n t i b o d y  combines 
with the surface an t i g e n  of the ba ct erium through the 
an tibod y co mbi nin g sites located in the F(ab')^ portion of 
the molecule. The Fc portion of the molecule, whi ch is 
critical to its functi on as an opsonin is then free to 
attac h to specific receptor sites on the surface of the 
pha go cyte  (Newman e_^ aj_, 1985) and co mplete  the bridge 
between ba c t e r i u m  and phagocyte. In the case of complement 
this bridge is formed by C3 components and its receptors. 
F l b r o n e c t i n  can also be involved in pha go cy tosis by 
enha nci ng ingestion of al ready opsonised particles  bound to 
the Fc or comp lement receptors (Wright and M e y e r , 1985; 
Pommier ej^ a 1 , 1983) .
Two major pathways of complem ent  act i v a t i o n  are 
recognised. The classical pathway is ge nerally activa te d 
by the interactio n of antib o d y  of the a p p r o p r i a t e  class and 
subclass. In man IgG 1,2 and 3 and IgM are capable of 
a c t i vatin g the classical pathway (reviewed by Joiner e ^  a 1, 
1984). A single IgM molecul e can fix complement, whereas 
two clos ely  spaced IgG mole cules are required, IgA, D and 
E have no com pl em ent binding ca pacity  (Ishizaka 
et a 1,1966).
A second major pathway of complem ent a c t i v a t i o n  has
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been termed the a l t e r n a t i v e  pathway. This is ac ti vated by 
binding of C3 or C3b, to certain types of surface. This 
path way  can be activat ed  by a number of bacterial organisms 
and part icles in the absence of specific Ig (reviewed by 
Joiner e_^ aj_, 1964) and can provide a n o n - s p e c i f i c  defence 
system for the host. All gram positive cell walls appear 
to ac tivate the a l t e r n a t i v e  pathway ef fi c i e n t l y  in non- 
immune serum, leading to the d eposi ti on of C3b on the 
bacterial cell wall (Verbrugh e_^ a 1 , 1980 ) .
1.4,2. Tr*n#f#rrin
T r a n s f e r r i n  (Tf) is a serum g lycopro te in of 80000 
molecular weight, the main function of whi ch is iron 
transport (M o r g a n , 1981). Most of the iron is delivered to
erythroid  pr ecursors for the synthesis of haem. Small but 
significant quantities  of iron are also deliver ed to non- 
er yt hroi d cells, espe ci ally those which are rapidly 
dividing (Brock and M a i n o u - F o w 1e r ,1983).
However another important proper ty of Tf is its 
an timicrobial activity. All micro -organism s, with the
possible e x c e ption of lactobacllli ( A r c h i b a l d , 1983),
require iron for growth. Hence Tf, by virtue of its high
af fin it y for iron, can retard microbial growth by 
restricting the a v a i l a b i l i t y  of this element. Tf may
therefore have an important role in defence against 
infection ( B r o c k , 1986).
Schade and Ca roline  (1944;1946) first d is covere d that 
specific iron binding proteins, present in human blood and 
in egg whites would Inhibit the growth of c e r tain bacteria. 
They concl ud ed that the proteins, now known as Tf in blood
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(Holmberg and Laurel 1,1945; Schade and C a r o l i n e , 1946) bound 
iron so tightly that bacteria  were u n a b le to obtain a
sufficient amount of the metal for growth. Addition  of 
iron was found to overcome this b a c t e r i o s t a t i c  effect of 
Tf. The enhanced  s u sce pt ibility  of animals injected with 
iron to inf ection is now well rec ognised and can be seen
with a number of different organisms eg Escher ichia o o 11
(Bullen eX. a 1,1968), C l o s tr idium welchii (Bullen et 
a 1,1967), S .aureus (Gladstone and W a l t o n , 1971) and 
Kl eb siel la  (Miles e ^  aj_,1979). In situations  where iron is 
not readily available, bacteri a norma lly acquire this metal 
by syn th esisin g high affinity, low mo lec ular weight iron 
ch elators (s i d e r o p h o r es ; Fink elste in  a 1,1983 ;
N e i l a n d s , 1981). Schade (1963) also showed ij% vitro that 
many strains of S.ep id ermldis  failed to grow in serum
without additional iron and their growth was inhibited by 
Tf. Miles e_t aj_ (1979), however, sug gested that only a 
minority among the environmental bacteri a can take
ad va nt age of the decre ased resistance asso c i a t e d  with such 
increased iron levels but this minor ity is likely to
include the more virulent strains. Iron compounds were 
also found to ab olis h the antibacterial effects of body 
fluids i_n vitro (Wei n b e r g , 1984; G r i f f i t h s , 1983; 
B u 1 1 en, 1981).
Thus Tf, like IgG and C3 is an important factor to
exa mine in the PDE of patients on CAPD, as any defi cienc ies 
may c ontr ib ut e s i gn if icantl y to defects In the defences of 
the peritoneum.
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The work prese nted in this thesis aims to examine the 
peritoneal immune defences of patients on CAPD. In
particular the activity of the cells with regard to their 
abi lit y to deal ad e q u a t e l y  with possible pathogens is 
Investig ate d and their ac ti vation or m a t u r a t i o n  state is 
studied by exam ining their abi lity to release and
express HLA-DR. In add it ion this work examines  the levels 
and activ it ie s of serum proteins in PDE. in particula r IgG 
and C3, and relates these to the opso nic cap ac it y of PDE, 
as inadequate ops onic act iv ity may impair the effi cienc y of 
the p h a g oc ytic cells. D e t e r mi na tion of the Tf levels and 
me as urem en t of i_n vitro growth of bacteri a in the PDE is 
also investigated, as de fec tiv e Tf-medi ated
b a c t e r i o s t a t i c  activit y of PDE would increase the chances 
of invading pathogens establis hing themsel ves  prior to 
m o b i l i s a t i o n  of p ha go cytic defences, and thus giving rise 
to peritonitis. This work also examines the relationship 
of these various cellular and humoral act i v i t i e s  with the 
Incidence of peritonitis, both in individual patients and 
by a 9 month longitudinal study of selected patients.
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CHAPTER 2
CHARACTERISATION OF HUMAN PERITONEAL CELLS
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M ac ro phages  are the first line of cellular 
defence ag ainst microbial invasion of the per i t o n e u m  in the 
CAPD patients. However, the removal of large numbers of 
cells each day from the peritoneu m by the dialysi s routine 
results in a rapid turnover of cells. Repl e n i s h m e n t  by 
cells other than by the normal resident peritoneal 
p o p u la ti on may immun o- comprom is e the immune system of the 
per it on eum and leave it. prone to infection. Indeed, 
G o l d stein  e_t (1984) suggested that the peritoneal
m acrop ha ge s from CAPD patients are rela ti vely immature 
b one-m ar ro w derived cells which might therefore have reduced 
act i vity.
Much of the work describ ed in this thesis seeks to 
identify any functional defects In these recent ly arrived 
cells which might impair the local antimicrobi al act ivity 
in some patients, leaving them prone to peritonitis. It 
also seeks to examine the effect the dialys is procedure has 
on the overall a c t ivity of cells in the PDE and compare 
these with the resident peritoneal m o n o nu cl ear ph agocyte 
p op ul ation no rmally  found in the peritoneum.
Before such studies could be u n d e r t a k e n  it was 
n e c es sary to establis h the qu an tit ative and qu alitati ve 
c h a r a c te risti cs  of cells in the peritoneal dlal ysate  of 
un in fect ed  CAPD patients.
In this chapter the peritoneal cell pop ul at ions of 
CAPD patients have therefore been c h a r a cter is ed and 
compar ed with normal human peritoneal cells.
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2.2.1. C u 1ture Med ium
This c o n si st ed of RPMI 1640 culture m e d i u m  with 25mM 
Hepes (Flow, Irvine, U.K.) containing 5% heat inactivated 
(56°C, 30 min) foetal calf serum (FCS : Flow).
2.2.2. Rea ge nts for <x-Napthy 1 Acetate Es terase  Stain
(i) Fix at i v e  Formol calcium solution c o n s is ti ng of 10% 
w/v f o r m a ld eh yde and 1% w/v CaCl^ was used.
(il) Ph o s p h a t e  Buf f e r (0.06M, pH 5) This consisted of a 
ratio of 98.5: 5 of KH^PO^ (9.08 g/1) : N a 2 H P0^.2H 20
(11.88 g/1) respectively. The buffer was ste ril ised by
a u t o c 1av i n g .
(iii)H e x a z otised  P a r a o s a n l 1i ne This co nt ained equal
volumes of two solutions which were prepared as follows : 
S o l ut io n A : 5 ml of c oncen tr ated HCl was added to 20 ml 
of di sti lled water to which  had been
pr e v iously  added 1 g of p a r a s o a n i 1ine (Sigma: 
Poole, Dorset, U.K.). This sol ut ion was 
gently warmed to dis so lv e the
p a r a s o a n i 1in e , allowed to stand at room 
tem perat ur e to cool and finall y filtered. 
The filtrate was then stored in the dark at
4°C.
S o l ut ion B : This was a freshly prepared soluti on of 4% 
NaNO.^ in disti lled water.
( 1 V ) (x-Napt hy i Acetate Esterase ( ANAE ) Stain A 2.4 ml 
volume of h ex az otised  paras oa n!line was added to 40 mi of
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the phosp ha te buffer. Next a freshly pr epa red solution of 
10 mg of a-napthyl ace tate (Sigma) in 0.4 ml aceton e was 
added and the pH raised to 5.8 with 2N NaOH, The stain 
was filtered before use.
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2.3.1. P a t i e n t Samp 1 es
Samples were obt ai ned from a total of 35 patients (19
\
females, 16 males) on CAPD (Table 1). Their ages ranged 
from 23 to 76 years and they had been on CAP D for times 
ranging from 1 day to 4 years. Fift een of the patien ts were 
on the Fr ese niu s sa fe-lock system and the remaind er on the 
Travenol Sy ste m II. A total of 76 samples were obtained  
(Table 2). P e r i to ni tis was diagnosed by the medical staff 
of the W e s te rn Infirmary by the criteria of abdominal pain, 
cloudy PDE, pos it iv e growth culture of m i c r o - o r g a n i s m s  and
3
a d i a l ysat e white cell count of greater than 100/mm in 
which n e u t r o p h i l s  predominated. Alt ho ugh these cr it eria are 
suitable for the actual diagnosis of peritonitis, no 
indication is given as to the types and numbers of cells 
found before and after its clinical diagn os is which it is 
essential to know in order to ensure that infected samples 
are not used as exam ples of cells found in the normal 
un in f e c t e d  PDE. Other crit eria for e x c l ud in g infected 
samples may therefore  have to be used to overc om e this 
problem, and this is discussed further in sec tion 2.5.1.
2.3.2. Normal Con trols
Normal peritoneal cells were obtained from 6 healthy 
women under going laparoscopy for sterilisation.
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SYSTEM DI A G N O S I S
A. Ba f e m a 1e 56 40 F* P o l y c y s t i c  Kidneys
A.Bl ma 1 e 70 9 T + G 1o m e r u I o n e p h r 11 i s
A . Ca f e m a 1e 75 7 F G l o m e r u l o n e p h r i t i s
W.Ch ma 1 e ' 40 g T D i a b e t i c  N e p h r o p a t h y
R. Co f e m a 1e 39 39 F G 1 omeru lonephritis
W. Co ma 1 e 33 0 T Un kn ow n
I . Cu f e m a 1e 68 7 T P y elon ep hritis
C. Fe ma 1 e 53 1 T D i a be ti c Ne ph ropathy
A.Fu f e m a 1e 42 1 F Unknown
M . Ge f e m a le 60 41 F Hyper tens i on
B.Go ma 1 e 23 16 T D i a b e t i c  Nep hrop at hy
N.Ja ma 1 e 37 19 F Di a b e t i c  Neph ropath y
I. Jo ma 1 e 37 6 T G l o m e r u l o n e p h r i t i s
W.Ka ma 1 e 46 0 T G l o m e r u l o n e p h r i t i s
R . Le ma 1 e 55 2 T Di a b e t i c  N eph ro pa thy
M. McA f e m a 1e 51 46 F Hyper tens i on
M.McC f e m a 1e 55 19 F An a l g e s i c  Neph ro pathy
A. McD ma 1 e 64 20 F G 1o m e r u 1o n e p h r 11 1s
J.McF ma 1 e 48 45 T G l o m e r u l o n e p h r i t i s
C.McG f e m a 1e 62 6 T A na l g e s i c  N e p h ro pa thy
L. McL f e m a 1e 55 7 F P y e 1onephr itis
M.McV f e m a 1e 54 7 F P o l y c y s t i c  Kidneys
P.McV ma 1 e 61 0 T P y e 1onephr itis
A . Me f e m a 1e 36 18 T G l o m e r u l o n e p h r i t i s
T. Mo ma 1 e 45 1 T G l o m e r u l o n e p h r i t i s
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SYSTEM DI A GNO S i S
A. My fema 1 e 42 27 T P o l y c y s t i c  Kidneys
S.Pa f e m a 1e 52 5 F P o l y c y s t i c  Kidneys
C. Pa f ema 1 e 68 46 F A n a l g e s i c  N e p h r opath y
M . Re femaIe 63 4 F D i a b e t i c  Nep h r o p a t h y
R . Ro ma 1 e 39 1 T Un kn ow n
I . Sc f e m a 1e 49 36 T A n a l g e s i c  N e p h r o p a t h y
M . Sm f ema 1 e 60 1 T P o l y c y s t i c  Kidneys
w.st ma 1 e 76 6 T Un kno wn
A.Wa f e m a 1e 49 1 F P o l y c y s t i c  Kidneys
W. Yo ma 1 e 44 21 T Di a b e t i c  Nep h r o p a t h y
* F = Fr e s e n i u s  sa fe-lock system 
+ T= Travenol Syste m II
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TABLE 2 : Differential White Ce 1 i Counts and Per i toni 1 1s 
Rates 1n the PDE of Dialysis Pat ients.
NUMBER PERC ENTAGE  OF FREQUENCY
PATIENT MONTHS  OF C E L L S ------------------------------------------  OF
INITIALS ON IN PDE MACRO- LYMPHÜ- NEUTRÛ- EOSINO- PERITONITI S 
CAPD xiO" PHAGES CYTES PHILS PHILS
+ A . Ba 40 <5 - - - - 0. 3
+ 41 <5 - — - - 0. 3
+ 42 <5 - - - — 0.3
A.Bl 9 <5 - - - - 2. 7
10 <5 - - - - 2. 4
A.Ca 7 45 78. 0 20. 0 2.0 0.0 6.9
9 24 71. 3 21. 8 4.6 2.3 5.3
13 ' 56 71. 9 15.5 9. 1 3.5 5.5
+ W. Ch 9 320 60.8 15.5 8. 1 15.6 1.3
11 203 62. 0 15.2 9. 8 13. 0 2.2
R . Co 39 <5 - - — - 0.0
W. Co 0 292 64.3 18.6 7. 8 9.3 0.0
* 1 12000 36. 5 5.5 58. 0 0. 0 12. 0
2 141 71. 0 17. 1 2.4 9.5 6.0
2 96 64. 8 28. 0 3. 8 5.4 6. 0
I . Cu 7 16 76. 0 22. 2 1.8 0. 0 1. 7
C. Fe 1 140 76.9 22. 3 0.. 8 0.0 12. 0
A.Fu 1 52 88.4 11.6 0. 0 0.0 0.0
+ M.Ge 41 < 5' - - - - 5. 3
B . Go 16 35 61. 3 24. 2 14.5 0.0 0.0
N.Ja 19 <5 - - - 0.0
22 <5 - - - - 0. 5
I.Jo 6 60 66.7 23.6 4. 7 5. 0 6.0
W.Ka 0 70 70. 3 25. 8 3.0 0.9 0.0
R i Le 2 20 69. 8 23. 9 3. 8 2. 5 12. 0
3 25 85. 0 14.0 1. 0 0.0 8.0
+ M .McA 46 960 13.0 6.0 79. 4 1. 6 2. 1
+ 47 480 21 . 7 19.6 28. 3 30. 4 2. 0
49 203 15.9 7.3 75.4 1. 4 2. 0
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T A B L E  2  c o n t .
NUMBER 
PATIENT MONTHS OF CELLS 
INITIALS ON 
CAPD
P ERCEN TA GE OF
IN PDE MACRO- LYMPHO- NEUTRO 





M.McC 23 <5 “ — - - 0.5
+ 19 168 37.0 17.8 8.2 37. 0 0.6
+ A .McD 20 <5 - - 2. 4
+ 23 <5 - - - — 2. 1
J . McF 45 <5 - - - - 2. 9
* 46 960 44. 2 3.4 52. 4 0. 0 2.9
49 <5 - - - - 2.7
C.McG 6 26 75.6 18.4 3. 5 2.5 0.0
9 172 60.6 13.5 14.8 11.1 2_. 7
+ 11 384 45.6 22. 6 16. 1 15.7 3.3
12 <5 - “ - - 3.0
L . McL 7 15 77.7 20. 6 1. 7 0.0 5. 1
M.McV 7 112 61 . 4 21. 0 6.2 11.4 5. 1
+ 11 104 39. 3 29. 7 15.3 15.7 4.4
P.McV 0 72 63.6 20.4 14. 2 1. 8 0. 0
1 114 52. 2 13.9 32. 2 1.7 0.0
2 43 50.3 42. 1 5.9 1. 7 0. 0
#A. Me 18 52500 27. 9 7.0 56. 1 7.0 4.0
19 136 61 . 1 30. 0 7.3 1. 6 3.8
20 12 65.4 24. 6 10.0 0. 0 3.6
T. Mo 1 24 75. 0 23. 0 2.0 0. 0 0.0
3 310 49.5 15.8 25.4 9.3 0.0
A. My 27 <5 - - - - 0.4
30 <5 - - - - 0.4
33 <5 - - - — 0.4
S. Pa 5 <5 - - - - 9.6
6 32 77.6 18. 3 4. 1 0. 0 8.0
+ C. Pa 46 <5 - - - - 0.5
+ 47 <5 - - - - 0. 8
+ 48 <5 - - - _ 0. 8
+ 49 <5 - - 0. 7
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T A B L E  2 :  c o n t .
NUMBER P E R C EN TA GE OF FREQUENCY









- N E U T R O ­
PHILS
E O S I N O ­
PHILS
PERITON
* M . Re 4 19000 20.0 5.0 75.0 0.0 6.0
5 460 58.4 16.7 23. 8 1. 1 4.8
6 76 64. 8 28.5 4.4 2. 3 4.0
12 120 71.7 11.9 15.0 1. 4 4.0
13 26 75. 0 14.0 11.0 0.0 3. 7
R.Ro 1 25 86. 0 12.0 2.0 0.0 0.0
.1 . Sc 36 21 74. 8 19. 1 6. 1 0. 0 1 . 0
37 <5 - - - 1.0
"M. Sm 1 48 32. 3 8. 7 54. 7 4.3 12.0
o 2 132 34. 3 16.9 48.8 0. 0 6.0
* 3 58000 10.7 1.4 87. 9 0.0 8. 0
W.st 6 64 66. 0 30.0 4.0 0.0 6.0
6 77 64.0 21. 0 15.0 0.0 6,0
A.Wa 1 84 68. 3 18.0 4.3 9.4 0. 0
6 <5 - ” - - 0.0
W.Yo 21 <5 - - - - 2.9
Mean 17 195 58.3 18.0 19.0 4. 7 3. 1
Minimum 0 <5 10.7 1. 4 0.0 0.0 0.0
Max i mum 49 58000 88.4 42. 1 87. 9 37. 0 12.0
* Samples from patients with Iactive iper i toni t i s
Samples from patients recovering from perit onitis
o Samples from patients just before clinical diagnosis of 
peri ton itis
+ Samples from patients with inflammatory or al le rg ic reactions 
- No differential cell count
# The freq ue ncy of pe ri tonitis was cal cul at ed by mult ip lying  the 
total number of episodes  exper ienced by each patient by 12 and 
dividing by the number of months on CAPD. D i a gn osis of peritonitis 
was d et er mi ned as des crib ed  in section 2.3.1.
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2.4.1. Isolât Ion of Peri t o n e a 1 Cells
The fluid from the overnight CAPD ex c h a n g e  was spun in 
a M.S.E. Mistral c e n t ri fu ge in 1 - litre bottles  at 500g for 
15 minutes. The sup ernat an t was removed and the cells 
r es us pended  in cu lture mediu m (2.2.1), washed by 
c e n t r i f u g a t i o n  at 250g and pooled. The cells were counted 
and vi ab ility  deter mi ned by eosin exclusion. Peritoneal 
cells ob tained by a s p i r a t i o n  of fluid from the pe ri toneum  
of normal women (samples were norm al ly 2-5ml) were 
c e n t r ifug ed  at 250g and the cells washed as above. If the 
pellet showed heavy c o n t a mina ti on with e r y t h rocy te s these 
were lysed by suspending  the cells in 1ml of distilled 
water for 1 mi nute followed by rea djus tment  to isotonicity 
with a 10-fold excess of culture medium (2.2.1).
2.4.2. Le 1shman Stainin g
Peritoneal cells were collected and counted as
4
de sc ri bed above. A p p r o x i m a t e l y  5x10 cells were depo si ted 
on clean glass slides in a Shandon cytoc e n t r i f u g e  at 600 
r.p.m. for 90 seconds and then air dried. The cells were 
then fixed and stained by first adding u n d i l u t e d  Leish man 
Stain (Exogen Ltd., Clydebank, Glasgow, U.K.) for 2 minutes 
and then dilutin g the stain with 2 volumes of distill ed 
water and leaving for 10 minutes. P r e p a r a t i o n s  were then 
washed in tap water, air-dried, and mounted in DPX.
Di f fer en t fields of view were e x a mine d in a Leitz-
4 4
Wetzlar light m i c r osco pe  (k 200) and the p ercent ag e of each 
cell type calculated.
2.4.3. ot-Napthy 1 Acet at e Esterase ( ANAE ) Staining 
C y t o s p i n  p repar at ions of peritoneal cells were
prepared as above. They were then fixed in formol ca lci um  
( 2 . 2 . 2 . i) at 4°C for 10 minute s and washed in tap water for 
20 minutes at room temperature. ANAE acti v i t y  was 
d e m o n stra te d by incubating with the ANAE  st aining reagent 
(2 . 2 . 2 . iv) for 2 hours at 37°C. Cell p r e p a r a t i o n s  were then 
wash ed gently in running tap water for 10 minutes, left to 
dry at room temp erature  and then c o u n t e r s t a ined with 2% 
methyl green for 30 seconds. Finally, cells were washed in 
tap water, air-dried, and mounted in DPX. Slides were 
ex am in ed using the light mi croscope (x400) and the 
different cell types scored.
2.4.4. Statistical Methods
Spe a r m a n  rank c o r r e l a t i o n  was the only test used
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2.5. 1. Pif ferent ia 1 White Ce 11 Counts of Per i t o n e a 1 Ce 1 1 s 
O b t a i ned from CAPD Pat ients
Macrophages, lymphocytes, neutrophils, and eo sinop hils  
were clas si fied using L e i s h m a n - s tained prepa ra ti ons  
acco rd ing to the normal criteria. Ma cr ophages  were
identified by their size and typical b e a n - s h a p e d  nucleus, 
lymphocytes by their large round nucleus and scanty 
cytoplasm, and pol ymo rp ho nuclea r leucocytes by their 
mu lt il obed nucleus. Neutrop hils and eos inoph il s could 
easily be di stin g u i s h e d  by the absence or presence, 
respectively, of staining of the cyto p l a s m i c  granules. 
Typical mor p h o l o g y  of each cell type is shown in Figure 1.
Differen tia l white cell counts of CAPD cell 
pr ep arat io ns  were performed whenever pos si ble on the 76 
samples obtained from patients. Overall the mean percentage 
of each cell type was 58.3% macrophages, 18.0% lymphocytes, 
19.0% neutrophils, and 4.7% eosinophils (Table 2). However, 
this was not a true representation of the cells found In the 
PDE of "stead y-stat e"  CAPD patients, as it includes several 
patients with on-going  peritonitis, as well as a few who 
were reco ver ing from peritonitis or just before it's 
clinical diagnosis. In additio n several PDE samples were 
obtained from patients with a l l e r g i c / i n f l a m m a t o r y
rea ctions (Table 2). Since the purpose of this study was to 
examine the normal pop ul ation of cells found in patients, 
it was important to esta bl ish criter ia for classifying
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F 1 CURE 1 : Peri t o n e a 1 Cells from a CAPD P a 1 1ent Stained with
Le i s hman 1x1600)
E : Eos i noph i 1 
N : N e u t r o p h 11
L : Lymphoc yte
M : Mac rophage
47
"st ead y-state " pat ients and avoid Including cell 
p opu lations  which may have been altered by factors outside 
the normal dialysi s routine.
When a bar chart was co ns tructed showing the 
pr oport io n of n e u t rophil s in the PDE of dialysis patients 
(Figure 2), it was found that all except 2 of the samples 
with 15% or less neu trophi ls  were from patien ts who were 
free from either peritonitis c o m p l i cations  or 
h y p e r s e n s i t i v i t y  reactions to the dialysis routine or the 
dl alysate itself. The 2 samples mentioned above were from a 
patient with sclerosing peritonitis and another who had 
had a recent catheter implanted. The proporti ons of 
eosinoph ils in these were 37.0% and 15.6% respectively. In 
view of this only samples contain ing <15% of both 
ne u t r op hi ls and e osin op hils were cons ide red a pp ro priate  for 
further invest igations of cellular ac tivity of cells from 
normal CAPD  patients.
When samples con ta in ing 15% or more of n eut ro phils or 
eo si noph il s were el iminated from those on which 
differential white cell counts were performed, 66% of 
samples remained. In these, the mean per ce ntage of each 
ceil type was 69.9% ma crophage s (range 50.3-86.4), 20.7%
lymphocytes (range 11.5-40.1), 6.1% n e u t rop hi ls (range
0-15.0) and 2.9% eo si nophils (range 0-13.0).
Since the presence of n on -specif ic  est er ase is highly 
c h a r a c t e r i s t i c  of macrophages, seven samples were also 
stained with ANAE as well as with Leis h m a n  in order to 
e st ab lish that the Lei sh man was adequa te  for routine 
ide ntifi ca tion of cells (Table 3). M a c r ophages  showed 
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F I GURE Propor t i on o f Neut r o p h i 1s in PDE.
I I Samples from patients with no diagnosed 
comp Ii cat i o n s .
Samples from patients with n o n- in fectiou s 
inflammatory or allergic reactions.
Samples from patients with peritonitis.
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TABLE 3 : Compar i son of Le i shman and <x-Napt hy 1 Acetate
■Esteras e (A N A E ) Staining of P e r l t o n e a 1 Cells 
from CAPD Patients.
L E I SHMAN STAIN 
P E R C E N T A G E  OF*:
N O N - S PECI FI C ESTERAS E STAIN 
P E R C E N T A G E  OF :
TIENT M A C R O ­
PHAGES
L Y M P H O ­
CYTES
N E U T R O ­
PHILS




A • La 78. 0 20. 0 2. 0 80. 7 5.0 14.3
W. Co 36. 5 5.5 58. 0 32. 7 4. 1 63. 2
A. Fu 88. 4 11.6 0.0 69. 1 6. 4 4.5
R. Le 85. 0 14.0 1.0 86. 0 8.0 6.0
S. Pa 77. 6 18.3 4. 1 81. 4 9. 7 8.9
I . Sc 74. 8 19. 1 6. 1 73.5 7.4 19. 1
A. Me 85. 6 24. 4 10.0 70. 0 9.9 20. 1
* None of these samples contained any eosinophils.
5 0
T - l y m phoc yt es con tained small brown spots. The remaining 
lymphocytes (presumed B-cells) and all other cell types 
remained unsta in ed (Figure 3a). Re sul ts showed that 
staining for n o n - s p e c i f i c  esterase verified the Le is hman 
stain (Table 3). For example, in Figure 3a (cells from 
patient W.Co) the perce nt age of A N A E - p o s i t i v e  cells 
(excluding T-cells) was low (32.7%) as the sample contained 
large numbers of n e u t r ophils and this com pa res well with 
the co rr e s p o n d i n g  figure obtained with L e i sh man stain 
(Table 3, and Figure 3b ; 36.5%). In contrast, the
p er cen tag e of AN AE- p o s i t i v e  cells (excluding T-cells) in 
Figure  4a (patient l.Sc) was 73.5%, which agrees well with 
74.8% asse ss ed by Le ishman  stain (Table 3, and Figure 4b).
2.5.2. Eos i n o p h i 1ia
An Intere sting o bserva ti on in several patients' 
samples was the presen ce of eosinophil la. Five patients, 
all with betw een 10^-10^ cells in their peritoneal 
effluent, had an increased average number of eosinophi ls  
(mean 22.7%) compared with the average of 4.7%  found in all 
the samples (Table 2). An example of cells from an extreme 
case of eosin o p h i l i a  is shown in Figure 5.
2.5.3. D 1f f eren tia 1 W h i te Ce 1 1 Counts of Peri t o n e a 1 C e T 1s 
Obtained from Normal I n d l v i d u a 1s
An av er age of 91.4% of normal peritoneal cells were 
identified as macr op hages by Lei shman stain (Table 4, and 
Figure 6b). Neutr oph ils were absent, the remaining cells 
being lymphocytes. Three of the samples were also stained 





F 1GURE 3 ; Peritoneal Ce t i s from a_ CAPD Pat i en t with 
Peritonitis. 1x1600)
Stained with:-
(m ) a-Naphyl Acetate Estera se (ANAE) Stain
(b) Leishma n Stain
TL : T - l y mphoc yt e
NEG : ANAE negati ve cel 1




F 1 GURE 4 t_ Perl tonea 1 Ce 1 1 s from a_ CAPD Fat i en t . (xl600)
Sta i ned with : -
(a) a-Naphyl Acetate Esterase (ANAE) Stain
(b) Leishman Stain
TL : T -ly mp hocyte
NEG : ANAE negative cell
M : Ma croph ages
L : Lympho cytes
5 3
F 1 GURE 5 j_ Péri tonea 1 Cells from a CAPD Pat i ent with 
Eos i noph ilia. 1x1600)
E : Eosinophil
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TABL E 4 1 Compar i son of Le i shman and oc-Napthy 1 Acetate





PE R I T O N E A L
CELLS)
LEISH MA N STAIN 
P E R C E N T A G E  OF i
MACRO- LYMPHÜ- 
PHAGES CYTES
N O N - S P E C I F I C  ESTERASE STAIN 
PE RC E N T A G E  OF :
MACRO- NEGATIV E 
PHAGES T-CELLS STAINING
1 86. 0 14.0 85. 4 5.0 9.6'
2 94. 1 5.9 93. 4 2. 3 4.3
3 90. 0 10. 0 88. 4 3.9 7.7
4 89. 0 11.0 * * *
5 89. 0 11.0 * ¥
6 92. 1 7.9 * ¥
7 96. 0 4.0 * * ¥
8 95. 1 4.9 * ¥
mean 91.4 8.6 * * ¥
m 1m i mum 86. 0 4.0 * * ¥
max 1 mum 96. 0 14.0 * * ¥




F I GURE 6 j_ No r ma 1 Peritoneal Ce Ils. 1x1600)
S ta i ned with : -
(a) a-Naphyl Acetate Esterase (ANAE)
(b) Lei shman Stain
NEG : ANAE negative cell
M : Macro phage
L : Lym pho cy te
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staining was found to be consistent with eq ui valent 
Leishman results (Table 4, and Figure 6a).
Overall therefore CAPD cells showed greater
heterogeneity, both in terms of the types and proporti ons 
of the cells found and in macropha ge  size, than normal 
peritoneal cells, which tended to be relatively  
h o m o g e n e o u s .
2.5.4. Number of Ce 1 1s 1 so 1 ated f rom t he PDE o f Pat 1ents on 
CAPD
The yield of cells obtained from the PDE varied
c on si d e r a b l y  from sample to sample, ranging from less than
5 9
5x10 in many samples, to 10 cells in extreme cases. Most
of the samples (61.8%) yielded a total of 10 -10 cells
(Table 2). Dif fer en ces in ce llularity  and cell comp os ition
were p arti cu larly noticea bl e in dia lysate obtained from the
five patients with peritonitis. A rise in cell u l a r i t y  with
n e u t r o p h i l i a  were typical features (Table 2, and Figure
8
3b). Of the samples con tai ning more than 10 cells, all
were from patients with activ e peritonitis. Althou gh the
7
vast ma j o r i t y  of samples which conta ined b e t we en 10 and
10^ cells were from patients who did not have active  
peritonitis, the ave rage pr op ort ion of m a c r op hages in this 
group was 51.6% which was lower than that of 69.9% from
7
samples with 10 or less cells.
In 34.2% of the samples, only low numbers of cells 
5
(less than 5x10 cells per bag) were recov ered from the 
overnight PDE, and there was a signific ant inverse 
corr e l a t i o n  be tw een  the number of cells in the fluid and 
the length of time the patient had been on CAPD (p<0.001;
5 7
Figure  7). Twelve of the fifteen samples c on ta ining less 
than 5x10^ cells came from patients who had been on CAPD 
for 1 year or more. However, there was no significant 
co r r e l a t i o n  between cell number and the number of 
peritonit is  episodes ex pe rienced by each patient per year 
(F i gure 8).
55
Number of cells 
xIO®
p<0.001






F I G UR E 2  i_ Compa r i son of Le ng t h  of T 1 me on CAPD with the 
T o ta 1 Number of Cells in the PerltoneaI Dialysis 
E f f lu en t
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Number of cells










4.0 8.0 12.0 
Peritonitis episodes/year
F I G U R E  8_ i_ Compar  i son o f the F r equency of Per i toni t i s with 
T o ta 1 Number of Ce 1 1s I so 1 ated f r om Per i toneaI 
Di al ys is Ef f 1uent
GO
gjA u. D U C U n i O N
The ch aract er istics and yield of cells
Isolated from the individual PDE of CAPD patients varied
considerably. In terms of total cell numbers this ranged 
from less than 5x10^ to as high as 10^ cells in extreme 
cases, the latter always being samples from patients 
diagn ose d with peritonitis. Very high neutrophil levels 
were, in ad d i t i o n  to raised cell counts, invariably 
as so ci ated with pe rit onitis as also shown by Hurley  et a I 
(1977) and Rubin e ^  aj_ (1980), and it was these cells which 
replaced the normal ma cr ophage  pop ul at ion as the major 
phagocyti c cell In the peritoneum.
High eosinophil levels, possibly due to allergic  or 
inflammatory reactions to either the dialysis solution or 
the dialysis procedure, were seen in five patients. Two of 
these had just received a replacement catheter following 
recurrent peritonitis, two had sclerosing pe ri tonitis and 
one had changed to a different form of CAPD with different 
solutions, all of which may be associa ted with inflammation 
of the peritoneum. This has been pr e v i o u s l y  noted by 
Digenis e_^ aj_ (1982) and Humayun e_t aj_ (1981) at the start 
of CAPD in the case of catheter Implantation. Possible
ex p l a na tions suggested include the body's first exp osure to 
the peritoneal dialysis solutions with their
u n p h y s i o 1o g i c a 1 I y ele va te d hydroge n ion and dextrose 
concentrations, dia lysate additives (eg heparin, N a C l , K C 1) 
or dial ysate c on ta minant s including p a r t icula te  matter such 
as silica, talc and pias ticizers released from dialysate
6 1
contain ers  and tubings (Digenis ejt aj_, 1982; Hu mayun et
a 1 , 1961 ; Spi nowi tz  e_t aj_, 1981; Po po vich e_t aj_, 1978; 
Lasker e_^ aj_, 1975; Lee & Schoen, 1967). The se substances 
may be irritant and/or allergic, either individu al ly or in 
combination. F ur th ermor e repeated inflamma ti on in the 
abdominal cavit y due to recurrent per ito ni tis or to
irritants or par ti cu late matter in the di al ysate solutions, 
were thought to be the cause of scle rosing  peritonitis 
(Shaldon ejt a 1 , 1986; Lasker ejt^  a 1 , 1975; Gandhi e_^ a 1 ,
1972; Pauli ej^ aj_, 1966).
However, the majority  of PDE samples contained 
p r e d o mina nt ly  mac roph ag es as shown also by Alobaidi ej^ aj_ 
(1986), Pet er son ej^ a 1 , (1985), and V e r br ugh e_^ aj_ (1984;
1983). On analysi s of the results, a value of 15% for 
neu tr op hils and eos inoph il s was conside red ap pr o p r i a t e  for 
exc lu ding  any sample that might have come from a patient 
with p eriton it is  from further Investigation of its cellular 
activity. Indeed, from work und er taken by others the normal 
range of ne utroph il s found varied from 0 - 22% in one case 
(Verburgh et a 1, 1983), and from 0-9% (Verburgh et a 1,
1984) in another. The 15% value used here therefore seems 
in line with the above findings which give an aver age value 
of 15.5%.
In spite of the fact that quite a number of the PDE
samp les were d iscounted when this co ndition  was i m p o s e d , i t
did ensure that the likelihood of a n a ly sing infected
%
samples, or samples where, the cellular ac tiv it y may have 
been influenced by no n- s p e c i f i c  in flammatory agents, was 
greatly reduced. It was also important to exclude samples 
with raised poly morph values because it was p r i m ar il y the
6 2
ac ti vi ty of the m a c r oph ag e populat ion that was to be 
examined, and some of the parameters could be affected by 
neut ro ph ils or eosinophils.
Even when one con siders only samples of PDE con taining  
15% or less polymorphs, the differential white cell counts 
of peritoneal cell samples from CAPD patien ts are still 
dif fe re nt from those of the normal cell p o p u lati on  found in 
the peritoneum. In par ticular the av er age pro po rtion of 
ma c r ophage s present in PDE and in normal controls were 
69.9% and 91. 4% respectively, a finding in line with that 
reported by Alobaidi e ^  a 1 (1986), Pe t e r s o n  a 1 (1985),
Go ld st ein e_^ (1984) and Verbrugh ejt a_l_ (1983). This
altered differential ratio of cells may sev er ely compromise  
the normal defences of the peritoneum, even if their
ac ti vi ty was unchanged, by upsetting the normal immune 
response m e c hani sm  of the peritoneum, thereby leaving it 
prone to infection. In particular, the flushing out of 
large numbers of cells each day may mean that the 
periton eu m may be replenished by immature cells as
suggested by G o l d st ein ejt aj_ (1984) leaving it severely 
short of mature macr ophag es  which play such a large part 
in many of the immune responses of the body eg an ti ge n  
presentation, an tibody  production, i m m u n o r e g u 1 ation
( K a m p s c h m i d t , 1984 ; Unanue ej^ a 1 , 1984 ; Staru ch and 
W o o d , 1983; U n a n u e , 1981). The greater siz« heterogene it y 
found in CAP D peritoneal cells, compa red with normal 
peritoneal cells, could be the result of the replacement of 
peritoneal cells in CAPD patients by a very mixed
popu la tion of mo nocytes all at dif fe rent levels of
maturat i on.
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The inverse c o r r e la tion found b e t we en the number of 
cells isolated from the PDE of patients and the length of 
time on CAPD might suggest that the cellular defence 
mechanism s in these patients would be se verely af fected by 
this cell shortage if they were of prime importance in
pr ot ecting the patient from peritonitis. However no such
increased su s c e p t i b i l i t y  to perit onitis was shown in these 
patients, which brings into question the importance of 
these cells as the front line of the defence system in the
peri toneu m of CAPD patients. It is possible, however, that
these patients* cells may become trapped by changes in the 
peritoneal membrane, and the number of cells in the fluid 
would repre sen t only a small fraction of those present in 
the peritoneal cavity. Indeed, marked  thi cke ning and 
sclero sin g of the peritbneal membran e (sclerosing 
peritonitis) has been noted in a number of patients 
(McWhinnie e_^ aj_, 1986; Shaldon e_t a 1 , 1986; Gandhi a 1 ,
1980) who have been on CAPD for at least 1-2 years. The 
exact reason for this thickening, c h aracter is ed by the
d ep os ition of a dense layer of fibrous tissue on the
peritoneal surface which comes to resemble a fibrous band
rather than an ul tr athin membrane, is unknown, but as 
su ggested earlier, repeated inflammation in the abdominal 
cavit y due to recurrent peritonitis or to irritant in the 
dialy sat e solutions has been blamed (Di Paolo e_^ s^, 1986;
Sh aldon et a 1 , 1986; Gandhi ej^ a 1 , 1980; Lasker et a 1 ,
1975; Pauli ej^ aj_, 1966). The dial ysa te might also cause 
peritoneal irritat ion  by virtue of its acidity (Gandhi e_t 
a 1, 1980), as initially the fresh di al ysate has an acidic
pH. The ph enomen on  of peritoneal thickening is of great
6 4
potential importance, since it may seriou sl y limit the long 
term a p p l i c a t i o n  of all forms of peritoneal dialysis.
In conclusion, it has been shown that macr ophages  are 
nor mal ly the predom inant cells found in the PDE of patients 
wit hout infections or inflamma tory complications. In the 
following chapters the cell samples will be examin ed for a 




DEVELOPMENT OF A RADIOMETRIC ASSAY FOR COMBINED MEASUREMENT 
OF INGESTION AND INTRACELLULAR KILLING OF B.EPIDERMIDIB
6 6
w .  INTRODUCTION
To e s t ablish whether m a c r op ha ges do indeed 
play an important role as a first line of defence against 
peritoneal infection in CAPD, it is nec e s s a r y  to estab lish 
whether they possess normal antimicrobial activity. This 
requires exam i n a t i o n  of the peritoneal cells isolated from 
the dia lysis fluid of a large number of patient s on CAPD. 
It was therefore necess ar y to develop a techn ique that 
would allow rapid ev al uation  of uptake and intracellular- 
killing of S_^ epidermi dis (the most frequent  cause of 
peritonitis in CAPD patients) and which would permit 
processing of several samples per day if necessary.
A major diff ic ulty in the qu a n t i f i c a t i o n  of 
ph ag ocytosi s over the years has been the lack of methods 
that dist i n g u i s h  prec isely  between m i c r o - organ is ms attached 
to, or ingested by phagocytes. This d i s t in ction is
pa r t i cu larly Important when at te mpt ing to eva luate the
capacity of phagocytes to kill ingested organisms.
Methods previous ly used for the e v a l ua ti on of 
phagocytos is  of m i c r o - orga ni sms include that of looking at 
stained smears, under light microscop y (Patterson and
Y o u m a n s ,1970 ; C h a n g , 1969), or by p h a s e - co nt rast micr os copy 
(Gibbs and Roberts, 1975; Swanson e t a 1, 1974). These
microscopical ex ami nat ions are time co nsu min g and liable to 
subjective error. Other approache s include the recovery of 
cel l - a s s o c i a t e d  microbes after attempts to remove or kill 
extrace ll ular organisms by exposure to enzymes, antisera or 
antimicrobial agents (Verhoef e_t aj_, 1977; Veale ej^ a 1 ,
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1976; Tan e_^ aj_, 1971). Chemi luminescence can also be used 
as another measure of phago cytic activity. However this is 
an indirect method of me asurin g phagocytosis, as at tachment 
of m i c r o - o r g a n i s m s  to the cells st imulates the plasma 
membrane, leading to acti vation of a re sp iratory burst
CEasmon e_t a_l_, 1980). This does not n e c e s s a r i l y  imply that
the m i c r o - o r g a n i s m s  are sub sequ ently p h a g o c y t o s e d , and
c h e m i l u m i n e s c e n c e  gives no indication as to the fate of the 
mic ro- organisms, i.e. whether they are killed or have
survived.
Most techniques for estimating the microbicidal
cap aci ty of phagocytes  require the sep ara ti on of
int rac ellular and extracell ular organisms. When bacteria 
are used, the separa ti on is us ua ll y achieved  by
differential ce n t r i f u g a t i o n  or dest r u c t i o n  of the 
extrac el lular organisms. Ra diometr ic  assays, which use
prelabel led bac te ria to mea sure phagocytosis, still require 
a sepa ra tion step, and bacterial death is dete rmined  by 
colony counting (Verbrugh ejt s^, 1978) which is tedious and
time consuming.
Bridges e ^  aj_ (1980) developed a r a d i o metric  assay 
based on an earlier method for mea su ri ng phag ocytosis 
(Yamamura e_^ a 1 , 1977) but, in add it ion to this, also
measu red  met ab olic death of C a n d 1 da albicans without 
involving any inconvenient plate counting or complicated 
se parat ion steps. Lam and Mathison (1979) also modified 
Yamamura* s method  (Yamamura e_^ aj_, 1977) to quantit ate 
bacterial phagocytosis. Both methods easily di st inguish 
be tween adher en t or ingested micro-organisms. The basic 
pr inciple of the assays was established by Yam am ura ej^ aj_
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(1977), who d e m o n st ra ted that incorpora tion of t H3 -u rid ine 
into albi cans was a good indicator of pha gocyt ic
function s i n c e : -
(i) a linear corr elatio n was found be tween uridine 
incorporat io n and yeast number
(il) C a n dida organisms surviving wi thin phagocytic  
cells did not take up uridine from culture medium, and 
(ill) p ha go cytic cells did not incorporate signific ant 
amounts of uridine in short term cultures.
Phagocyt os is can thus be determined by comparing the
uridine inco rp oration  into a fixed number of m i c r o ­
organisms in the presence and absence of phagocytes. 
Intracellular killing can be determined in a similar manner 
by measuri ng  the uridine incor poration after cell lysis, 
which results in ingested but still viable organ ism s being 
released, and thus able to incorporate uridine.
In this chapter, the dev elopment of a simple but 
accurate radiomet ri c technique for me asuring  phagocytosis  
and killing of S^_ epide rm idis based upon inc orp orati on of
3
C H]- uri di ne into viable micro- organi sm s is described. 
Altho ug h based on that of Bridges aj_ (1980), many of the 
parameters had to be adapted for use here, as their assay 
was de veloped for me asu rin g phagocytosis and intracellular 
killing of Candi da albi cans by blood neut rophi ls  and not of 
S . ep id ermidis by peritoneal macrophages. This method 
allows phagocy to sis and intracellular killing to be 
measured s i m u l t a n e o u s l y  making it possible to determine 
whether increased survival of the mic r o - o r g a n i s m s  is due to 




3.2.1. P h o sphat e Buf fe red Saline (PBS)
This cons isted of NaCl (6 g/1), K C 1 (0.2 g/1),
Na ^HPO^ (1.15 g/1) and KH^PO ^ (0.2 g/1), (all Analar grade, 
BDH Che mi cals Ltd., Poole, Dorset, U.K.). The PBS was then 
divided into 10ml al iquots and sterilised by filtration.
3.2.2. PBS 2. G 1 ucose
This consisted  of glucose (1 mg/ml) in PBS. Aliquots 
were ster il ised by fil tration  and stored at 4°C.
3.2.3. Normal Human Serum (NHS)
Serum was obtained from the clotted blood of 30 normal 
individuals, pooled and aliquo ts stored at -20°C.
3.2.4. Tr i tiated Uridine
The 5, G [ H3- uridi ne used had a specific ac tivity  of 53 
C i / m m o 1 (Amer sham p . I.e., Amer s ham, U.K. ),
3.2.5. C u 1ture of Sta ph ylococc us  ep idermid  i s
A strain of Sj^ epidermi dis isolated from the fluid of 
a CAPD patient with active per itonitis in the Western 
Infirmary, Glasgow, was used throughout this work. It was 
typed by Dr Anne Easta wa y (Dept of Bacteriology, Western 
Infirmary, Glasgow) using the APl -S taph typing system (API 
L a b o ra to ry Produc ts Ltd., Hampshire, U.K.) which  gave a 
99.7% proba bi lity of id entif ication as S .epi d e r m l d l s . The 
organism was routi nely cultured in meat extract broth and 




3.3. 1. Standard Tur bi dity Curve of S . epi dermid i s
In order to calculate  the number of bac te ria in a 
sample for use in the assay without having to plate out a 
sample overnight it was nece ssary to relate bacterial 
numbers to tur bidity readings from a spectropho tometer.
A 1ml aliquot of an overnight culture of S .
epidermi dis in meat extract broth was added to 20ml of 
fresh broth and incubated at 37°C. After two hours of 
incubation, and at 45 minute intervals thereafter, 2 m 1
aliquots of the sus pension were removed and serially 
diluted up to 10^ times with ice cold sterile saline. The 
number of viable bacteria was then determ in ed by the plate 
counting method of Miles and Misra (1938). Plots of the
number of viable bac te ria with time were made and the log-
phase d e t e rmin ed  (Figure 9). The reading of the
bacteria  present in the remaining 1ml volume was measur ed
against a meat extract broth blank on a LKB Ult ro sp ec 4050 
spectrophotometer. From these results, a plot of the 
reading aga in st the number of viable ba cteri a was made 
(Figure 10). This standard curve was used to estimate  the 
number of viable bacteria at the beginning of each 
individual experiment.
3.3.2. Uridine I n c o r p o r a t 1 on Into Bacter ia and Cells
A BOOpl aliquot of an overnight cultur e of S .
ep id erm idi s was incubated in 10ml of fresh broth for 2.5
7 1









mid—log phase of growth
F I G U R E  9 Î Gr ow t h  Curve of S . e p i d er midis in Meat Extract 
Broth.
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F 1GU R E  10 : Plot of Number of Viable S. e p i d e r m i d  i s Against
T u r b i d i t y  at 550nm.
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hours as in 3.3,1. The bacter ia were then washe d 3 times in 
PBS and resuspe nded in 10ml of PBS-glucose. The turbidity 
of the su s p e n s i o n  was me asu red as above, and the number of 
b ac te ria per ml calculated. App ropriat e dilutions of 
bacteria, made up in culture medium (2.2.1) to 0.5ml, were 
then dis pe nsed into 1.5ml plastic mi cr ovlal s to which 2|iCi
3
of C H]*-uridine was then added. Control tubes containing 
similar c o n c e n tration s of dead bac te ri a (heated at 100°C 
for 15 minutes) were also set up to ensure that the uridine 
was being inc orporated by specific met a b o l i c  ac tivity 
rather than by passive absorption. All the tubes were then 
incubated for one hour at 37°C on a blood tube rotator 
(Stuart, Croydon, U.K.), after which time the bacterial 
suspensions were har vested on a Mi 1 1ipore Milli titre 
ap par atus (Mi IIipore UK Ltd., Harrow, Middlesex, U.K.). 
Each sample was split into 2x200|il aliquots and each was
drawn by suction through a separate well of a Millit it re
96-well plate fitted with a 0.4pm type STHA filter base. 
All wells were washed twice with 200pl of PBS and the 
filters cut out with a Mi ItIpore filter punch. The filters
3
were dried and H ac ti vity counted in a 4450 s c in ti llatio n 
counter (Packard Instruments, Caversham, Berks, U.K.). A 
graph of bacterial number against uridine in corporati on was 
then plotted (Figure 11). From the graph it is apparent
that urid ine inc orporatio n increases linearly with the
number of viable bacteria. In contrast urid ine was not 
incorporated by the dead bacteria.
A similar experim ent was carried out on the PDE cells 
Isolated from patients on CARD (2.4.1) to ensure that the 
cells could not incorporate significant am ounts of uridine
7 4
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and the refore interfere with the assay. A su sp ensio n of 
55x10 cells in 0.5ml of culture mediu m was incubated with
3
2jiCi of [ H] -u r i d i n e  in 1.5ml plastic microvials. Tubes 
co nta ining only culture mediu m were also set up. After one 
hour the tubes were harvested as described  above. It was
3
shown that al t h o u g h  the inc orporat ion of t H]- ur ld lne by
cells was usually  greater than the counts obtained from
controls con ta in ing culture medium alone, it was not high
enough to greatly affect results (Table 5) as it was much
lower than the incorp oration  by S .epi derm i d i s , c.f. Figure
311. In any event C H3-u ridine  inc orp orati on by the cells 
is taken into acc oun t when calculating results.
3.3.3. V i a b i 1ity of Cells
In order to ensure that the viability of the cells
isolated from the PDE of CAPD patients (2.4.1) was
5
m ai nta ine d over the assay time, 5x10 cells in 0,5ml of 
culture me diu m were rotated on a blood tube rotator for
varying lengths of time (Table 6). No decrease in
viability, de te rmined by eosin stain exclusion, was
observed during a 3 hour period (Table 6).
3.3.4. Préparât ion of Opsoni sed S.epider mid i s
A BOOjil aliquot of an ove rnight culture of
S.e pider mi d! s in meat extract broth was incubated in 10ml 
of bro th in a water bath at 37°C for 2.5 hours. The
bac te ria were then pelleted at 1750g for 5 minutes,
re suspen ded in 1ml PBS, and 1ml of NHS added to opsonise 
the bacteria. After i n c u b a t i on at 3 7 °C for 15 minutes, the 
bac te ria were washed three times and resuspen ded in 10ml of
7 6
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TABLE 5 ! C_ H 3 “Urldtne I ncorporat  i on by CAPD Perl tonea i
Ce lis.
CPM
E X P E RI ME NT
NUMBER
IN SAMPLES
CAPD PERIT ON EAL 
CELLS
CONTAINING:








counts per m i nute
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TABLE 6 ; V 1ab i 1i ty of Ce 11 s From PDE S a m p 1 es After Var i ous 
Lengths of Time.
LE NG TH  OF PER C E N T A G E  VIA BI LTY OF CELLS FROM PDE
TIME CELLS SAMPLE NUMBER
WERE ROTATE D 
(MIN)
0 98.9 100.0 98.0
30 90.0 97.6 96.3
60 94.3 95.1 94.1
90 96.7 94.3 100.0
120 90.9 97.6 90.7
150 97.7 100.0 93.3
180 97.8 94.7 95.3
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PBS c on taini ng  1% glucose (3.2.2). The turbi dity of the
sus pe nsio n was mea su red at 550nm in a spectrophotometer,
and the number of ba cter ia  per ml ca lculat ed  from the
tu rbidity curve (Figure 10). The s u s p ens io n was then
5
a dju sted to 8x10 bacter ia  per ml.
3.3.5. P r e p a r a t i o n  of Cells
Peritoneal cells were prepared as pr eviousl y described  
(2.4.1) and re su spended in culture medium (2.2.1).
3.3.6. 1ncubat ion of Cells With Bacter ia and Subsequent 
S ep ar ation of 1ntrace 1 lular and Ex trace 1 iular Bacterla.
A p p r o p r i a t e  numbers of cells in 250pl aliquo ts  (3.4.2)
were d i s p en se d into 1.5ml plastic microvi al s along with a
5
sus pe ns ion of 2x10 S.epi dermi di s in 250pl of culture 
medium. Control tubes were set up cont ainin g either
ba cteri a or cells only, and the volume made up to 0.5ml 
with culture medium. The tubes, which were set up in 
triplicate, were than incubated at 37°C on a blood tube
rotator .
After one hour the tubes were removed and each 
suspension  split into two aliquots, one for measu ring
per cen tage killing and the other percent age  ingestion. All 
the tubes cont aining cells were then spun at low speed 
(250g) for 5 minutes in order to pellet the cells, but 
leave the ba cteria  in suspension. The su pe rnata nts were 
removed and those from the control tubes, con ta ining cells 
only, were discarded. The sup ernatants from the tubes 
con tai ning both cells and bacteria were tra nsfe rr ed ‘to new 
tubes and spun at high speed (i750g), along with the
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control tubes co ntaining only bacteria, to sediment the 
organisms. All sup ernatants  were discarded. The




3.4.1. V a r i a b 1 es 1n the Phagocyte s i s Assay
The basic princ iple of the assay was de scrib ed by 
Bridges ej^ a 1 (1980), who studied the a b i lity of human
blood n eutrop hi ls to ingest and kill Cand i da a l b i c a n s , and
by Lam and liathison (1979) who measured uptake, but not
killing, of S .aureus by human neutrophils. Some of the
parame ter s in the present work were based on the earlier 
studies. However, these used different organisms, and blood 
ne utrophi ls rather than peritoneal macrophages. It was
therefore nece ssary  to optimise a number of paramet ers for 
the particu lar conditio ns of this study. ^
3.4.2. Ce ll:Bacter  ia Rat i o
Initially, ex perim ents were ca rri ed out using 
diffe ren t ratios of ce 1 1s :b a c t e r i a . A ce I 1 :ba ct er ia ratio 
of 2:1 was found, in pr el iminary experiments, to result in 
60-90% ingestion in most cases (Table 7). At a 4:1 ratio, 
ingestion tended to be close to 100% with little variation 
between samples, while at a 1:1 ratio only a small 
proportion  . of the bacteria  were ingested. High
ce 11 :bacte ri a ratios were also impractical as they required 
larger numbers of cells than were gen er ally available. A 
2:1 ratio of ce 11s :bacter ia  was therefore used throughout 
the assays.
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TAB LE 7 : Ingestion of S.e pid ermid is  by D i f fer en t Ratios of
Cel Is:Bacter ia
PERCENTAG E INGESTION OF 
RATIO OF S.E PIDE RMIDI S BY
CELLS : BACTER  lA^  ^ P E R I TO NE AL CELLS FROM CAPD PATIENTS
EXPERIMEN T NUMBER
1 2 3 4
4 : 1 92 94 96 100
2 : 1 63 71 90 88
1 : 1 20 17 32 Not
Done
A suspen si on  of 
medium was used
2x10^ S.e pidermi di s in 250ul 
throug hou t the experiments.
of culture
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3.4.3. Lys 1 s of Cells to Re 1 ease Int race 1 lular B a c t e r 1a
In order to measu re the bactericidal ac t i v i t y  of the
cells it was n e c es sa ry to ensure that e f f e ctiv e lysis of
the cells occured so that any ingested but still-vi ab le
3ba cte ri a would be released and have access to the C H ]- 
ur idine when added. For this Bridges e_t (1960), who
wo rke d with Candida, used d e o x y c h o 1 a t e , but this was 
unsuita bl e for use with bact eria as it di ss olves comp on ents 
of bacterial cell walls. Instead the effec t of Triton X-100 
(BDH C h e m icals Ltd.) on cellular and bacterial via bi lity  
was tested. Al iquot s of cell su spension or S.epi dermidi s of 
known co n c e n t r a t i o n s  were pelleted and res us pe nded with 
lOOpl of various dil utio ns  of Triton X-100 in dis ti lled 
water (Table 8). The cells were then vor te xe d and left for 
two minutes, after which the detergent was diluted with a 
fiv e- fold  excess of cult ure me dium (2.2.1). Cell viability 
was de te r m i n e d  by eosin exclusion, and bacterial via bi lity
3
by [ H3-u r i d i n e  inc orp orati on  as d e s cr ib ed in section
3.3.2. T rit on X-100, at a c o n c e ntra ti on of 0.01% was found 
to give 100% lysis of cells (Table 8), but unlike higher 
con cen trations, did not signific an tly affect vi ability of 
S . e p I d e r m i d i s . A 0.01% solution of Triton  X-100 was 
there for e used to lyse cells. Lam and M a t h i s o n  (1979) who 
worked with n eutro ph ils used distilled water, but in the 
present studies this was found to leave an aver age of over 
40% of the cells still intact -(Table 9).
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TABLE 8; Effect of Triton  X-100 On Viability  of 
S . e p i de rmidis  and Periton ea i Ce 1 Is.
C O N C E N T R A T I O N  % OF P ERITO NE AL V I A B I L I T Y  OF BA CTERIA
OF TRITON  X-100 CELLS (% OF C O N TROL WITH OUT
(%) VIABLE TRITON X-100)
0. 1 0 22
0.01 0 93




TABLE 9 : S u r v 1 va 1 of Per i t o n e a 1 Cells After Exposu re to 
D i s t il le d W a t e r .
% OF VIABLE P E R I T O N E A L 
SAMPLE NUMBER CELLS AFTER 1 MI NUTE IN








AV ERAGE  41
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3.4.4. Procedu re  for the Me asureme nt of Ingestion and
Intrace 1 1u 1ar Killing of Bacter i a .
To the ceil pellets in the tubes to be used for
ass ayi ng killing, obt ain ed as described in section 3.3.6, 
100|il of 0.01% Triton X-100 in distille d water was added, 
the tubes vortexed and the liquid added to the 
c orres po nd ing bacterial pellet. To ensure uniform 
conditions, 0.01% Triton X-100 was also added to the
bacterial pellet from the b a c t e ria -o nly control tubes to be 
used for the int racellular killing part of the assay. All 
the tubes were vortexed and left for two minutes to allow 
the cells to lyse, and then 380pl of culture medium
(section 2.2.1) was added to each tube.
The tubes used to measure ingestion (section 3.3.6)
were treated in a similar manner, except that the medium
was added first and used to recombine the cells and
bacteria, 0.01% Trito n X-100 being added afterwards. This 
was done to allow for any possible effect of Tr iton X-100 
on sub seq uent bacterial growth; once di luted with medium
(section 2.2.1) it was no longer s uffi ci ently con centrat ed
3
to lyse the cells. Finally 20pl of L H3- u r i d i n e  (2pCi) was 
added to each tube and these were then rotated at 37°C for 
one hour.
After one hour the cultures were harvested  (section 
3.3.2). The percentage ingestion and killing were 
calculated  using the following formula, the ap pr opriate 
controls being used in each case:
A + B - C
percentag e ingestion or killing = -----------  xlOO
A + B
8 6
where, A,B and C are the ave rage counts in tubes contain ing  
bac te ria only, cells only, and bacter ia  and cells 
respectively. Variation  in counts be tween triplicate 
samples was no rm al ly very good and well centred about the 
mean (Tab le 10).
3.4.5. C o m p a r 1 son o f Rad i ometric Me t hod With C o n v enti on s 1
Co 1ony-Count  ing T e c h n i q u e .
The ac cu racy of the assay method as finally devised
and des cr ib ed above was tested by co mpa rin g the results 
3
obtained by C H3- uridi ne  incorporation with those using a 
conventional c o l o n y -coun ti ng technique. For this an aliquot  
of each sample was removed and serially diluted with ice- 
cold saline for plate counting by the method of Miles and 
Misra (1938) immediately prior to passing the remainder 
through the filter (3.3.2). Four samples of cells from CAPD 
patients, in which the cells varied in their ability to 
ingest and kill S . e p i d e r m i d i s , were used, and in all cases 
good agreemen t was found (Table 11).
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t a b l e  10 ; V a r i a t i o n  i n Counts Per Minute After C_ H3- Ur idine 
1n c o r p o r a t i o n  B e t ween  Tripli cate Samp les.
TYPE OF EXA MP LES OF MEAN
SAMPLE COUNTS PER (CPM)
MINUTE (CPM)
% VARIATI ON  
ABOUT MEAN
PeritoneaI 












Per 1t o n e a 1 












Peri t o n e a 1 











14932 ± 3 . 3
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T A B L E  1 1 ; Co mp a r I s o n  of Ingestion and Killing of S . 
e pi de rmi dis by Human Per i toneaI Cells Using t he
3
L  H ]-Urid in e Incor porat i on Assay or Co 1ony
Coun ting.
% INGESTION
% KI LLING OF 
INGESTED BACTERIA
SAMPLE C^H3-URIDINE COLONY C^H ]-UR ID1NE COLONY
NUMBER INCORPORATION COUNTS I NCORPORATI ON COUNTS
1 64. 4 62. 6 67.7 83. 1
2 78. 1 78.4 79. 4 79. 8
3 93. 1 92. 6 93. 1 94.6
4 70. 0 69. 7 100, 0 99. 6
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3.4.6. Sum mary o f Comp 1ete Assay Proc edure
1. Opso nised  S.e piderm id is were prepared as previo usly 
de scribed in section 3.3.4.
2- The peritoneal cells, after isolation from PDE (2.4.1), 
were re suspen de d in culture medium (2.2.1) at 1.6 x 10^ 
cells per ml.
3. The method for the incubation of cells with bacteria,
and the sub seq uent separat ion of intracellular and 
e x trac el lular bacteria was as describe d in section
3.3.6. A 2:1 ratio of cells to ba cte ri a was used
througho ut ie 250jil of the cell s u s p ensio n at 1.6 x 10*^ 
cells per ml was incubated with 250^1 of bacterial
5
su sp ensi on  at 8x10 bacteria per ml.
4. Cells were lysed to release intracellular bacteria  using 
lOOjil of 0.01% Triton X-100. Details of the method used 
are as described, in section 3.4.4.
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& A  DISCUSSION
In order to evaluate the ingestion and 
intrace llu lar killing of S_^ epidermidi s by peritoneal cells 
isolated from the PDE of patients on CAPD, an assay had to 
be de ve loped  which would be both accura te and simple enough 
to be carried out routinely. It is also important to 
es tabli sh  if their activi ty  is reduced co mp ared with normal 
peritoneal cells, and whether this reduced activity, if 
any, could acc ount for the Increased s u s c e p t i b i l i t y  of some 
patients to peritonitis. With this in mind a radio metric  
assay has been de veloped based on that des cri be d by Bridges 
e t a 1 (1980) but with m odif ic ation of a number of
p a r a m e t e r s .
The method develope d is simple, convenient, accurate 
and fairly inexpensive in terms of money and time which are 
essential requirements  if the assay is to be carried out 
ro utinely for monitori ng patients* cells. It also does not 
Involve tedious colo ny - c o u n t i n g  used to dete rm ine bacterial 
viability in previous methods (Verburgh ej^ a 1 , 1978 ) or 
microscopical e x a m in at ion of slides (Patterson and 
Y o u m a n s ,1970 ; C h a n g , 1969) which is t i m e - co ns uming and 
subject to error.
Unlike Lam and Ma th ison (1979), water was found to be 
u n s a t i s f a c t o r y  for lysis of cells. Instead a 0.01% soluti on  
of Trito n X-100 was used, a co nce n t r a t i o n  which while 
lysing cells did not adversely affec t the bacteria. 
Deo xyc ho late, used by Bridges e_t^  aj^ , (1980) is unsuitab le  as 
it disso lves co mponents of bacterial cell walls.
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A cc ur acy and re liabilit y of the assay were tested by 
comparing results obtained from the r a d i om et ric assay with 
the conventional co lony-c ou nting technique. in all cases 
good agree me nt was found. There was also little var iation 
be tw een triplicate samples.
The tec hnique des cr ib ed here therefore allows rapid 
evaluat io n of phagoc ytosis and bactericidal act iv it y of 
cells from patients on CAPD. Both are measured 
simultaneously, making it possible to de termine whether 
increased survival of the mi cr o- organi sm s is due to reduced 
ingestion or reduced abil ity  of cells to kill the ingested 
bacteria. Unlike many methods (Verbrugh et_ aj^ , 1978; Verhoef 
et a 1 , 1977 ; Tan e ^  aj_,1971) the problem of precisely 
disti n g u i s h i n g  between attachme nt or ingestion of m i c r o ­
organisms does not arise as only unin ge sted bacteria  have
3
access to the C H 3-uri di ne which is not taken up by the 
cel Is.
This a s ssa y described here has been used in the 
following chapter to evaluate the a c t ivi ty  of peritoneal 
cells from patients on CAPD compared with those cells from 
normal individuals. Pos sib le dif fe rences in ac tivity
between patients and controls, and within  patients may 
provide an ex pl a n a t i o n  for the increased su scep t i b i l i t y  of 
some patients to peritonitis.
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CHAPTER 4
FUNCTIONAL PROPERTIES OF HUMAN PERITONEAL MACROPHAGES
9 3
ijju. iNTncpyffiiJ-flM
Rec en tly there has been increasing interest in 
peritoneal defense mechanisms, aiming at clarif ying the 
root causes of perit oni tis in CAPD patients, and 
identi fyi ng ch ar ac t e r i s t i c s  of patients with high infection 
rates (Diskin e_t ^ , 1 9 8 3 ;  Rubin e_t a_l_, 1983 ; Verbrug h ejb a 1 , 
1983). Work by Tsakiris e_t aj_ (1986) on the skin reaction 
of CAPD patients to dinitr oc h I o r o b e n z e n e  (DNCB) suggested 
that intrins ic di fferences  may exist in the host immune 
response among CAPD patients. They showed that patients 
with strong DNCB responses have a better chance of 
remaining free of pe riton itis for longer than those with 
poor responses. This may indicate di ff erences in the actual 
peritoneal defence mec ha nism within patients, and may 
con tri bute to the increased sus ceptibi li ty to peritonit is  
found in some patients. The DNCB skin test has the 
advanta ge  over those using recall antigens of not testing 
immunological memory, since it Is a new a n t i g e n  to which 
patients will not have been exposed to (Bramwell e_t_ 
a_l_, 1985 ; Wats on ej^ a 1 , 1979 ) .
I mm un osuppressi ve effects of ur ae mia have been 
reported, and have frequently been a ttribut ed  to inhibitory 
or toxic factors retained in the serum of u r ae mi c patients- 
the so-call ed middle molec ule s CFunck- Br e n t a n o  et a l ,1975; 
Touraine e_t^  aj^ , 1975). An improvement in cell mediated 
immunity (CMl) during CAPD compati ble with the removal of 
uraemic sub sta nces that inhibit T -lym ph ocyte functions has 
been observed (Young e ^  aj_, 1986; G i a n g r a n d e  e_^ a 1 , 1964 ;
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G i a cc hi no  a 1 , 1983 ) . However, while imp rovement in CM I 
may increase resista nce to fungal, viral and intracellular 
bacterial infections such as m y c o bacter ia  it is unlikely to 
confer any clinical a d v antage against per it onitis  by normal 
ext racel lu la r G r a m - n e g a t i v e  or G r a m - po sitive bacteria. In
addition, as Young ejL aj^( 1986 ) suggested, a de pl etion of
spe cif ic enzymes, vitamins or trace elements  cannot be
exclu ded  and this could have an important effect on the 
immune response.
While there is eviden ce that CAPD patients have 
impaired immune responses, there is little information as 
to the po ssi ble defects in specific mechanisms, and in 
particular of the resident mononuclear p ha gocytic  cells 
wh ich  may be of prime importance in the p ro te ction of the 
per it on eum from infection. Any defects in these cells may 
greatly impair host resistance, and increase the 
pos sibil it y of organisms est abli shing themselves, thus 
giving rise to peritonitis. In general it has been shown 
that patients with defects in their phago cy tic cells suffer 
from recur rent and severe infections, not infreque ntly with 
a fatal outcome (White and Gall in, 1986; S t o s s e 1, 1974). 
Ph a g o c y t i c  dy sf uncton  most commonly occurs seconda ry to
acquir ed diseases such as rheumatoid arthritis, diabetes 
mellitus, m a l n u t r i t i o n  or certain viral infections (White 
and Gall i n, 1986). In view of this it seems important and 
a p p r o pria te  to examine the antimicrobial a c t iv ity of the 
peritoneal cells from patients on CAPD to de termine whether 
these cells are also defective.
Further informati on about the a c t ivity of these 
peritoneal cells may be provided by ex am ining their ab ility
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to release as levels are bel ie ved to be related
to the bactericidal ac tivi ty  of the cells and to their 
mat urational or activational state (Takemura and Werb,1984; 
Nathan e ^  a ^ , 1983,1979; Joh ns ton 1981). This appears not to 
have been investi gated  in CAPD patients. In general 
patients whose pha goc ytes lack the ab i l i t y  to generate 
reactive ox ygen derivatives, such as those with chronic
g ra nu lom atous disease, have impaired microbicidal activity 
which emphasis es their Importance in killing bacteria 
(Gall in ejt . aj_, 1983 ; Holmes ej^ aj_, 1987,1986).
I*3acrophages also play a key role in the development of 
spe cif ic immune responses by processing antigens, which
requires the presence of HLA-DR antigens. Indeed membrane 
e xp re ssion of human la-like molecules (HLA-DR) by 
mac ro ph ages is critical for the induction of T-cell
responses to foreign antigens (reviewed by Unanue 
et a 1,1984 and U n a n u e , 1981). C on si derably  less Information 
is avai lable  about HLA-DR expr es sion on human monon ucl ear 
phagocy tes  compared with the mouse and in particular it is 
not known whether patients on CAPD show any a b nor ma lities 
in this respect. Such information could be of relevence to 
the immune status of CAPD patients, as low levels of HLA-DR 
e xpres si on  on macr ophag es  may hamper ini tiation of specific 
immune responses. The re fore ab norm a l i t i e s  in the 
pr ope rties of macr ophage function may inhibit not only the 
n o n - sp ec ific ph agocytic role of macrophages, but might also 
co ntribute  to an overall lowering of the whole immune 
r e s p o n s e .
HLA- DR expression, like H^O^ release, may be related 
to the maturational or activational state of the CAPD
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patients* peritoneal macrophages, as it is widely known 
that cells acti vated  through gamma 1FN have raised levels 
of HL A-D R and release compared with those in the
resting state (Gershon ejt a 1 , 1985 ; Wilson and Wes ta 1 1 , 1965 ; 
Sztein e_t aj_, 1984; Basham and lier i g a n , 1963 ; Nathan 
et aj_,1983). It was therefore cons id ered wo rt hwhile to 
exam ine  HL A-DR ex p r e s s i o n  and H 2 O2 release by peritoneal 
cells from CAPD patients to provide In formati on about their 
functional ability which may be related to their state of 
actlvat ion.
The work reported in this chapter was there for e aimed 
at ex amining the c h a ra ct eristic s of the CAP D  cells in 
regard both to their role in peritoneal defence against 
infection and to their relatio nship to other human 
mononuclear phagocytes. This involved:-
(1) exami ning their bactericidal activity and comp aring it 
with that of normal human peritoneal cells. It was also 
important to relate these findings to the frequ ency of 
peritonitis to determine whether patients* cellular 
activity could be corre la ted with their s u s c e p t i b i l i t y  to 
Infectlon.
(2) me asu rin g the levels of H^O^ released by the peritoneal 
m ac ro phages  from the patients on CAPD and compar in g their 
activity  with that of peritoneal macrop hages from the first 
exchange PDE of patients commencin g CAPD, normal peritoneal 
macroph ag es and of blood monocytes.
(3) det erm in ing the expr es sion of HLA-DR by mononuclear 
phagocytes from the same sources as in (2).
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MATERIAL#
4.2.1. E t h y l e n e d i a m i n e - t e t r a - a c e t i c  Ac 1d (E D T A ) Glycine 
Buf f e r .
This consi sted of O.IM glycine (BDH Chemicals) and 
0.0 25M  EDTA (Koch-Light Laborato ri es Ltd., Colnbrook, Berk, 
U . K , ). The pH was adj us ted to 12 with NaQH.
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4.3. PATIENTS AND CONTROLS
In order to study the phag oc ytic and 
bactericidal act iv it y of peritoneal cells from patients on 
CAPD, 28 peritoneal cell samples from 18 patients were 
an al ys ed along with 8 normal peritoneal cell samples by the 
assay pro ce dure descr ibed in chapter 3. Det ails of each of 
these patients and controls, and the samples tested, were 
given in chapter 2 (Tables 1,2 and 4). To study 
release by peritoneal macrophage s from pat ien ts on CAPD, 
peritoneal cell samples from 10 patients com mencing CAPD 
and 22 from patients es tabli shed on CAPD were analysed. 
Details of these patients are given in Tables 12 and 13. In 
ad dit io n 9 normal peritoneal macrophage samples from women 
und er go ing laparoscopy and 7 peripheral blood monocy te 
samples from normal controls were also tested. HLA-DR 
e xp re ssion was analysed using peritoneal m a c r o phages from 
12 patient s com menc in g CAPD and 18 patients e stablis he d on 
CAPD (Tables 14 and 15). In ad ditio n 17 normal peritoneal 
ma croph ag e samples and 9 blood monocyte samples from normal 
controls were tested.
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TABL E 12 : Details of Patients whose Peritoneal Macrophage s
from the First Exchange PDE were Used to Measure
Release of
PATIENTS' SEX AGE ORIGINAL
INITIALS (YEARS) DIAGNOS IS
H.Ca F e m a 1e 53 Pol y c y s t i c  kidneys
V. De Ma I e 39 P y e 1onephr it is
M. Fo FemaIe 74 G l o m e r u l o n e p h r i t i s
J . He Ma 1 e 63 Anal ge sic N ephro pa thy
M. I I FemaIe 55 G l o m e r u l o n e p h r i t i s
H. Le F e m a 1e 56 G l o m e r u l o n e p h r i t i s
M. Me FemaIe 66 Diabet ic  n e p h ropath y
M. Mi F e m a 1e 25 G l o m e r u l o n e p h r i t i s
J . Sh Ma I e 45 G l o m e r u l o n e p h r i t i s
F . Sm Ma 1 e 18 Unknown
All patients were commenced  on the Travenol Disconnect  
System.
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TABLE 13: Deta ils of Patients Es tab 11 shed on CAPD whose
P e r i t o n e a 1 Ma cro phages were used to Measure
Release of 










M . An Fema 1 e 77 2 An a lge si c ne phropathy
J . Be FemaIe 30 15 G 1o m e r u l o ne ph ritis
B. Ca Ma I e 64 12 Hyper tens i on
R • Ca F e m a 1e 40 60 G I o m e r u 1onephr itis
R . Co Fema 1 e 40 15 G l o m e r u l o n e p h r i t i s
W. Co Ma I e 32 10 Hyper tens 1 on
A. Cr Ma I e 32 6 Obstruc ti ve uropathy
P. Cr Ma I e 60 17 Renal ar te ry thrombosis
W. Do Ma I e 73 1 Ne ur o g e n i c  bladder 
fol lowing whipla sh  injury
J. FI F e m a 1e 52 6 D i a be tic n eph ro pathy
R.Fu Ma 1 e 71 4 G l o m e r u l o n e p h r i t i s
I.Jo Ma 1 e 39 28 G l o m e r u l o n e p h r i t i s
W . Ka Ma 1 e 47 16 G l o m e r u l o n e p h r i t i s
R.Ke Ma I e 49 12 G I o m e r u 1o n e p h r 11 i s
H. Me Fema 1 e 21 9 Relux neph r o p a t h y
M. Me F e m a 1e 56 10 P o l y c y s t i c  kidneys
W. Me Ma I e 69 4 Pr o sta ti c o bst ru ction
M . Mu FemaIe 72 15 Unknown
W. Ra Ma I e 65 3 Dia b e t i c  n ephr op at hy
W.Ro Ma 1 e 57 6 An a l g e s i c  neph ropath y
P . We Fema I e 66 12 A n a lg es ic nephrop at hy
M. Wh F e m a 1e 67 3 H y p e r t e n s i o n
A I I pat i ents were on the Travenol Disconnect Sy stem except for
R.Ca who was on Fresenius.
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TABLE 14 ; Petal Is of Pat i ents whose Per 1t o n e a 1 Macrophages 
from the First Exchange PDE were Used to 









J . Ha 
R. Ha 
J . He 
R. Ho 
H. I 1 
R . Ke 
S. Me 
J . Ra 
J. Sh 
M. Wh
Ma 1 e 
F e m a 1e 
F e m a 1e 
Ma I e 
Ma 1 e 
F e m a 1e 
F e m a 1e 
Ma 1 e 
F e m a 1e 
Ma 1 e 
Ma I e 













G l o m e r u l o n e p h r i t i s  
Diabe ti c nep hropa th y  
P o l y c y s t i c  kidneys 
O b s t ructi ve  uropa th y 
A na lg esic neph ropathy  
Renal ar tery thrombosis 
G l o m e r u l o n e p h r i t i s 
G l o m e r u l o n e p h r i t i s  
Reflux n e p h r o p a t h y  
O bstru ct ive uropathy 
Gl ome r u l o n e p h r i t i s  
Hyper tens i on
All patients were co mmenced  on the Travenol Disconnect
S y s t e m .
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TABLE 15 ; Petal Is of Pat i ents £stab 1i shed on CAPD whose 
Per i t o n e a 1 Macrophag es were Used to Deter min e the 
P r o p or ti on of HLA-DR Positive Ce Ils.
MONTHS
PATIENTS' SEX AGE ON
INITIALS (YEARS) CAPD
OR IG IN AL
DI A GNO SI S
J . Be F e m a 1e 30
A . Ca FemaIe 77
B. Ca Ma 1 e 64
J . Co Ma 1 e 31
W. Co Ma 1 e 32
W . Do Ma I e 73
J. FI FemaIe 52
B. Go Ma 1 e 24
H. I 1 F e m a 1e 55
A. Ka Fema 1 e 64
W. Ka Ma 1 e 47
R . Ke Ma I e 49
R. Lo Ma I e 47
C. Me Ma I e 55
D . Me FemaIe 64
W . Me Ma I e 69
A. Me F e m a 1e 37
A. My Fema I e 44
15 G l o m e r u l o n e p h r i t i s
27 G l o m e r u l o n e p h r i t i s
12 H y p e r t e n s i o n
21 G l o m e r u l o n e p h r i t i s
7 H y p e r t e n s i o n
10 Neu r o g e n i c  bladder 
following whiplash injury
6 Di ab etic n e p h r opat hy
31 D i a betic  nephropa th y
3 G l o m e r u l o n e p h r i t i s
2 Pol y c y s t i c  kidneys
16 G l o m e r u l o n e p h r i t i s
12 G l o m e r u l o n e p h r i t i s
11 P y el on ephrit is
3 Diabeti c nep hropath y
26 Ana l g e s i c  n ephropa th y
4 Prost at ic ob st ruction
20 G l o m e r u l o n e p h r i t i s
46 Po l y c y s t i c  kidneys
All patients were on the Travenol D is connect  System except 
for A.My who was on the Travenol System II.
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HOLATION fit CELL#
4.4.1. Peri t o n e a 1 Mac ropha ge s
CAPD and normal peritoneal cells were isolated as 
de scr ibed in section 2.4,1.
4.4.2. Monoc yte s
Blood m on onuclea r cells were isolated by layering 2 
volumes of hepa rinis ed  blood mixed with an equal volume of 
PBS over 3 volumes of separating mixture (Lymphoprep, 
Nycomed U.K. Ltd., Birmingham, U.K.). The samples were then 
c en tr ifuged at 400g for 30-40 minutes. The cells were 
removed from the interface layer by a Pasteur pipette, 
washed twice with PBS and resuspended in culture medium 
12.2 .1.).
All cell samples tested contain ed 15% or less 
neutroph ils or eosin oph ils when stained with Leishma n
12.4.2.). Cell vi ability was always greater than 95% as 
determined by eosin exclusion.
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4.5. METHODS
4.5.1. Pif f erent i a 1 Stainin g of Adherent Ce 11s
Adherent cell cultures were prepare d by adding 1ml of
a 10^ cell/ml suspens io n in culture me dium (2.2.1.) to
sterile round glass covers lips (16mm diameter : MacF arlane
Robson, Glasgow, U.K.) placed in 25 square well plastic
culture dishes (Sterilin Ltd., Feltham U.K.). These were
then incubated for 2 hours at 37°C in 10% CO^. Non -adherent
cells were removed with a Pasteur pipette and adh er ent cells
washed twice with medium. Enu mer at ion of n on -adhere nt  cells
5in a hae mocy to meter revealed that ap p r o x i m a t e l y  4- 5x 10  
cells had attached to the covers lips in each well. 
Mo nol ayers were allowed to dry at room te mperature  before 
staining. Differential cell counts of the adh er ent cell 
samples were determi ned routinely using Leish ma n stain 
(2.4.2.) and some prep arations were also stained with ANAE 
(2.4.3.). Only adherent  cultures where more than 97% of 
cells were identified as mac rop ha ges and where 
co nt a m i n a t i o n  with either neutrophils or lymphocytes did 
not exceed 2% were used for determining release or
HLA-DR expression. Examples of cells from all four sample 
types used for meas ur ing H^O^ release and HLA- D R  ex pr essio n 





(a ) Peritoneal ma crophages from patients est ablis he d on 
CAPD, stained with Leishma n 1x1600)
(b) Peritoneal mac ro ph ages from patients e stabli sh ed on 





(a) Peritoneal macro phages from patients c ommen ci ng CAPD, 
stained with Leishman 1x1600)
(b> Peritoneal ma crophages from patients comm encing CAPD 





(a) Normal peritoneal macro phages stained with Leishman 
(X1600)





(a) Normal blood mon ocytes stained with Leis h m a n  (xi6ÛÛ)
(b) Normal blood mon ocytes stained with ANAE (xl600)
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4.5.2. M e a s u r e m e n t  of Rel ease and Es t i mat i on of DNA
Cont ent  of Adh er ent Cells.
Cul tu res were e st ab lished at 2x10^ cells in 1ml of 
culture medi u m  (2.2.1.) in Linbro f l at-b ot tomed 24-well 
tissue cult ure plates (Flow Laboratories). After 2 hours at 
37°C in 10% CO^f mon ol ayers were washe d twice with warm 
Hanks Ba l a n c e d  Salt So l u t i o n  without phenol red (HBSS; 
Gibco, Paisley, U.K.) to remove n o n - a d h e r e n t  cells and 
fresh HBSS added.
The method of Ruch e_t aj_, (1983) was employ ed for
de t e r mi ni ng H^O^ release, which depends on the o x i dati on  of
ho m o v a n i l l i c  acid (HVA) to a fluorescen t dimer, the
ox ida tion being med iat ed by horse radish peroxidase. The
HVA o x i dati on  product (a mea sure of ^2^2 release) was
determine d using a P e r k i n- El mer model 1000 fluorimeter with
excitat io n at 312nm and emissi on  measur ed at 420nm. A stock
/ml
s uspen si on  of 20mg/y zym os an (Sigma) in PBS was prepared and 
washed twice in PBS. From this, freshly op s o n i s e d  zymosan 
for use as the tr ig gerin g agent for ^2^2 release was
prepared each day by incubating one volum e of the 
suspens io n with an equal volume of pooled normal human sera 
(3.2.3) for 15 minutes at 37°C, and ce nt r i f u g e d  at 2000g 
for 10 minutes. The pellet was washed twice in HBSS and 
resu sp ended at a final c o n c e n tra ti on of 5mg/ml in HBSS.
The H V A - p e r o x i d a s e  solution consis te d of 400pM HVA 
(Sigma) in HBSS conta in ing 4 units/ml of horse radish 
pe ro xi dase (Sigma). The solution  was prepa re d every week 
and stored in aliqu ots at 4°C.
F o l l ow in g removal of non -adher en t cells from
mac r o p h a g e  monolayers, 1ml HBSS, 0.5ml o p s o ni se d zymosan
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and 0.5ml of H V A - p e r o x 1dase were added to each well, and 
incubated at 37°C for 1 hour. Control wells were also set 
up with no zymosa n to measure the spont aneous release of 
*^2^2* S up ernata nt s were then tr ansferred  to conical 
bottomed plastic tubes, centrifuge d at 1800g for 5 minutes 
to pellet any loose cells or cell debris and the resultant 
supernatant s transfer red to glass tubes. To stop the 
reaction 0.25ml of E D T A - gl yc ine buffer (4.2.1.) was added, 
the tubes vortexed and H^O^ assayed by fluorimetry. A 
standard curve was obtained using varying c o nc en tration s of 
^2*^2 (Boots Ltd., Nottingham, U.K.). The fluorimeter blank 
consi ste d of 1.5ml HBSS, 0.5ml H V A- peroxi da se and 0.25ml of 
E D T A - gl ycine buffer.
DNA was de termined accor ding to the metho d of Cesarone 
et a 1 (1979). After removal of the cell su per natan ts above,
200jil of 0.05% (w/v) sodium dodecyl sulphate  (SDS; BDH 
Chemicals) was added to the macrophages in each well of the 
plate. They were then free ze- thawe d once to comple te lysis 
of the cells. Fol lowing add it ion of 1ml PBS each lysate was 
mixed and tr ansferre d to a conical bottome d plastic tube. 
These were then cen trif ug ed at 900g for 5 minutes after
which GOOpl was transfer red to glass tubes c ont ai ning 4.4ml
—
PBS. Each tube received 20pl of 7.5x1 0 M b i s - b e n z i m i de 
(Hoechs t 33258 ; S 1 g m a ) and was then vo rtexe d before 
incubation in darkness at room temperature for 30 minutes. 
The DNA content of each tube was s u b s e quent ly  assayed by 
fluor ime try . (excitation 364nm, emission 448nm) using a 
standard curve (Figure 16) prepared from calf thymus DNA 
(Sigma). The fluorimeter blank consisted of 4.9ml PBS plus 
lOOpl 0.05% SDS and 20pl of bis-benzimide.
Ill






120 6 102 8
J4g DNA
F I GURE 16 2. Sta nd a r d  Curve for Meas u r e m e n t  o f DNA 
* E x c i t a t i o n  364nm
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The results both for release and DNA content
were means of duplicates, in which v a r iat io n did not exceed 
10% of the mean. Results were expre ssed as p.mH^O^/ÏO pgDNA.
4.5.3. E x p r e s s i o n  of HLA-DR Ant i gen by H u man  Ma crophages 
and M o n o c y t e s .
Huma n m a c r o p h a g e s / m o n o c y t e s  isolated from blood, 
normal peritoneal fluid and CAPD  fluid were e s t a b l i s h e d  as 
m o n o la ye rs on circular glass covers lips (4.5.1.). After 
adherence, cell m o n o la ye rs were fixed for 10 minutes with a 
2.5% so lutio n of f o r m a ld ehyde in PBS (ie 1 volume of 40%
V / V stock f orma ld eh yde 'in 15 volumes PBS) at room
temperature. Cells were then washed for 5 minutes with PBS 
and stained by direct immu no fluores ce nce with one drop of a 
1:3 di l u t i o n  of a p h y c o e r y t h r i n - c o n j u g a t e d  monoclonal 
an tibod y to human HLA-DR  an tigen (Becton Dickinson, 
La b o r a t o r y  Impex Ltd., Twickenham, Middx., U.K.).
After 30 minutes in the dark, cultures  were washed for 
5 min utes in PBS. Covers lips were then removed from the 
wells, moun ted  with PBS-glycerol (4 parts PBS:l part
glycerol) and the edges sealed with nai.l varnish. Initially 
cells were p r e i n cu ba ted for 30 minutes with normal mouse 
serum to mask any Fc receptors to which the monoclonal 
a n t ib ody might have adhered. No d i f f erence  was found with
or without the masking step, and so this was discontinued.
The cells were exami ned under oil in a Le it z Ortholux 
f luore sc en ce m i c r osc op e with a Fluorota r objective. 
St ain ing of HL A-DR was sta ndardi se d using the . HLA-DR
ne gat ive and positi ve cell lines K562 and B-JAB
repectively. The K562 is a trans forme d human erthy roi d
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pre cursor cell line, which lacks the HL A-DR  antigen. It was 
kindly supp lied by Dr. M.J. Lesko, Dept. of Immunology, 
We st er n Infirmary, Glasgow. The HLA-DR  pos it ive cell line, 
B-JAB, is a human lymphoma cell line which was provided  by 
Dr. W. Cush ley, Dept. of Biochemistry, U n i v er sity of 
Glasgow. S t a in ing of the B-JAB cell line was performed by 
Dr. A. Hughes.
The cells were obser ved using e x c i t a t i o n  wa velengt hs 
of 550nm. A m i n im um of 2ÛÛ cells were counted and scored as 
positive only if a sharp peripheral f l u o r escenc e was 
o b s e r v e d .
4.5.4 Statistical Ana lysis




4.6. 1. Uptake and K 1 1 1Ing of S.epider mi dls by Peri tonea t 
Ce Ils.
In most cases the peritoneal cells from the CAPD
patients were ef fic ient at ingesting and killing opsonised 
S .epidermidi s (Table 16). The majority were able to ingest 
over 80% of the test culture from patients and in only 2 
samples (A.Ca and L.McL) were less than 60% of the 
organisms ingested. Intracellular killing of the ingested
organisms was normally >80% with again only 2 samples, from 
patients A.Ca and I.Sc, giving <60% killing. Seven of the 8 
cell samples obtained from normal individuals ingested >80% 
of the organ ism s and for the remaining sample (sample 
number 1, Table 17) the figure was 68%. In all these 
samples the intracellular killing was vir tu al ly 100% (Table 
17). Overall, the peritoneal mac ropha ge s from normal 
individuals were no more efficient at Ingesting 
S .epi d e r m i dis than were the cells from CAPD patients 
(p>0.05>, but they were signifi cantly better at killing the 
ingested orga nisms (P<0.001).
4.6.2. Re l a t i o n s h i p  Be tw een  Phagocyt i c Act ivity of Cells
and F r equ ency of Pe ritonitis i n CAPD Pat i e n t s .
There was no cor r e l a t i o n  between the degree of 
ingestion or of intrac ellular killing by cells from CAPD 
patients with the frequency of episodes of peritonitis 
(Figure 17). However, in Table 16 it can be seen that cells
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T A B L E  1 6  i_ I n g e s t ! o n and Intrace 1 1u 1ar K i 11ing 
S .epi derm i d i s by CAPD Peri t o n e a 1 Ce 1 Is
o f
CAPD % OF S.
P A T I E N T S ’ EPIDER M ID IS 
INITIALS INGESTED
% OF INGESTED 
5.E PID ERMI DI S 
KILLED
FREQUENCY  OF 
P E R I T ONIT IS  
(see Table 2)
A . Ca 32. 1 48.0 6.9
64. 7 97. 8 5.3
61. 4 73. 3 5.5
W.Ch 70. 2 100. 0 1.3
74. 5 80.5 2.2
W. Co 98. 2 95. 9 0
75. 4 80. 6 6.0
64, 4 67.7 6. 0
C.Fe 83. 1 97.5 12.0
A. Fu 78. 1 79. 4 0
B. Go 97. a 90. 5 0
W. Ka 70.6 78. 2 0
R . Le 90. 1 80. 6 12.0
81.4 62. 0 8.0
A . Me 80. 2 93. 0 3. 8
93. 7 91. 2 3. 6
T. Mo 91. 0 94. 5 0
M . Re 87. 4 88. 4 4 . 0
62- 8 87.7 4.0
95. 0 99. 2 3.7
C.McG 85. 1 97. 4 0
81. 8 84. 6 2.7
L . McL 36. 9 88.6 5. 1
M. McV 93. 6 92. 3 4. 4
P . McV 88. 5 82. 6 0
I . Sc 72. 9 57. 2 1. 0
W. St 90. 4 88. 2 6.0
A . Wa 89. 2 94. 2 0
Median 81. 6 88.3 3.8
r quertile 70. 3 79. 7 0
r quertile 90. 3 94. 4 5. 9
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TABLE 17 ^  Ingestion and Intrace 1 lular Kil ling of
S . epidermi dis by Norma 1 Peri t o n e a 1 Ce Ils.
NO RM AL  
P E R I T O N E A L  CELL
% OF 
S. EP IDERM IDIS
% OF INGESTED 
S . E P I D E R M I D I S
SA MPL E NU MB ER INGESTED KILLED
1 67. 8 98. 5
2 89. 8 96. 3
3 93. 4 100. 0
4 86. 0 100. 0
5 98. 9 100. 0
6 98. 5 99. 9
7 84.7 99. 6
8 90. 0 99. 9
Median 89.8 99. 9
Lower quertile 65.0 98.8



























p : N S
0 4.0 8.0 12.0
Peritonitis episodes/year
F I G U R E  17 ^
(a ) C o m p a r i s o n  of Ingestion of S. e p i d e r m i d i s  witn Frequ ency of 
P e r i t o n i t i s  (Data from Table 16).
Cb) C o m p a r i s o n  of Intracellular K i l ling of Ingested
S .e p 1 d e r m i dis with  Fr eq uency of P erito ni tis (Data from Table 16),
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obtain ed from one patient (A.Ca) with a high incidence of 
p er it onitis  (6.9 episodes  per year on average) showed a low 
level of ingestion, and similar results were obtaine d with 
two subs eq uent samples from the same pa tient over a six 
month period, the av erage  ingestion being 53;^15% for the 
three samples. In two of these, intra cellu la r killing was 
also low (48% and 73% of the ingested bacteria). The cells
in a single sample obtain ed from another pa tient (L.McL) 
with a high incidence of pe riton itis (5.1 episo de s per year 
on average) also showed very poor ingestion (37%), though 
intracellular killing was normal. Thus a l t h o u g h  in most
cases peritoneal ma cr o p h a g e s  from CAPD patients  appear to 
effi c i e n t l y  ingest and kill S.ep id ermidis  it is possible 
that in isolated patients this function may be impaired and 
this could 'be a cause of the patient being more prone to 
peri toni t i s .
It should be noted that for statistical reasons only
one sample from each patient was used to relaté 
bactericidal ac t i v i t y  to frequency of peritonitis. Where 
more than one sample was tested the last sample was used in 
each case.
4.6.3. Re 1 ease by Peri t o n e a 1 Ma cr o p h a g e s  and Monocytes
Peritoneal cell samples from the PDE of 10 new and 22 
es ta b l i s h e d  CAPD patients as well as 9 normal peritoneal 
cell samples from women undergo ing  laparoscopy for
sterilisation, and 7 normal peripheral blood monocy te  
samples were an al ysed for their cap ac ity to produce H^O^, 
with and withou t stimu la tion with op son ise d zymosan.
The amo unts of produced both on s t i m u l a t i o n  with
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zy mosan and spon t a n e o u s l y  is shown in Table 18. A 
sig ni fi cantly  greater amoun t of was released by
m ac ro phages  from PDE of new CAPD patients, compared with 
all the other cell types examined (p<0.005). Rel ease of 
^2^2 normal peritoneal mac rophag es  was also
si gnif i c a n t l y  higher than that from m ac rophag es  from
e s t a b lish ed  CAPD patients and from blood mon ocytes
(p<Û.Ûi). However no si gnifica nt differenc e in H^Og release 
was found between peritoneal macr oph ages from established 
CAPD patients and normal blood monocytes. The amount of 
H^D^ released s pontan eo usly by all cell types was very 
s m a 11 (Table IB).
4.6.4. E x p r es si on of HLA-DR Ant i gen by Huma n P e r i t o n e a 1
M ac ro pha ges and M o n o c y t e s .
Peritoneal cell samples obtained from the PDE of 12 
new and 18 esta blish ed  CAPD patients, as well as 17 normal 
peritoneal cell samples and 9 normal blood monocy te 
samples were stained with anti HLA-DR monoclonal. Results 
are shown in Table 19.
C o n s i d e r a b l e  vari at ion in the level of HLA-DR 
ex pr essi on  be tw een dif ferent samples was seen. The 
intensity of the staining also varied e x t e n s i v e l y  within a 
sample, from vi rtually nothing through faint surface 
staining to well defined peripheral rings. As a conseq uence 
of this, cells were initially only cl as sified  as positive 
if an intense wel l-defin ed  peripheral ring was observed. 
These are the cells labelled " s t r o n g ” in Table 19. An 
example of the staining is shown in Figure 18.
However the p roport io n of HLA-DR pos itive monoc ytes
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T A B L E  1 8  i _  R e 1 e a s e  b y  P e r i  t o n e a I M a c r o p h a g e s  a n d
M o n o c y t e s .
P E R I TO NE AL MACROP HAGES  FROM:
----------------------------------------------------  NORMA L
PATIENTS NEW NORM AL  BLOOD
E S T A B L I S H E D  CAPD PERI T O N E A L  MON OC YT ES
ON CAPD PATIENTS CELLS
* * * *
ZYM OSA N + + + -  +
NUMBER
OF 22 13 10 10 9 7 7 5
SAMPLES
H O  RELEASE 
(pm7 lOpg D N A ):
MEDIA N 6.4 ND 13.4 0.3 10.6 ND 7.1 ND
LOWER
QUARTILE 5.0 ND 12.3 ND 9.2 ND 6.3 ND
UPPER
QUART IL E 6.6 0.2 1^.6 l.S 11.4 ND 7.7 ND
* Only de te rmine d when enough cells were availab le  in each 
samp i e
ND= not det ect ab le
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TABLE 19 E x p r e s s i o n  of HLA-DR by P e r i tonea i Ma cr ophages 
and Monocytes.
CAPD P E R I T O N E A L  MACROPHA GES FROM:
------------------------------------------------------  NORMA L
PATIENTS NEW NOR MAL BLOOD
E S T A B L I S H E D  CAPD C O N TROLS MON OCYTES
ON CAPD PATIENTS
STAINING INTENSITY:
STRONG FAINT* STRONG FAINT STRONG FAINT STRONG FAINT
NUMBER
OF 18 8 12 6 17 9 9 7
SAMPLES
% OF HL A-DR 
+VE CELLS;
MEDIAN 38 60 68 84 5Ô 88 39 68
LOWER
QU ART IL E 34 56 60 78 48 74 36 64
UPPER
QU ART IL E 49 64 81 90 62 90 46 70
* The des ig nation of HLA-DR positive mac ropha ge s was 
extended to include not only those cells with strong 
peripheral staining but also those which were faint. Such a 
recount was only per formed on a r e pres en tative proportion 





FIG URE  16
(a ) sta ining  of CAPD peritoneal cells with a p h y c o e r y t h r i n ­
c on jug ate d monoclonal ant ib ody to HLA-DR antigen.
(b) Same field as (a) seen under p h a s e - c o n t r a s t
P  —  positiv e cell with sharp peripheral cell fluoresc ence  
F —  faint fluo re scence  
^  —  negative cell
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thus obt ai ne d was co nsi d e r a b l y  less than the 60%, 70% or
vi rtual ly  100% posi t i v i t y  quoted by others (Volk et 
a 1 , 1985 ; Ng ejt aj_, 1982; Smith and Ault, 1981). In order to 
accou nt for this d i f f erence some of the samples were r e ­
examined, with  the c l a s s i f i c a t i o n  of HL A-D R positive cells 
being exte nd ed to include those cells with faint staining. 
These figures are also shown in Table 19. As a result, the 
pr op orti on  of HL A- DR pos itive monocyt es was near l y  doubled 
from a m e dian of 39% to 68%, a figure more in line with 
those reported previously. The pr op o r t i o n  of HLA-DR 
positiv e cells therefore depends to a large extent on the 
criteri a used for clas s i f y i n g  cells as either positive or 
negative.
Nevertheless, when only the s t r o n g l y - s t a i n i n g  cells 
were counted a sig ni f i c a n t l y  greater p r o p o r t i o n  of HL A-DR 
positiv e ceils were found in macrop hages from PDE of new 
CARD pa tients compar ed with all the other m ac ro phages
tp<0.01). E x p r e s s i o n  of HLA-D R by normal peritoneal
m a c r o phag es  was also greater than in ma cr o p h a g e s  from 
e st ab lished  CARD patients or blood mo nocytes  ip<û-01). The 
p r o p or ti on of HL A- DR  positive cells in peritoneal
ma c r ophage s from patients esta blished  on CAR D and in blood 
monocytes  did not differ signifi cant 1 y . If however this 
c l a s s i f i c a t i o n  was ext end ed to include faint staining as 
well as strong, the p r o p or ti on of HLA-DR pos it iv e cells was 
found to be greater in normal blood m o n ocy te s than in 
peritoneal m a c r o ph ag es from patients e s t a b l i s h e d  on CARD.
1 2 4
4,7, DISCUSSION
Investigation of the a c t iv it y of cells from 
the p e r i to ne um of patients on CARD was u n d e r t a k e n  in order 
to detect any defects which might pos sib ly ac count for the 
increased incidence of perit onitis ob se rv ed with certain 
patients. It was also important to compare the properties 
of these peritoneal cells with normal peritoneal cells to 
give an indication of possible effects of the CARD process 
itself on the immune system of the peritoneum.
4.7.1. Bacter i c l d a 1 Act iv ity o f CARD Peri t o n e a 1 Cells
The peritoneal cells, the ma jorit y of which were 
macrophages, in the RDE of uninfe cted CARD patients were 
able in most cases to eff ici en tly p hagocy to se and kill 
opsonised  S . e p i d e r m i d i s . However, when co mpare d with 
peritoneal ma cropha ge s obtaine d from normal individuals 
u nd er going laparoscopy, the cells from CARD patients were 
si gn if icant ly  less efficient at killing ingested organisms, 
al tho ug h there was no differe nce in the degree of 
ingestion. Lamperi and Carozzi 11986a) also found 
d efici en ci es in the killing ability of some CARD patients' 
peritoneal macrophages. These workers, however in contrast 
to the results reported here, also found that cells from 
CARD patient s with high perit onitis rates were 
s ig ni f i c a n t l y  less able to kill ba ct eria than those from 
normal subjects. The reason for this diffe re nce is not 
clear, al th o u g h  the bactericidal assays employ ed were 
different. The reduc tion in bactericidal ac t i v i t y  of the
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peritoneal mac r o p h a g e s  observed by Lamperi and Carozzi 
(1986a) c o r r elat ed  directly  to their ab ility to release PG 
suggesting that the cells in the peri t o n e u m  of CARD 
patients are in an inflamma tory environment, their cellular 
activit y being suppressed by the RG which is a well known 
regulator of infla mmation (reviewed by Gemsa,1981).
The reduced ability of CARD peritoneal cells to kill 
ingested bact er ia may be due to the immaturity of the 
macroph ag es ob tained from CARD patients as they are thought 
to be re centl y arr ived and relatively immature cells, whose 
microbicidal mech an isms may not be fully developed. 
Go ld st ein ejt aj_ (1984) found that peritoneal cells from 
CARD patients exhibited a signific an tly lower uptake of 
ei co sano id  precursors (ie ara chidon ic  acid) compare d with 
normal peritoneal macrophages, a finding which suggests 
immaturity as inc orp oration of these fatty acid pre cursors 
appears to increase with cell maturity (Pawlowski ejt a 1 , 
1983; Scott e_^ a 1 , 1980). In ad dit ion the ab sen ce of ecto-
5* n u c l e o t i d a s e  (Goldstein e_^ a^,1984) suggests that these 
peritoneal cells are blood -d erived monocytes which have not 
yet diff er e n t i a t e d  into macrophages, as peripheral blood 
monocytes in humans lack de tectable qua nt ities of this 
enzyme (Edelson, 1981) but accumulat e large ammoun ts as 
they mature into mac ropha ge s either jji vivo or iji v i t r o . 
The cont inuous removal of 30-40 mil lion peritoneal cells 
daily may stimulate bone marrow replacement of resident 
cells at an excessive rate, so that instead of the 
p er itonea of patients on CARD con taini ng  mature tissue 
macrophages, they may instead be popul ated by cells more 
akin to immature blood monocytes. The increased
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c h e m otact ic  ac tivit y of these cells shown by G o l d st ein e_t 
a 1 (1984), may agai n reflect this Immaturity as Wil kinson
(1982) has p rev io usly shown that young m ononuc le ar cells 
elicite d by an inflammatory stimulus are more 
c he m o t a c t i a  1 1 y activ e than are their older equi va lents in 
the form of resident macrophages.
An alte r n a t i v e  e xp lanati on  for the decreased 
bactericidal act iv it y of CARD patients' peritoneal 
ma crophag es could relate to the effect the dialysis fluid 
may have on their function. CARD involves constant  contact 
with commercial dialysis solutions which when instilled are 
rel ati vely hyperton ic and acidic (Duwe ej^ a 1 , 1981 ) . Before 
the fresh dialy sat e approaches isoton ici ty and 
physiological pH, the cells may be sign if i c a n t l y  damaged. 
Duwe e_t a_l_ (1981) found that commercial dialysis fluid 
suppressed the act iv it y of peripheral blood leucocytes as 
measu re d by chemilumines cence, phag ocytosis and bacterial 
killing. S uppr es sion was found to be due to the low pH and 
high osm olali ty  of the fluid. Alobaidi ej^ a_l_ (1986) also 
found that RDE sup pressed peritoneal ma c r o p h a g e  function, 
al tho ug h the effect de creased with increasing dwell time. 
How important this finding is to the results reported here 
is debat ab le  as Alobaidi e_t a_l_ (1986) also found that 
over nig ht RDE, from which all the cell samples here were 
obtained, did not affect cellular function, it is possible 
however that the initial hour after each exchange, before 
the RDE has had time to adjust, may sev er ely hamper the 
act iv ity of the phagocytes and e l i m i n a t i o n  of any 
co ntam i n a t i o n  at this point may be inadequate. Ratient s may 
th erefore be parti c u l a r l y  at risk each time an exchange  is
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performed.
Even  if cellular ac t i v i t y  were normal the large fluid 
volum e may disrupt the usual i n t r a p e r i t o n e a 1 flow and 
cl earan ce  of ba ct er ia from the p e r i tone um  (Dunn ejt a 1 , 1985 ; 
Duwe ej^ a_l_, 1981 ; Vas, 1981; Hau a 1 , 1979). This failure
of the normal transport me ch anism may meap that anti gen 
will not be deliv er ed to the lymph nodes, which is 
essential for the init iation of specific immune responses 
and the resul tant ef fective  e l i m in ation of pathogens  from 
the peritoneum. In a d d ition it is possible that the an ti ge n 
pre sen ting fun ct io n may be defectiv e due to the immaturity 
of the peritoneal macrophages, or the su pp r e s s i v e  effect of 
the PDE (Duwe ejt a_l_, 1981 ) may also severe ly  inhibit the
mo unt in g of these spe ci fic immune responses. E xpe ri ments by
\
Duwe e_^ aj_ (1981), and Verbru gh  e_t aj_ (1963), also suggest 
that the c o n c e n t r a t i o n  of peritoneal m a c r o p h a g e s  in PDE may 
not be sufficient  to handle bacteria that gain entrance to
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this site. jjn^  v i v o , less than 100 ph ag ocytic cells per mm 
of blood (as in g r a n u l o c y t o p e n i c  patients) is well known to 
pre di sp ose patients to b l o o d st ream infections. Only during 
pe ritoni tis is this number reached in CAPD pat ients.
4.7.2. R e l a t i o n s h i p  o f Microbicidal Ac t i v i t y  of CAPD 
Peritoneal Ce 1 1s to F r equency o f Peri toni t i s .
Overall there was no c orr el ation b e t ween either 
ingestion or killing of S.epidermi di s by m a c r ophage s from 
CAPD patient s and fre quen cy  of peritonitis, indicating that 
an intrinsic defect in phagocyte function  is not likely to 
be a major cause of increased s u s c e p t i b i l i t y  to 
peritonitis. However, in two cases (patients A.Ca and
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L.McL), cells from patients with a high incidence of 
p erito ni ti s did show reduced ab ility to ingest and/or kill 
S .epi d e r m i d i s , sugg esting that in some patients defect ive 
ph ag o c y t i c  ac tivit y may be a c ontri bu ting factor. Indeed, 
recur ren t or per s istent Staphylococcal infection s seen in 
some patients due to Intraleucoc yte s e q u e s t r a t i o n  of
bacteria, (Buggy e_t a_l_, 1984) may possibly  result from
def ec ti ve intra cellular killing.
4.7/3. A b i li ty of Cells to Release H. 0^ _
In view of the importance of reactive  oxygen
i nt er med iates in the process of intracellular killing and
as a marker of the act i v a t i o n  state of the cells, the
amount of released by peritoneal ma cr o p h a g e s  from CAPD
patients and con tro ls was examined. Blood mon oc yt es from 
normal con trols and peritoneal ma cr ophages from patients 
esta b l i s h e d  on CAPD appear to be analog ou s in terras of
their ab ilit y to release which would support the
previo us s u g g es tion in sec tio n 4.7.1 that the CAPD cells 
are re la t i v e l y  immature. Alternatively, as CAPD patients
have a ten dency to a n aemia (personal communica tion; J.D. 
Briggs), the lower than normal levels released by CAPD
peritoneal m acr op hages might be due to insufficient 
m e t a b o 1i c a 1 1 y active intracellular iron (Thompson
et aj_,1986) which is believed to be involved in 0^ 
met a b o l i s m  (eg as a compo nen t of cytochromes; Brock and 
M a i n o u “F o w 1e r ,1986). Low 0^ tension in the peritoneal 
fluid, pos si ble due to the adverse effect of the large 
fluid volume as suggested  by Duwe ej^ a_l_ (1961), may also 
impair production, an effect which may not nece s s a r i l y
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be all e v i a t e d  after two hours in culture.
In contrast, the greater amount of released by
normal peritoneal macr o p h a g e s  compared with those from 
patients e s t a b l i s h e d  on CAPD agrees with their increased 
bacteric ida l activity, refl ecting their inc reased maturity. 
The increased ^2^2 Pro d u c t i o n  by peritoneal m acro ph ages 
from new CAPD patients, compared with normal peritoneal 
macrophages, which in theory should be analogous, may be 
due to a c t i v a t i o n  of the CAPD peritoneal macrophages. This 
may pos si bly be brought about indirectly via IL-1, which is 
produ ced  in response to steroids such as estroge ns  (Flynn, 
1986) released by an infla mmato ry re action to the catheter 
impl ant at ion a fortnight before. IL-1 will in turn
st imu late pr o d u c t i o n  of lymphokines (K a m p s c h m i d t ,1984 ; 
Staruch and W o o d , 1983) such as gamma IFN, which is known to 
increase p r o d uctio n by cells (Wilson and W e s ta 1 1,1985 ;
Nathan  e_t aj_, 1983). An al te r n a t i v e  cause of the increased 
release by peritoneal ma crophages from new CAPD
patients could be factors secreted by p o l y morp hs  (Bird et 
aj_, 1984). ■ P o l y mo rp h supernatants, lysates, and their 
respective  u l t r a f i l t r a t e s  were found to enhance the 
c h e m i l u m i n e s c e n c e  responses of normal macrophages. The 
peritoneal cel Is from these new CAPD pati ents co nta ine d 
15.5% of neut r o p h i l s  compar ed with 3.8% in patients 
e st a b l i s h e d  on CAPD.
In con tr ast to the results reported here, Peterson
et a 1 (1985) found that CAPD patients* peritoneal
macroph ag es  gene rated greater c h e m i l u m i n e s c e n c e  than normal 
resident peritoneal macrophages, p r e s u m a b l y  ref lecting  
their increased ab il ity to produce 0^ . A possible
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e x p l an at ion for this may be that c h e m i l u m i n e s c e n c e  measures 
an earlier step in the chain of the r e s p ira to ry reaction 
than release and the refore 0^ levels may not
c o r r es po nd to levels. Secondl y un like the ^2p2 B^^ay
described in this chapter, which was p e r f or me d on adheren t 
cells, the c h e m i l u m i n e s c e n c e  was pe rforme d on cells in 
suspension. As a result the average p o l y m o r p h  co nta m i n a t i o n  
of the CAPD patients* cells in the study of Pe t e r s o n  ej^ aj_
(1985) was 6% comp ared with 1% in the present work. This 
is important as M a c Gow an  ej^ a_l_ (1983), have shown that each 
polymorph produces ap p r o x i m a t e l y  four times the 
ch e m i l u m i n e s c e n c e  of every macr ophage and therefore  any 
pol ym orph  c o n t a m i n a t i o n  might artif i c i a l l y  raise results. 
In addition, Pet er son ej^ aj_ (1985), were comp ar ing CAPD 
cells con taini ng  6% polymorphs, with suspensi ons of normal 
peritoneal cells in which the polym orph cont ent was only 
2%. In the studies reported here, there was less than 2% 
neutrophil c o n t a m i n a t i o n  in each case (4,5.1).
4.7.4. HL A-DR E x p r e s s i o n  by Peri t o n e a 1 Macr o p h a g e s  and 
M o n o c y t e s .
The an t i g e n  p re sentin g function of .CAPD peritoneal 
macrophages, as well as their maturational or act ivational 
state, was in vestigate d indirectly via the p r o p ortio n of 
HLA-DR positive cells.
Large dif fere nc es exist in the pe r c e n t a g e  ex pressi on  
of HL A-DR found on mo non uclear pha gocy te s by di ffe ren t 
groups. Costabel e_^ a_l_ (1986), found that more than 90% of 
alveolar m ac rophag es  express ed HLA-DR wh er ea s RaZma e_t a_l_ 
(1964), found much  lower levels (21%). Some groups were
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unable to detect HL A-DR negati ve subsets among human
peripheral or peritoneal ma cr ophages (Smith and A u l t , 1981) 
while other studies have found negat i v e  cells (Ng 
et a 1,1982). This d iscorda nc e may be due to the diffe rent  
s en si tiviti es  of the methods used, Costabel ej^ aj_ (1986) 
used immu no p e r o x i d a s e  which was more sensit iv e than direct 
immunof l u o r e s c e n c e  used by Razma e_t a_l_ (1984), and direct
immunof 1 Içuorescence used in this work. Costabel ej^ aj_
(1986) may therefore  have classi fied as pos it ive cells that 
expressed only small amounts of HLA-DR a n t i g e n  on their 
surface. S e c ond ly  Razma et a 1 (1984) studied adheren t
m a c r op ha ges after 24 hours culture rather than m acroph ag e  
prepara ti ons made im media tely after isolation. Cells in 
culture may alter their surface marker characteristics. 
Differe nc es in the reacti vity and s p e c i f i c i t y  of differ ent 
anti HLA-D R antibo di es used by differe nt groups may also 
account for d i s c r epanci es  betwee n the results of different  
groups. Clerici ej^ a 1 (1984) showed that variable  results
were obtained  for HLA-DR  exp re ssion  depe nd ing on the 
monoclonal antib od y used, suggesting that not all anti-HLA- 
DR a n t i bodie s recognise  the same ant ig enic determinant.
Peritoneal macr o p h a g e s  from new CAPD patient s were 
found to express a greater prop ortion of HL A-D R positiv e 
cells than m a c r op ha ges from es tablish ed CAPD patients, 
normal peritoneal macrophages, or blood monocytes. Again, 
as with H^O^  release, ac t i v a t i o n  or s t i m u l a t i o n  of these 
cells with possi ble IL-1 producti on may be the cause. 
Flynn (1986) has shown with murine cells that the 
a c t i v a t i o n  of la e x p r ess io n co rrelat ed  with lL-1 
production. This is also probably med ia ted through gamma
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IFN, which is well known to increase HL A-DR e x p r e s s i o n  on 
cells (Gershon ejt aj_, 1985; Sztein et aj_, 1984; Basham and 
M e r i g a n , 1983).
The si mi l a r i t y  in the degree of HL A- D R  e x p r e s s i o n  by 
peritoneal m a c r o p h a g e s  from patients e s t a b l i s h e d  on CAPD 
and by blood mon oc ytes (also shown by Smith and A u l t , 1981), 
may, as with the amount of H^O^ released by these cells, 
again suggests that these CAPD m a c r o p h a g e s  are indeed 
immature cells closely similar to monocytes. Smith and Ault 
(1981) showed a 2-3 fold increase in e x p r e s s i o n  of HLA-D R 
on culture of both blood monocytes and CAPD patients' 
peritoneal cells, which also suggests that the CAPD cells 
are immature m o n o c y t e - l i k e  macrophages, which mature on 
cu lture to resemble resident tissue macrophages.
If, however, the CAPD peritoneal m a c r o phages from 
e stabl is he d pat ients were more like c h ronic inf lammatory 
cells than monocytes, as sug gested by Be el en  et a 1 (1986),
then the decr ea sed staining for HLA-D R compared  with other 
cell types could be explained by the d a m pening  effect of
PG, which is released during inf lamm at ion (Humes
et aj_, 1977). Snyder e_^ a_l_ (1982), have shown that PG
mar ke dly inhibited la ex pr e s s i o n  on m a c r o p h a g e s  prev io usly 
st imulated  by lymphokines. PG may provide a physiological 
dampening m e c ha ni sm that in concert with the positive 
s t i m u lati on  of the T-cell lymphokines regulate the levels 
of la e x p r e s s i o n  in a given population. R e d u c t i o n  of HLA-DR 
e xp r e s s i o n  has also been suggested to be due to R Û 1 which 
are released  at inflamma to ry sites (Gruner et aj_, 1986) and 
this might occur in the peri toneum  of CAPD patients. ROI
a ch ieve their effect by influencing PG synth esis (Gruner
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et a i ,1986).
When the criteri a used to classify cells as HLA-DR
po sit ive was ext ended  to include not only those cells with 
bright peripheral staining, but also those with faint 
fluorescence, the ave rage pro port io n of positiv e staining 
for monoc ytes was higher than that for the CAPD cells,
which also may suggest that HLA-DR levels are suppressed in 
CAPD patients' peritoneal macrophages. It would also have 
been of interest here to examine blood mo no cytes from CAPD 
patients and compar ed HLA-DR exp re ss ion on these with that 
found on the normal blood monocytes to see whether HLA-DR 
e xp re ssion is depress ed generally in patients on CAPD.
Lamperi and Carozzi (1986a) found peritoneal ma cro phages
from a group of high peritonitis rate CAPD patients
released larger amounts of PG and lesser amo unts of IL-1 
than cells from CAPD patients with low peritonit is rates or 
from normal subjects. This could ex pla in why these
patients' cells show reduced HLA-DR expression. This also 
suggests that the normal eq ui librium state which exists
be tween the positive and negati ve signals is distu rbed in 
some of these CAPD patients, who may o ve rproduc e PG and as 
a result suppress their immune responses. However the 
importance of PG in the regulation of HL A-DR ex pressi on
has re cen tly been called into questi on by the finding of
Kunkel ej^ sU_ (1986), who reported that while PG did indeed 
depress la/HLA expre ss ion in murine cells no effect was
found with human cells. It must also be noted that
G ol ds tein e_t aj_ (1984), Indicated that CAPD cells had 
morpho^l ogi cal ch aracte ri stics of resting rather than 
sti mul ated mo nonucl ear phagocytes, based on the lack of
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me mbr ane ruffling and c h ar acteri st ic organel le  content, 
suggest ing  again  that PG may not be resp on sible for the 
reduced HL A-DR express io n on CAPD cells.
The s u p p r es si on of HLA-DR anti gen in CAPD patients 
might be beneficial, in that it could prevent or limit 
pr e s e nt ation of alte red self determinants or unrevealed 
hidden ant ig ens aris ing during tissue dest r u c t i o n  by 
inflammatory effector mechanisms. The benefits of this 
de cre ased HL A-DR level may, however be outw eighed  by the 
si multaneo us decrease in the peritoneal def ences of these 
CAPD patients as reduced expres sion of HLA -DR in addition 
to f un ction al ly defective antigen pres entin g cells may 
severely comp romise any mounti ng of specific  immune 
responses. Indeed such a decrea se in immune re sponsiveness  
has been noted in certain CAPD patients on challenge with 
DNCB (Tsakiris et a l ,1966).
In summary therefore it appears that at least some of 
the cellular activities  of CAPD peritoneal cells are 
reduced in c om pariso n with the pop ula tion found in the 
normal peritoneum. This is shown both by their reduced 
bactericidal ac t i v i t y  and by a dec reased ab i l i t y  to release 
H^O^. There is also a reduced express ion of HL A-DR antigen. 
These di fferenc es are probably caused pr im arily by the 
immaturity of the CAPD cells rather than by actual defects 
in their activity. This immaturity will we ake n not only 
their importance in phag ocytosi s but may also impair other 
macr op hage functions, such as interactions with T- 
lymphocytes. It is also clear that the peritoneal
macropha ges from new CAPD patients are not analogo us to 
normal peritoneal macro pha ges but appears to have un der gon e
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some kind of ac ti v a t i o n  or stimulation, perhaps due 
insertion of the catheter.
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Up to this point the thesis has focused on the 
intrinsic propertie s of the CAPD macrophages, however 
efficient bactericidal activ it y of ph a g o c y t i c  cells
generally requires that the m i cro -o rganism s be opsonised 
with molecul es  that facilitate their ingestion. Of these, 
IgG and C3, which represent the traditional h ea t- stable  and 
heat-lab ile opso ni sing elements respectively, are generally 
considere d to be the most important (Keane and 
P e t e r s o n , 1984 ; Johnston and Stroud, 1977; S t o s s e 1,1974 ; 
W i n k e l s t e i n , 1973).
The c o n t r i b u t i o n  of opsonic mol ecules to host defences 
against infection has been demonstra te d in a variety of 
diseases (Johnston and S t r o u d , 1977; S t o s s e 1,1974 ;
W i n k e l s t e i n , 1973) and any quantitativ e deficie nc y of
opsonins can seri ous ly com pro mise the bactericidal functi on 
of phagoc yt ic cells (Keusch e_^ a 1 , 1982 ; Lew e_^ a 1 , 1979 ) . 
Indeed it has been sug gested that infection of the 
peritoneal cavity by G r am -negat iv e organi sms in patients
with alc o h o l i c  cir rhosis and ascites is related to a 
def ic ie ncy of hea t- la bile opsonins in as citic fluid
secon dar y to decre ased complem ent levels (Simberkoff et
aj^ , 1978; Fromkes a 1 , 1977 ) «
The frequent fluid changes involved in CAPD means that 
not only p h a g ocy ti c cells, but also soluble proteins are 
c o n s tantl y removed from the peritoneal ca vit y in the 
peritoneal dialysis  eff luent  (PDE) and replaced by a large
quantity of fresh fluid which is complet el y devoid of
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both proteins and cells. This may ad v e r s e l y  affect the 
normal antimi crobial  act iv ity of the peritoneal cavity. 
Indeed, it has been shown that the bactericidal act iv ity of 
peritoneal macr o p h a g e s  and blood leucocytes suspended in 
PDE was impaired due to suboptimal levels of opsonins 
(Verbrugh eJL a 1 , 1984; Verbrug h a 1 , 1983) , which means
that even if the phagocy ti c activity of the peritoneal 
ma crophag es from CAPD patients were intact, (as appears to 
be the case from results reported earlier in this study), 
inadequate levels of serum proteins may se ver e l y  under min e 
the defences of the peritoneum. Hence, while eff ective 
pha go cy tosis early in the course of bacterial invasion may 
limit the spread of ba ct eria and prevent ongoing infection, 
ineffective phagocytosis, due to inadequ ate levels of 
opsonins, may lead to unc ont rolle d bacterial mu ltip l i c a t i o n 
and o v e r w he lm ing infection.
Another serum factor involved in defence against 
infection is the iron transport protei n tra nsferr in  (Tf), 
which binds any availabl e iron and thereby helps to prevent 
bacterial growth, as iron is an essential nutr ient for most 
bacteria (Brock, 1986). It may be that the dilutional 
effect ment io ned above reduces the co nce n t r a t i o n  of Tf in 
CAPD fluid to a level where it is no longer able to provide 
b a c t e r i o s t a t i c  activity.
It is gen erally believed that the protein s present in 
the dialysate, including IgG, 03 and Tf, ma inl y originate  
from the blood by passage through the peritoneal membrane, 
although local syn thesis of some proteins by cells in the 
peritoneu m has been suggested (Dulaney and H a t c h , 1984; 
Kowalewski et_ a 1,1971). Some authors reported elevate d
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al bu mi n to globulin  ratios in dialysate c o m pared  with those 
in serum (Gordon and Rubini,1967) su gg esting some 
r es tr iction  to the pa ss age of high mo 1 e c u l a r-weigh t
proteins. Others were unabl e to find such dif f e r e n c e s  in 
peritoneal pr otein clearances, and instead suggested that 
prot ein  enter ed  the pe ri ton eum by free diffusion  
( B 1 u m e n k r a n t z  e_^ a 1 , 1981).
In the light of this, the present study was u n d e rt aken 
to de termin e the c o n c e n t r a t i o n  and a n ti mi crobia l a ct iv ities 
of IgG, C3 and Tf in PDE from patients on CAP D and compare 
them with normal peritoneal fluid and sera, both from 
normal co ntrol s and CAPD patients. Finally, in order to 
asc e r t a i n  whether any of these factors are of clinical 
si g n i f i c a n c e  with respect to sus c e p t i b i l i t y  of patients to 
peritonitis, each of the above was related to the frequ ency 
of epi sodes  of pe ri tonitis exp er ienced by each patient.
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&L& MATERIALS
5.2.1. Peri t o n e a 1 Fluid Samp 1 es
Ove rn ight  dwell (10-12 hours) PDE was o b t ain ed  from a 
total of 44 patients on CAPD, details of whom are given in 
Table 20. One or two samples were obtained  from each 
patient, with at least two weeks between samples in the 
latter case. Only PDE samples where per itoni ti s had not 
occurred within three weeks either side of the date of the 
sample were used in this study. Three weeks was considered 
to be an ad eq uate period for normalisation, as no sample 
taken ou twith this period was found to co nt ai n more than 
15% of neut ro phils or more than 10® total cells in PDE 
(c.f. section 2.5.1). Samples of PDE were spun at 250g for 
5 minutes to separate the cells and then stored in frozen 
aliquots- Normal peritoneal fluid, which was obtained by 
a s p i ra ti on from 8 healthy women unde rgoing laparoscopy for 
sterilisation, was simil arly treated.
5.2.2. Serum Samp 1 es
Serum samples from 17 CAPD patients were obtain ed at the 
same time as peritoneal fluid and stored at -20°C (see 
Table 20). Normal human serum (NHS) was obtained from 
healthy volunteers and stored at -20°C. Some samples were 
pooled.
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TA BLE 20 : De ta i Is of Patients Used in Mon it or ing the







SYSTEM OR IGINA L
D IA GNOSIS
R. Ad ma 1 e 59 21 T P y e 1onephr i t i s
M. Ba f e m a 1e 55 7 F Glomerulonephritis
A . Ba f e m a 1e 59 42 F P o l y c y s t i c  Kidneys
A. B I ma 1 e 70 9 T G l o m e r u l o n e p h r i t i s
* A . Ca f e m a 1e 75 5 F G l o m e r u l o n e p h r i t i s
W.Ch ma 1 e 48 9 T Di ab et ic N eph ro pa thy
*R.Co fe m a 1e 56 1 F P o l y c y s t i c  Kidneys
R . Con f e m a 1e 39 47 F G 1 orner u lonephritis
*W.Co ma 1 e 33 1 T Un kn own
C. Fe ma 1 e 53 2 T Di abeti c N e p h ro pathy
A. Fu f e m a 1e 42 2 F G lo m e r u l o n e p h r i t i s
*M.Ge f e m a 1e 80 53 F H y p e r t e n s i o n
I.Jo ma 1 e 37 5 T G l o m e r u l o n e p h r i t i s
B . Go ma 1 e 33 1 T Di ab et ic Nep hro pa thy
*J.Gr ma 1 e 29 1 T G l o m e r u l o n e p h r i t i s
W . Ka ma 1 e 46 1 T Glomerulonephritis
R. Ke ma 1 e 47 1 T G l o m e r u l o n e p h r i t i s
*R.Le ma 1 e 55 2 T D i a be tic N ep hr opathy
*M.McA f e m a 1e 51 47 F Hype r tens i on
R. McA ma 1 e 64 4 T Un known
*M.McC f e m a 1e 56 23 F A n a l g e s i c  N ephr op at hy
J.McF ma 1 e 48 45 T G l o m e r u l o n e p h r i t i s
*C.McG fe m a 1e 62 6 T A n a l g e s i c  Neph ropath y
J . McK f e m a 1e 64 1 F Hyper tens i on
L. McL f e m a 1e 55 7 F P y e 1onephr itis
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SYSTEM  ^ O R I G I N A L 
DI AGNOS IS
A . McL ma 1 e 51 1 T G 1o m e r u 1onephr i t i s
* M .McV f e m a 1e 54 8 T P o l y c y s t i c  Kidneys
P . McV ma 1 e 61 1 T P y e 1onephr itis
*A.Me f e m a 1e 36 18 T G l o m e r u l o n e p h r i t i s
C. McC ma 1 e 47 18 T G l o m e r u l o n e p h r i t i s
*T.Mo ma 1 e 45 1 T G l o m e r u l o n e p h r i t i s
A. My fema 1 e 43 27 T P o l y c y s t i c  Kidneys
# M . Mu f emaIe 71 1 F G 1om e r u b n e p h r i t i s
*C.Pa f emaIe 68 48 F A n a l g e s i c  Neph r o p a t h y
*M.Re f e m a 1e 84 6 F Di a b e t i c  N e p h rop at hy
R . Ro ma 1 e 39 1 T Renal Tumour
B. Pa f emale 50 9 F Di a b e t i c  Ne ph r o p a t h y
I . Sc f e m a 1e 49 36 T A n a l g e s i c  N ep hr opathy
E. Si f emaIe 43 32 T Glomerulonephritis. ■
M. Sm f e m a 1e 60 1 T P o l y c y s t i c  Kidneys
W. St ma 1 e 75 2 T G l o m e r u l o n e p h r i t i s
*A.Wa , f e m a 1e 49 1 F P o l y c y s t i c  Kidneys
J . Wi ma I e 51 10 T P o l y c y s t i c  Kidneys
*W.Yo ma 1 e 44 27 T D i a b e t i c  Nep h r o p a t h y
F = Freseni us System
T = Travenol System I I
* Patien ts from whom a serum s a m p 1e was also ob tai ned
1 4 3
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5.3.1. D e t e r m i n a t i o n  of Opsonic Act iv ity
This was carried out by radiometric as sa y as described 
in Chapter 3. In each experiment, aliquots of S . 
ep id er mid is were opsonised for 15 minutes at 37°C with 
either NHS or the test fluid sample. A third aliquot, 
suspended in PBS, was used for tur bid ometric d e t e r m inatio n 
of the bacterial count. Su spensio ns of the total CAPD 
peritoneal cells (predominantly macrophages) were prepared 
as in section 2.4.1. The sample opsonised with NHS was 
included in each expe riment in order to standardise 
conditions so that dif ferenc es  In cell ac t i v i t y  would not 
affect the results. The opsonising capaci ty  of the fluid 
was cal cul ated as follows
% of b a c teri a ingested when opsonised with sample
------------------------------------------------------------------  XlOO
% of bac te r i a  ingested when opsonised with NHS
5.3.2. D e t e r m i n a t i o n  of Bacter i o s t a t i c  Act iv ity
A sus pe nsion  of 2x10® log-phase epider mi dis in
50|il of PBS was added to 0.5ml of f i l t e r -s terilis ed  
peritoneal fluid or serum in a pl astic microtube. 
U nr es ticted  growth was det ermined  in controls conta ining 
RFMI 1640 medium + 25mM Hepes (Flow Laboratories) instead 
of the sample. To all of the tubes 50^1 of PBS was also 
added. In ad di ti on to evalu ating the growth of bacteria in 
each of the peritoneal fluids and sera, the effect of
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addi ng extra Tf to each of these was also tested in order
to determi ne  whether the level of Tf in each sample was
optimal. This was achieved by addition of SOpl of Img/ml
so lut ion of iron-free human Tf (B e h r i n g - H o e c h s t , Hounslow,
U.K.) in PBS instead of just PBS. Finally 20pl (2pCi) of 
3
[ H]-u ri di ne was added to each tube, and these were
incubated at 37°C for two hours. The samples were then
harv est ed and counted as described in 3.3.2. Each sample 
was set up in triplicate. The b a c t e r io static a c t iv it y of 
the test fluid was calculated as the pe rcenta ge  growth in 
the test sample compared with the RPMl 1640 control. The 
effect on growth of S. epidermid is of ad d i t i o n  of extra Tf 
was calc ula ted as follows : -
Change in growth = t% growth in (% growth in
test sample) test sample + Tf)
5.3.3. D e t e r m i n a t i o n  of T o ta 1 Protein
Protein was pre cipitat ed  with sal icy 1 sulp ho nic acid 
and the tur bidity of the suspens ion at GSOnm  compar ed to a 
standard curve. (This procedure was carried out by Dr. 
Spooner in the B i o c h e m i s t r y  Department, Gartnavel General 
Hospital, Glasgow.)
5.3.4. Es t i m a t i o n  of 1g G , C3 and Transfer r in Levels
This was carried out by radial immunod if fusion, using 
Parti gen LC plates (B e h r i n g - H o e c h s t ). A p p r o p r i a t e  dilutions 
of standard normal human serum (B e h r i n g - H o e c h s t ) were used 
to constru ct standard graphs.
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5.3.5. Stat istlcal Methods
The met hods used were sum of ranks, signed rank, and 
Spe ar man rank correlation, as appropriate.
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5.4.1. L e v e 1 s of Ig G , C3 and T r a n s f e r r in in Per i t o n e a 1 
F Iuids and Sera.
The levels of IgG, C3 and Tf in 38 of the 44 
individual PDE samples were measured and compared  with 
those in normal peritoneal fluid, CAPD p a t i e n t s ’ sera, and 
normal sera (Table 21). The levels of all three proteins in 
PDE were much lower than those in the sera or normal 
peritoneal fluid, the differe nce being of the order of 50 
to 100 fold. Levels in normal peritoneal fluid did not 
differ sign i f i c a n t l y  from those in normal sera, and the IgG 
and C3 levels in CAPD p a t i e n t s ’ sera were also similar to 
those in normal sera, alt ho ugh Tf levels were slightly 
1ower (p < 0 . 05).
When the results from Individual samples were 
considered, a sig ni ficant corr elation was found between the 
levels of IgG, C3 and Tf (p<0.001) in PDE (Figure 19). No 
such c o r r e la ti on was found for normal peritoneal fluid or 
for sera (Figures 20,21 and 22). There was also no 
c o r r elati on  betwee n the levels of IgG, C3 or Tf in PDE and 
those in the c orrespo nd ing p a t i e n t s ’ sera (Figure 23). In 
ad d iti on  no si gn ificant diff erence in levels of IgG, C3 and 
t r a n s ferr in  in PDE was found when pati ents were grouped 
according  to diag nos is (Table 22). In particular no 
diff er ence was found between the levels of proteins in the 
PDE of d i a be tic and non- d i a b e t i c  patients.
In 28 of the patients tested, the level of total
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TABLE 21 j_ Serum Pr ot ei n L e v e I s i n Péri t o n e a 1 Dialysis 
Ef fluent, N o r m a 1 P é r i t o n e a 1 Fluid and in N o r m a 1 
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T RA NS FERRIN
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(2.5-6.7)
225 200 # 250
(204-230) (168-242) (214-305)
* Median (interqua rtile  range). All figures are mg/dl 
+ p<0.001 co mpa red with normal human serum
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F I GURE 19 2. Compar  1 son of L e ve 1 s of I g G , C3 and Transf err in 
in Per i t o n e a 1 Dialys i s Ef fIuent f rom CAPD 
Pat i e n t s ,
(a) IgG compared with Tran s f e r r i n
(b ) C3 compared with 1gG
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F I G U R E  20 i_ Compar i son of Leve I s of I gG« C3 and Tr an s f e r r i n  
in Norma I Peri t o n e a 1 Fluids
( a )  IgG compar ed with T r a n s f e r r i n
(b) C3 compared with IgG






































F I G U R E  21 i_ Compar i son of Leve I s of I gG, C3 and Transf err In 
1n CAPD Patients * Sera
( a )  IgG compared with T r a n s ferrin  
<b) C3 compared with IgG
































F IGURE 22 2_ C o m p a r I s o n  of Leve t s of IgG , C3 and Transferr  In 
in Nor ma 1 Human Sera
(a) IgG compared with T r a n s f e r r i n 
<bJ C3 compared with IgG
(c) C3 compared with T r a n s f e r r i n
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F I G U R E  23 2. Compar i son of Leve 1 s of I gG, C3 and T r a n s f e r r i n  
in CAPD Patients' Sera with  LeveIs in 
Cor responding Dia lysis Ef fIuents 
<a) IgG
(b) 03
Cc) T ra ns ferrin
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TAB LE 22 : Ser um Prote in Levels in P e r l t o n e a 1 Dialysis 
Ef f 1uent f rom Fat ients on CAPD G r o uped According 
to their Prig i n a 1 Di a g n o s 1s for Rena 1 Failure.
ORIGINAL DIAG NOSIS
G L O M E R U L O N E P H R I T I S  DIABETIC PO L Y C Y S T I C

































* Median (interquartile  range). All figures are mg/dl 
+ This group includes patients with pyelonephritis,
hypertension, a n a lgesic  n ephropa th y and those with their 
diagnosis unknown.
There were no signif icant difference s be tw een any groups.
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protein in the PDE was also measure d and found to cor relate 
si gn i f i c a n t l y  with the levels of IgG, C3 and Tf (Figure 
24). There was no diff erenc e in the total prot ein levels in 
PDE be tw een  patient s on the two systems (Travenol and 
Fresenius) the media n figures being 1.3 ig/ 1 (interquartile 
range 0.6-1.6) and 0.9 g / il (0.6-1.1) respectively. A
signific ant inverse c o r r e lation  (p<0.05) was found between 
the level of total protein and the length of time a patient 
had been on CAPD (Figure 25). However, if patients  who had 
been on CAPD for less than six months were excluded, the 
co rr e l a t i o n  became non-significant.
Al t h o u g h  the levels of IgG, C3 and Tf in PDE varied 
widely  be tween individual patients, they remained 
re lativel y constant between success ive samples in each of 
the 13 patients from whom two samples were obtain ed (Table 
23).
5.4.2. Opso nic  Activity
The a b i l i t y  of PDE to opsonise S . e p i d e r m i dis for 
ingestion by peritoneal cells was si gn i f i c a n t l y  lower than 
that of normal peritoneal fluid (p<0.001), the median 
ingestion being 59% (interquartile range 46-71) and 86% 
(i n t e r q u a t r i 1e range 82-93) respectively, of the ingestion 
oc curring when bac teria  were opsonised with normal human 
serum. A c or relati on  (p<0.01) was found between the 
opso nis ing capacity of the PDE and the level of IgG (Figure 
26a). A less significan t corr elatio n (p-0.02) was also 
found with C3 levels (Figure 26b). No such c o r r e latio n was 
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F I G U R E  24 C o m p a r i s o n  of Leve I s of Total Protein l_n
P e r l t o n e a 1 Dialysis E f f 1uent wit h Co rr es p o n d i n g  
Level s of 1g G . C3 and Transferr In.
(*) IgG
(b) C3
(c ) Tran sferrin
1 5 6
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F I GURE  25 j_ Compar i son o f Le ng th  of Time on CA P D  with the 
LeveI of T o t a 1 Protein  in Per i toneaI Dialys is 
Ef f 1u e n t s .
1 5 7
TABLE 23 Leve 1 s of I g G , C3 and Transferr in 1 n Péri tonea 1 
Dialysis Ef f 1uent of I n d l v i d u a 1 Pat i ents from 
whom Two Separate Samp 1 es were O b t a i n e d .
b Second Sample
TIME C O NCEN TR ATION ( m g / d l ):
PATIENT BETWEEN
NUMBER SAMPLES IgG C3 TRA NSFE RR IN
(MONTHS)
1 1 19.4 m 3. 6 4.0
18.4 b 3. 2 2.6
2 1 5.0 0.9 1. 7
4. 8 0. 5 1.4
3 2 7.8 1. 3 3. 4
6.8 2. 1 3.8
4 3 6. 6 0.5 1.3
4.8 1. 2 1.0
5 1 3.5 2. 8 5.4
4.8 2.8 8. 1
6 0.5 12.8 3. 4 6. 5
14. 2 2.4 6.3
7 4 10.5 2. 3 5.8
14.2 2. 8 7.3
8 3 8.6 1. 1 2.4
7.8 1. 1 2. 3
9 2 8. 1 1. 9 4.3
7. 3 2. 1 3. 8
10 2 12. 6 2.4 4.9
13.0 2.8 4.2
11 1 16. 2 2. 3 3. 2
12. 5 1 . 7 2. 0
12 0.5 15.9 2. 3 3.2
15. 2 1 . 8 0.9
13 5 9.4 1.3 3.6
11.4 2. 5 4.2
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F I GUR E  26 Compar i son of Qpson i sing Capac 1 ty of Perl tonea 1 
Di a l y s i s  Ef fIuent from CAPD Patlents with the L e v e 1s of 
(*) IgG and (b)C3, and Compar i son of Op so n i s i n g  Capac x ty of 
Nor ma I Peri tonea i Fluid with t he Levels of (a ? 1gG and (d )C3 
« P e r ce nt age inges tio n of S. e p i d e r m l d i s  is relati ve to 
in ges tion of bac te ri a opson ised with normal human sera.
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5.4.3. B a c t e r i o s t a t i c  A c t i v i ty
The growth of S.epiderml di s in peritoneal fluids and 
sera was always  less than in RPMI 1640 culture medium which 
was used as a control (Table 24). However, growth in PDE 
was signi f i c a n t l y  greater than in normal sera (p<0.05). 
There was no sign ifi cant diff erence betw een  the growth in 
normal or CAPD patients' sera, or normal peritoneal fluid. 
In a d d it ion no c o r r e lation was found between growth of 
S . e p i derm id is in PDE and in the co rr e s p o n d i n g  patients' 
sera (Figure 27). A sig nificant effect of adding extra Tf 
was only shown with PDE from CAPD patients (p<0.05) and not 
with normal peritoneal fluid or sera (Table 25).
A signi fic ant inverse correlat ion was found between  
the level of Tf and the growth of S . ep idermld is  in PDE 
(Figure 28a; p=0.002). There was no such c o r r e l a t i o n  for
normal peritoneal fluid, patients' sera or normal sera 
(Figure 28b,c ,a nd d). A signif icant inverse corr elation  
(p<O.Oi) was also found between Tf levels in PDE from CAPD 
patients and the effect of adding extra Tf, i.e. the lower 
the level of Tf found in the PDE the greater the effect of 
adding extra Tf (Figure 29a). Again no such correlat ions  
were was found with the controls (Figure 29b,c and d).
5.4.4. Re 1 at i onshi p to Peritonit i s
When the opsonic activit y of PDE samples was compared 
with the frequen cy of episodes of peritonitis, a 
significa nt inverse c o r r e la ti on was found (p<0.01; Figure 
30). Furthermore, the incidence of pe ritoniti s was one 
episode per 14.8 patient months in patients with high PDE 
opsonic ac ti v i t y  (>70% of control) ag ainst S .epidermidis
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TABLE 24 j_ Gr owt h of S.epider ml dis in Per i t o n e a 1 Dialysis 
Ef f 1u e n t , Norma 1 Peri toneaI Fluid, and Norma 1 





























as percen tage of growth in control (RPMI 
medium)
med ian  (in terquartile range)
p<0.05 compared with normal human serum
1640 cuIture
1 6 1
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F IGURE 27 i_ Compar i son of the Growth of S. e piderm ld is In 
Patients* Sera with Growth in the Co rres p o n d i n g  
Per itoneaI Dialys i s Ef f 1u e n t s .
* as p e r c entag e of growth in control (RPMI 1640 culture 
raed i u m )
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TABLE 25 The Effect on Growth of S .epider mi dis of 


















P ERCEN TA GE  
RE DUC TI ON IN
GROWTH OF 2.0 -0.1 1.2 0.7
S. ep id ermldi s (0.38-8.58) (-0.88-0.18) (-0.05-3.60) (-0.30-2.48) 
ON ADD IT ION OF 
EXTRA Tf
+ Median (in terquartile range)










































F IGURE 28 Compar i son of Gr ow th  of S . e p i d e r m l d i s  with the 
L e v e 1 of Tra nsferr i n
(a) in peritoneal dialysis effluent of C APD patients
( b ) in normal peritoneal fluid
(o) in patients' sera
(d ) in normal serum
*G r o w t h  Index = rate of growth as pe rcentage of growth in 
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F I G U R E  29 The Effect on Growth of S. epldertnidis gf_ 
Add i t ion of Extra T ransf err in Compar ed with the 
L e ve 1 of Transferr in
(a ) in peritoneal dialysis fluid from CARD patients
(b ) in normal peritoneal fluid
Cc) in CARD patients' sera
C d ) in normal sera 
* see section 5.3.2. for de finition
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PERITONITIS EPISODES /  YEAR
F IGURE 30 Compar i son of the Frequ en cy of Per i tonitis 
Ep i S Q d e s  in CAPD Patients with the Qps on ising
C a p a c 1ty or their Peri t o n e a 1 Di alysis Ef f 1uents
* P e r c e n t a g e  ingestion of S .ep idermi d i s is relative to
inges tio n of bacteria opsoni se d with normal human serum.
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(Table 26), but was nearly 3 times greater (one episode per 
5,4 pat ient months) in patients with low op sonic act ivity  
(<70% of control). However, no c o r r e l a t i o n  was found 
betwe en the levels of either 1gG or C3, and perit oni tis 
(Figure 31a and b ). There was also no c o r r e l a t i o n  between 
the frequency  of perit oni tis episodes with either the 
b a c t e r i o s t a t i c  activity  of the fluid or with Tf levels 
(Figures 32 and 33),
1 6 7
TABLE 26 ^  R e l a t i o n s h i p  Between Peri ton i t i s and Qpsonls ing 
Ac ti vi ty of Peri t o n e a 1 D i a l ysate Ef f 1uent
>70% OPSONIC <70% OPSONIC
ACTIVITY OF CONTROL ACTIVI TY OF CONTR OL
NUMBER OF 







TO TA L EX POSURE 
TIME (MONTHS) 177 352
TOTAL NO. OF 
EPISODES OF 






# Media n (interquart ile range)


























F I G U R E  31 Compar i son of the Freque nc y of Peri to nitis
Episodes in CAPD Patients with (&) IgG and Cb)
C3 Leve I s in their Peri tonea I Dialysis
Ef f 1 uents.
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F I GUR E 32 Compar i son of the Fre qu ency of Per i ton! 1 1 s 
Ep i sodes in CAPD Patients with G r owth  of 
S .ep idermi d i s in P e r i t o n e a 1 Di alysis Ef fIuent.
* G r o w t h  Index = rate of growth as p e r c entage of growth in 
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Peritonitis Qpisodes/year
FI G U R E  33 }_ Compar Ison of the Fr equ enc y of Peri toni tls 
Ep i sodes in CAPD Pat i e n ts with the Leva Is of 
Trans ferrin in Peri t o n e a 1 Di alysis  Ef f I u e n t s .
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During CAPD, the frequent drain ag e of fluid 
and rep la cement by fresh dia lysate results in the removal 
of proteins such as opsonins and Tf. It is the refore not 
surprising that the levels of these proteins in PDE are 
only 1-2% of those found in serum or normal peritoneal 
fluid. These findings are similar to those reported by 
others (Steen e_t aj_, 1986; Keane et^ aj_, 1984; Verbrugh 
et aj_, 1983). Furthermore, in this study the level of these 
proteins was measured in PDE following the long ove rnight 
dwell time when the levels would be at their highest. 
During the day, with shorter dwell times, the levels of 
these proteins  in the peritoneal cavity will be even lower.
When levels of IgG, C3 and Tf in PDE and the 
correspo nd ing p a t i e n t s ’ sera were comparée! no co rrelati on 
could be found, i.e. the level of proteins in sera had no 
effect on the levels found in the peritoneum. This is in 
agreement with the conclus io n that p e r m e a b i l i t y  of the 
peritoneal membrane is the major factor in deter mi ning the 
quantity of serum proteins that gain entry to the 
peritoneal cavity rather than the actual serum levels 
(Krediet e_t aj_, 1986; Du lan ey and Hatch, 1984). Fu rther more 
a signi fic ant c o r r elation  was found betw ee n levels of IgG, 
C3, Tf and total protein which suggests that the entry of 
serum proteins into the peritoneal cavity does not involve 
a specific transport process but depends on the filtering 
effi ci ency of the mem br ane itself. Yewdall aj_ (1986),
have recent ly also shown that plasma proteins, including
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o psoni ca ll y active proteins, enter peritoneal fluid in 
rela ti vely n o n - s e 1ective proportions with the effect that 
CAPD fluid res embles a very dilute plasma.
When levels of total protein in PDE and length of 
time on CAPD  were compared, a sign ifican t inverse 
c o r r elati on  was found, suggesting a decre as e in the 
p e r m e ab ility of the peritoneal membrane with the pas sage of 
time. As the corr e l a t i o n  was not seen if only patients who 
had been on CAPD for more than 6 months were examined, the 
main change in mem brane  per me ability  may occur with in the 
first 6 months of dialysis.
Similar losses of serum proteins in the PDE were found 
in both diabe ti c and n on -d iabeti c patients, which is in 
dis agr eeme nt  with the finding of Krediet e_t aj_ (1986). A 
possibl e e xplan at ion for this differe nce  couId simply be 
due to the way in whic h the protein levels were measured. 
The work here was based on the levels of proteins  in the 
over nig ht dwell PDE. However, Krediet e_^ aj_ (1986) worked 
on the average  daily protein loss in the PDE over 3 
co ns ecut iv e days, whi ch therefore included pr otein losses 
in all the daily exchanges. If there were indeed even 
small dif fer en ce s in the p e rmeabi li ty of the peritoneal 
me mbr ane betw een diabet ic  and non-d ia betic patients, and 
hence dif fer en ce s in the rate of protein loss, this could 
be emp hasis ed  and pos sibly become s ig ni ficant  over the four 
hour dwell times, but not overnight. The ov ern ight eight 
hour dwell time may allow sufficient time for the levels of 
proteins to equil ib ra te in the two groups and hence no 
di fferenc e would be found. Protein loss in the PDE has also 
been shown to be s u b s t antial ly  increased during peritonitis
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(Krediet e_t ^ , 1 9 8 6 ;  B 1 umenkrant z e ^  1961 ; Rubin e_t
aj_,198i) due to possible al terat ions in the peritoneal 
blood flow aff ec ting membra ne surface area or permeability.
Al th ou gh the levels of IgG and C3 were similar in 
CAPD patients* sera and normal sera, as also found by 
Keane e_t aj_ (1984), a sign ificant diff erence between the Tf 
levels was found. De pre ssed Tf levels have been reported in 
patients with chronic renal failure (Mllman ej^ a 1,1984) and 
is a common feature of inflammatory disease (Bothwell 
et aj_, 1979). Protei n deple tio n has been suggested as an 
a lt er native  expl a n a t i o n  for low Tf levels (Bothwell e_t a 1 , 
1979), but no di fference was seen in serum IgG or C3 levels 
betw een  CAPD patients and normal controls which might have 
been expect ed if protein deple tion were involved.
It is well esta bl ished  that t ra ns ferrin  provides an 
important antimicrobial defence mechan ism by rendering iron 
u na va ilable  to m i cr oo rganism s i_n vivo (Brock, 1986). The 
finding of a si gni ficant inverse c o r r ela ti on bet wee n the 
growth of S.epidermidi s in PDE and the level of Tf, which 
was not found with normal sera or peritoneal fluid, and 
the di ff er ence in growth rates in PDE and controls suggests 
that the Tf levels are not optimal in PDE. This is further 
su pported by the finding that in PDE the degree of 
d epres si on  of growth on ad dit io n of extra Tf correlated 
inversely with the level of Tf in the PDE. No such effect 
was seen in normal peritoneal fluid or sera, in which Tf 
levels were much higher. It must also be rem embered  that 
al thoug h PDE did allow growth of epidermidi s , it was 
still con si de ra bly less than that observed in the RPMl 
control. Hence, a l t ho ug h PDE was s i gnif ic antly less
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b a c t e r i o s t a t i c  than control peritoneal fluid or sera, it 
was by no means an ideal culture mediu m for bacteria.
Also, even when extra Tf was added to control sera, some 
growth of S .epi de rmldi s still occured, wh ic h suggests that 
other factors (possibly nutritional or immunological) in 
ad ditio n to inadequate Tf levels may det er mine the 
b a c t e r i o s t a t i c  act iv ity of PDE.
A l t h o u g h  no c orrela ti on was found betw een 
b a c t e r i o s t a t i c  acti vi ty of individual PDE samples and 
s u s c e p ti bi li ty to peritonitis, the greater growth of 
bacteri a in PDE in comp ar ison with sera or normal 
peritoneal fluid may in part be resp onsib le  for the 
p r e d i s p o s i t i o n  to peritonitis. It has been sugge sted that 
the entry of iron into PDE as a result of haem olysis would 
further reduce the antimicrobial ac tivity of PDE 
(Bloodworth and Harber, 1986).
Levels of IgG and C3 in PDE were found to correlate
with opsoni c activity, in agree men t with the findings of 
Lamperi and Carozzi (1986b), Steen e t a 1 (1986), and
Ve rbr ug h ej^ a 1 , (1983). No such corr e l a t i o n  was found in
normal peritoneal fluid which suggests that the level of 
opson ins  are sub-optimal in PDE. The a b i li ty of PDE to 
e ff i c i e n t l y  opsonise S.e pi derml dis is believe d to depend
prim ari ly on the ant ib ody or heat stable com pone nt s of PDE
rather than the comp lement or heat labile ones. This was 
shown by Keane and Pet er son (1984) when they opsonised 
bacteria . i: with d e c o m p lem en ted NHS (heat
inactivated) and showed that phagocytosis of S.epi de rm ldis 
was still efficient. However when the op son ic  source was 
IgG-deficient serum which contained normal levels of
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complement, pha go cytosis  of S . epiderm id is by peritoneal 
macroph ag es was rela ti vely inefficient. Escher ichla c o 1i 
and S .a u r e u s , on the other hand, require to be opsonis ed by 
h eat -labile  components, i.e. complement, for effective 
pha gocyt os is  (Keane and Peter s o n , 1984 ; Pe te rs on ej^
sQ_, 1977). Wi thout complement, p h a g o cytosi s of these 
org anisms was found to be minimal. These reports also show 
that phagoc yt os is of S.epi derm 1 dis proceeds p r e d o mi na ntly 
through an Fc receptor mechanism, while that of E_^ co 1 1 and 
S . aureus occurs p r e d o min an tly via C3b receptors. In the 
present work the opson is ing activi ty of PDE was also found 
to be less than that of normal peritoneal fluid, showing 
that the levels of opsonins are indeed suboptimal in PDE. 
This may sev ere ly inhibit optimal ph ag ocytic a c t ivity  as it 
is well known that opsonins are required for efficient 
ingestion of micro -o r g a n i s m s  by phagocy tes (Johnston and 
S t r o u d , 1977; S t o s s e 1,1974 ; W i n k e l s t e i n , 1973).
An additional effect of a quantitati ve  defi ciency of 
comple men t could be possible interferen ce with the
rec rui tment of cells into the peritoneu m in the immune
response, due to lack of c h e m o a t tractants C3a and C5a.
Inadequate antibod y levels may produce the same effects, as 
in a g a m m a g 1o b u 1inaemia depres sed produc tion of che motac ti c 
ac ti vi ty was noted by Steerman ej^ a 1, (1971) due pos sibly  to 
insuffi cie nt i m m u n e - c o m p 1 exes being formed to st imulate C3a 
and C5a pro d u c t i o n  by the classical pat hway of complement 
act ivation.
Recent work by Verbrug h e_^ aj_ (1906), suggests that
complement, even when present, may not be functional ly
active. Inactivation of complement by CAPD solution s was
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de m o n st ra ted to be largely due to the low pH of these 
solutions. This may mean that al th ough co mp lement was 
de tec ted here in the PDE of patients it may be fun ctionally 
Inactive. Hence it is possible that both q u a l i tative  and 
q u a n t it ative defects may exist which may severely hamper 
the defences of the peritoneum.
When op sonic activit y of PDE samples were compared 
with the fr equency of episodes of peritoni tis a significant 
inverse corr e l a t i o n  was found, in a g r ee ment with the 
findings of Lamperi and Carozzi (1986b) and Steen ejt aj_ 
(1986). This finding may allow pos sible early
identifi ca tion of patients at high risk. Such a corre la tion 
was not seen be tw een the levels of IgG or C3 and
peritonitis des pite the fact that the c o n c e n t r a t i o n  of
these prot eins corre lated with opsonic activity. Here the
specifici ty  of the IgG for S_^ _ epidermidi s , rather than just 
the level of IgG, may be important. Also, as far as
S.epider mi dis is concerned, complement is not thought to be 
as important as IgG in its opso n i s a t i o n  (Keane and 
P e t e r s o n , 1984). In any case, the causes of pe ritoniti s are 
un d o ubtedl y multifactorial, and the inability to obtain a 
significant c or re lation  between  periton itis rates and any 
single parameter is not unexpected. Inadequate fibronec tin 
secretion by CAPD peritoneal macr ophages has, for instance, 
been suggested by Pol in and Douglas (1984), to play a part 
in the increased peri ton itis rate seen in some CAPD 
patients. This may be related to the ab ilit y of fibronectin 
to act as an opsonin, thereby enh ancing the att ach me nt and 
phagocyto si s of mic ro-organisms. The ad di ti on of purified 
IgG to PDE has been proposed as a method of enh an ci ng the
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host's immune defences against p e r i t onitis (Keane and 
P e t e r s o n , 1984) and there is some clinical evidence in 
favour of this (Lamperi and Carozzi,1986b). In conclusion, 
it there fore appears that the normal humoral defence 
mech an is ms of the p er it oneum are weakened in patients on 
CAPD when compared with those of normal controls, and this 




A LONGITUDINAL STUDY OF PERITONEAL DEFENCE MECHANISMS OF
PATIENTS ON CAPD
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W .  INTRODUCTION
All the work presented in this thesis up to 
this point has been related to CAPD patien ts as a whole, 
and the results obtaine d compared direc tl y with samples 
obtained from normal controls. On no occas io n was any 
systematic  attemp t made to examine what changes in 
peritoneal immunity may occur the first few months on CAPD.
This area has also been neg lected by other workers as 
there appears to be no data currently av a i l a b l e  giving a 
complete overvi ew of changes that may occur in the first 
few months to the peritoneal defences of patient s on CAPD. 
Young e_t aj_ (1986) did examine changes in prot ein  levels in 
CAPD patients* plasma as dialysis proceeded (but not in 
the PDE itself) and found a decrease in plasma IgG during 
the early months on CAPD. However, this gives no
indication as to the situation in the perito ne um over the 
same initial period. Steen e_t a_i_ (1986), on the other hand, 
did examine IgG and C3 levels and the opso nising capacity 
of PDE and found no corr el ation  with time on CAPD. However, 
their study was not performe d with new patients followed 
through for a period of time, but with a rando m selection 
of patients who had been on CAPD for times varying bet ween 
1 and 37 months. No emphasis was therefore placed on 
examining the pos sibly important changes during  the initial 
few months. In view of this, and in order to provide more 
information about the immune status of these uraemic 
patients this chapter reports the results of a study on 16 
patients who were monitore d for a 9 month period from the
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day of c ommen ce ment of peritoneal dialysis. During this 
time p e r io di c samples of PDE were analysed for levels and
ac ti vi ty of IgG, C3 and Tf, and for the number and 
antimicrobial activit y of the peritoneal cells.
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6.2 MATERIALS AND METHODS
All the mate rials and methods used in this 
chapter have been desc ribed  previously. The levels of IgG, 
C3 and Tf in the PDE were measure d as in 5.3.4. The 
pe rc en tage o pso ni sing ac ti vi ty and pe r c e n t a g e  growth of 
S.e pi de rmidis  in the PDE were measured as in sections 5.3.1 
a n d '5 .3.2 respectively. Finally the bactericidal activity 
of the peritoneal cells from the PDE was assa yed by the 
technique whose develo pment was described in chapter 3.
fixi PATIENT DETAILS
Sixteen patients commenci ng  CAPD were 
m o n i to re d for up to 9 months. Details of these patients 
are shown in Table 27.
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T A B L E  2 7 D e t a i l s  o f  P a t i e n t s  w h o s e  C e  1 1 s  a n d  S e r u m
Pr otein L e v e 1s and Act ivities in PDE were Mon it ored i n ^  







N UMB ER OF RE ASON FOR 
MONTHS ON ABA NDO NI NG 
STUDY CAPD
*C. Ba Ma I e 39 G l o m e r u l onep hr itis 9 N.A.+
A. B 1 Ma 1 e 70 G l o m e r u lonep hr itis 6 Died
W. Co Ma 1 e 32 Hyper tens i on 9 N. A.
J . Ha F e m a 1e 53 P o l y cy st ic Kidneys 9 N. A.
R . Ha Ma 1 e 75 Hyper tens i on 4 Moved to Edinbu rg h
C. He F e m a 1e 47 Diabe ti c Neph ro pathy 1 Catheter removed
R. Ho F e m a 1e 69 Renal ar ter y thrombosis 1 Died
R.Lo Ma 1 e 46 P y e 1onephr itis 9 N. A.
H. McC F e m a 1e 21 Reflux Nephro pathy 9 N.A.
W. Me I Ma 1 e 56 Hy p e r te nsion 6 Died
A . McL Ma I e 51 G l o m e r u l on ep hritis 6 Catheter removed
S. McL F e m a 1e 48 Hyper tens i on 9 N. A.
J . McN Ma 1 e 54 Diabet ic  Nep hr opath y 1 Trans p 1 anted
J . Ra Ma 1 e 74 G l o m erulo ne ph ritis 2 Catheter removed
M.Wh F e m a 1e 60 Hyper tens ion 4 Died
J . Sh Ma I e 46 G 1 ornerulonephr iti s 1 T r a n s p 1 anted
* all patients were on the Travenol Disc o n n e c t  System 
+ N.A. = not app li cabl e
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Altho ug h it was originally intended to monitor 
all 16 patients for 9 months, only 6 of these remained
c o n t i nuou sl y on CAPD for the duratio n of the study. The 
other patients ceased CAPD for a number of reasons (Table 
27). It was therefore not thought a p p r o p r i a t e  to look at 
the individual results from each patient but instead to 
examine the overall differences bet ween PDE samples
obtained on day 1 and at 2 , 4 , 6 , and 9 months, on CAPD.
6.4.1. IgG and C3 Levels
When IgG and C3 levels in the PDE of CAPD patients
were measu re d over the 9 months on dialys is their 
co nc e n t r a t i o n  was found to s ignif ic antly d e c rease with time 
on CAPD (Figure 34a and 34b; p<0.05). The drop in the
co nc e n t r a t i o n  of these proteins was p a r t i c u l a r l y  no ticeable 
up to 4 months on dialysis after which time they appeared 
to level out. Tf levels also showed a tendency to decrease 
from the starting level but this was not signific ant 
(Figure 3 4 c ).
6.4.2. Qp sonic Act 1v 1ty
Since it has alre ady been shown that o p soni c activit y 
is directly  related to the levels of IgG and C3 (5.4.2) a 
c o rres po nd ing dec rea se in the opsonic a c t i v i t y  would be 
expected and this was indeed found (Figure 34d; p<0.02).
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6.4.3. Bacter iostatic Act 1v i ty
The b a c t e r i o s t a t i c  act iv it y of the PDE, as measured by 
the growth of S.ep id ermidis  in the fluid, was shown to 
increase si gn i f i c a n t l y  with time on CAPD (Figure 3 4 e ; 
p<0.05). The increase in growth was p a r t i c u l a r l y  large over 
the first 6 months on CAPD and, like the IgG and C3 graphs, 
tended to level off thereafter. It also c o r r e sponde d with 
the tendency of Tf levels to fall (Figure 34c).
6.4.4. Total Ce 1 1 Numbers 1n PDE
The total number of cells isolated from the PDE of 
CAPD patients over 9 months decreased signi f i c a n t l y  (Figure 
3 4 f ; p<0.05). This reduction was greatest in the first 4
months after whic h the cell numbers tended to stabilise.
6.4.5. A nt im icrob i a 1 Act ivity of the Pe r itoneaI Ce 11s
The ab il it y of the CAPD peritoneal cells from these 
CAPD patients to ingest S . e p i d e r m ! dis did not decrease 
s i g n i fica nt ly with time on CAPD (Figure 34g). However a 
small but signific ant decrease in intra cellular killing 
ability was ob serve d over the same 9 month period (Figure 
34h; p<0.01).
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F I GURE 34 Change With Time on CAPD of :
L e v e 1 s o f -
(#) IgG in PDE 
(b) C3 in PDE 
< c )  T ra n s f e r r i n  in PDE 
(d) Opso ni sing Cap ac ity of PDE 
(•) B a c t e r i o s t a t i c  Activity of PDE 
( f ) Number of cel Is in PDE 
<|) Ingestion of S. epidermidis  
(h) Intracellular killing of S . ep id ermidis  
(Figures are on Pages 187-190)
# shows individual results from patients 
o shows the mean


















Time on CAPD (Months)
% Opsonic Activity
( d )
Qpson i c Activity: 
P e r c e n t a g e  of
S . e p i d e r m i d i s  ingested
when o p s onised  with PDE 
r ela tive to ingestion or 









Time on CAPO (Months)
188
(#)
G r o w t h  Index = growth of 
S.epi d e r m l d 1s as a
p e r c e n t a g e  of growth in 





Time on CAPO (Months)
N0.0I cells xIO'




Î  4 6
Time on CAPO (Months)
189
(g)












Time on CAPO (Months)
1 9 0
gJJ.£V6fJ M
The decrease in the levels of IgG and C3 in 
PDE and the c o rre sp onding decrease in related opsonic 
a c t iv it y with length of time on CAPD suggests that the CAPD 
process reduces the immunity of the peritoneal cavity in 
patients that are believed to be alr eady Imm un osupp re ssed 
by the u r a emic state (Mezzano e ^  aj_^1984; F u nck-B re ntano 
et aj_, 1975; Touraine ej^ a 1 , 1975 ) . Reduct io n in the opsonic 
cap aci ty of PDE will hinder the defences of the pe ri toneum 
in particu lar that of e li mi natio n of pat hogens by 
phagocytes. Changes in the perm eabil ity of the peritoneal 
membrane, dis cussed pre viously in Chapter 5, may be 
r esp onsible  for the tenden cy for the levels of 1gG and C3 
in patients' PDE to level off after 4-6 months on CAPD. By 
this stage the peritoneal membrane may be alt ere d by the 
CAPD process so that its pe rm eabil ity becomes the major 
factor in dete rm in ing the quant 1ty of serum proteins that 
gain entry (Krediet e ^  1986; Dulaney and Hatch, 1984).
The decr easing  bac ter io static  activit y of PDE with 
time on CAPD  adds further emphasis to the finding in 
Chapter 5 that CAPD fluid was si g n i f i c a n t l y  less 
b a c t e r i o s t a t i c  than normal peritoneal fluid. The tendency 
for Tf levels to decrease also implies that the growth of 
b ac te ria in the fluid may depend, at least \ o  some extent, 
on Tf levels. However, the decrease in Tf levels did not 
reach statistical significance, pos sibly  beca use Tf, being 
a smaller molecul e than IgG or C3, may be less affected by 
any decreas e in p e rme ab il ity of the peritoneal membrane.
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When the act iv ity of the cells was exa mi ned over the 9 
month period, no s ignifi ca nt change was found in their
abil ity  to ingest S . e p i d e r m i d i s . In contrast, there was a 
sig nific an t decrease in intracellular killing of 
S .epldermi d i s over the same time period. These , findings 
are su pported by the previous evidence in Chapter 4
showing that peritoneal cells from patients on CAPD had a 
s ig ni f i c a n t l y  lower intracellular killing capacit y than 
those from normal controls, whereas there was no diffe rence 
in their ability to ingest S . e p i d e r m i d i s . it therefore 
appears that not only is the activi ty of the peritoneal
cells reduced in CAPD patients, but the total number of
cells isolated over the 9 months from the PDE signific an tly 
declines. This aga in agrees with the finding in Chapter 2 
of a c o r r el ation  between the number of cells isolated from 
different CAPD patien ts and the length of time they had 
been on CAPD (2.5.4) and may also be due to thickening of 
the peritoneal membrane.
Overall it seems that after the initial few months 
when the conce n t r a t i o n  and activity of the serum proteins 
in the PDE level off, no c or relati on  would be found between 
the levels of these proteins and length of time on CAPD.
The failure by Steen ej^ a_l_ (1986), to find a signif icant
correlation, after 9 months, between pr ote in  levels in PDE 
and time on CAPD is thus in agreeme nt with the results 
reported here.
It was orig in ally intended that the parameters 
examined above should be related to the incidence of 
perito nit is in each patient. However due to the low
fre quency of perit oni tis in the patients examin ed  here, and
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the fact that only 6 patients were mo nitored for the full 9 
months, it was not possible to relate the above findings to 
s u s c e pt ibilit y to infection.
The gradual decrease in the immune defenc es of the 
per it on eum shown here in the initial few months after 
co mme nc em ent of dialysis may mean that patient s are less 
able to protect the perito ne um from infections after 6-9 
months than they were at the start of CAPD. The clinical 
implications of such a decrease are provided by the 
findings of Smith ejt aj_ (1986) and Young e_t aj_ (1986), both 
of whom found that the incidence of peri to nitis increased 
with time on CAPD, suggest ing  that a redu ct ion in cellular 
and serum proteins levels and activities does indeed have a 
detrimental effect on the overall peritoneal defences of 
patients on CAPD. However, in additio n to this Young ejt aj^ 
(1986) also found a c o rr es pondin g improvement in CM I during 
CAPD whi ch was ob viousl y not reflected by a reduction in 
the incidence of peritonitis. This suggests that CM 1 may 
th erefore be of little importance in the long term in 
pr otecting  the periton eu m from bacterial infection, which 
pro bab ly depends instead on humoral and phagocyti c 
mechanisms. It is pos sib le that a l t hou gh  initially CM 1 
responses to DNCB, for example, are indicative of the 
immune status of patients commencing CAPD  (Tsakiris 
et aJL, 1986) it may bear little relevence to patients 






Altho u g h  CAPD has been e x t e n s i v e l y  used since 
1978 little inform ation has been avai la ble regarding the 
immune status of the p eri to neum in these u r a e m i c  patients, 
and exact ly how the technique may affect its defences. In 
ad di ti on it must be remembere d that these patients are
al re ad y belie ved to be i m m u n o s u p p r e s s e d , so that any
further reduc tion in the immune defe nces of dialysis 
patients may have far reaching effects, wh ic h in normal 
individuals would not be significant.
The two most important arms of the defence system of 
the pe ri toneum  are the peritoneal cells and serum proteins 
and it was these factors that were examined in this thesis.
Overall a we ake ning of the defences of the pe ritoneum 
was found, probably as a consequenc e of the dialysis
regime. In particular the CAPD peritoneal cells were found 
to be def ec tive  in their ability to cope with int racellular 
killing of bacteria.
The immaturity of the cells, thought to be the cause 
of this reduced activity, may also affect the anti gen  
pr es enting function of macrophages, a s ug ge stion supported 
by the reduced e xpre ss ion of HLA-DR an tigen by peritoneal 
macrophag es and this may hamper initiation of specific 
immune responses. Another factor related to the activity 
of these peritoneal cells was their cap ac ity to release 
which again was found to be deficient in patients on 
CAPD. The ac ti vity of these peritoneal cells therefore
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appears to be sub-normal in several different ways, each of 
which could affect the immune status of these patients. 
However, the studies of H^O^ p r o d uc ti on and HLA-DR 
e xp re ssion sugge sted that patients com men ci ng CAPD may have
an initial in fla mma tory reaction perhaps due to the
im pla ntation  of the catheter which causes a temporary
increase in m ac rophage  activity.
The reduced levels of IgG, C3 and related opsonic 
ac tiv it y in the PDE will further decrease the efficiency  of 
the peritoneal phag oc ytic cells as op son i s a t i o n  is
essential for ef fec tive el im ination of most pathogens. The 
similar red uctio n in Tf levels and in the correspo nd ing 
b a c t e r i o s t a t i c  effect may impair the restr ic tion of growth 
of bac te ria in the periton eum on initial infection,
therefore allowi ng inadequate time for the cellular 
defence s to be activated. The thickening of the peritoneal 
membrane which may be resp onsible for the reducti on  in the 
levels of the above proteins is probably  an inevitable 
consequen ce  of instilling 2 litres of an unphysiolo gical 
electroly te  soluti on c ontinu ou sly into an e n v i ronm en t which 
normally contains very little fluid.
When the activ it ies and levels of the cells and
proteins in PDE were related to the frequency of
peritonitis a significant  correlation  was not found in 
every case, in spite of finding that most individual
parameters indicated reduced ac tivity compa re d with normal 
controls. This, however, may be due to the fact that the 
suscep t i b i l i t y  to peritonitis of patients on CAPD is not 
related solely to a def ici en cy in one arm of the immune 
response, but is multifactorial. Individually, therefore,
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a par ti cu lar defect may have no effect on the overall 
p er it onitis rate, but co llectively they could be clinically 
signifleant.
Since CAP D was first introduced there have been vast 
imp rovements in reducing the possible  sources of 
co ntam i n a t i o n  when using the technique. Within the last 
three years, the intro duction of the Travenol ”0" 
Dis co nn ect system in the Western Infirmary has greatly 
reduced the incidence of per itonitis (J.D. Briggs personal 
communication). More recently still, the Travenol "Y" set 
has been brou ght out which may reduce even further the 
likelihood of infection. The prevention of infection in 
the first place by good sterile technique is ob viously of 
prime importance in co nt rolling the peri ton itis rate. All 
these improvements are essential as it is important to 
reduce the chances of exposi ng these patients with 
suboptimal defenc es to pathogens which to normal 
individuals would present no risk. In any one individual 
therefore, the two factors of sterile technique and 
peritoneal immune defences will determine the infection 
rate.
Many areas of research in this field still need to be 
examined, including the actual antigen pres entin g function 
of the peritoneal macrophages. Me as u r e m e n t  of the
ex press io n of HL A-DR on patients' blood monocy te s may 
dete rmi ne whether they are analogous to the peritoneal 
cells or normal blood monocytes. It would also be of 
Interest to mea sure levels of specific an ti bodie s to 
certain bac te ria as well as total IgG levels, as this might 
be more clos ely related to the perito nitis rate. In
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ad ditio n serum levels of specific antibodie s may provide 
more in formati on as to the immune co mpetence of patients. 
The levels of these specific antibodies might correspon d 
more closely to levels in PDE than was found when total IgG
levels were examined. Levels of IgA in PDE could also be
w h i c h
me asu red as serum IgA, unlike secretory I gA can act as an
\
op sonin  (M. Kerr personal communication) and may also be
relevant to the defences of the peritoneum.
Al th ou gh the resuits reported in this thesis may have
no immediate clinical implications they have given a more
det ai led picture of the immune defences within the
p e r i to ne um of CAPD patients than was pr eviously available. 
Pos si ble direct improvements in the future might Involve 
the ad ditio n of human Tf to the dialysate. Ad ditio n of 
IgG has al ready been found by Lamperi and Carozzi (1986b) 
to have beneficial effects. It is also possible that
leaving the per i t o n e u m  empty overnight may give time for 
the p e r i to neum membrane  to recover and allow it to "rest".
Al t h o u g h  rigid adherence  to strict aseptic technique 
is essential in pre ven ti ng peritonitis, other factors play 
a part such as those relating to the reliability of 
connec tor s and lines, and other less well defined factors 
such as the q u a li ty  of patient training, medical and
nu rsing c o m p etence and experience. As mentioned before, 
the i n t r o ducti on  of the disconnect system has greatly
reduced the f r e q uenc y of peritonitis but even this has not 
totally era d i c a t e d  the incidence of peritonitis. The risk 
of deve lo ping pe ritonitis therefore rests on a delicate 
balance be tw ee n co lon i s a t i o n  of micro- organis ms  within the 
CAPD system, the dose of bacteria invading the peritoneal
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cavity and the local peritoneal host defence mechanisms at 
the time of the insult. Improvements in catheter ' design, 
esp ec ia lly the use of material resistant to col onisation 
could be particular ly important ' in controlling 
S . ep id ermidis infections. Stimulation of local host
defence, po ssibl y through the introduction of a vaccine
I
might further reduce the incidence of perit oniti s to more 
acc ep ta ble levels. Total era dication of peritoniti s may
not be a re alistic  goal and should not be a condition for
cont inu ed use of CAPD.
Another major problem of CAPD which must be faced is 
the possible loss of ultr af iltrati on  capacity and
d ev el opm ent of sclerosing encapsulating peritonitis, both 
of which are worrying complications of long term use of 
CAPD. The technique has only been e xt en sively used for
about 10 years, and it is not yet known what the long term
effects of such a regime might be. Glucose, which is used
in the dialysis fluid as an osmotic agent is not ideal as 
it is believed to cause loss of ultrafiltration,
hyper 1ipidaemia and obesity in addition to a possible
de let erious effect on the membrane. A suitable alternative 
has not yet been found.
In spite of these problems it must be remembered that 
CAPD has vastl y increased the avai labilit y of dialysis to 
groups whi ch oth erwise might not have been given the
opportunity; it has overcome the shortage of h a e m o d i a 1 y sis 
machines and offers a patient a more flexible approach  to 
dialysis. But the results presented in this thesis
empha sis e the need for clinicians to consider the
pe rit oneum of the CAPD patients as an immunocompromised site,
1 9 8 b
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